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The	   improvement	   in	   the	   quality	   of	   life	   (QOL)	   and	   consequent	   increase	   of	   life	   expectancy	   are	  
accompanied	  by	  the	  expanding	  demand	  for	  the	  repair	  of	  damaged	  organs	  and	  tissues.	   	   Bone	  tissue	  
regeneration	   remains	   an	   important	   challenge	   in	   the	   field	   of	   orthopedic,	   maxillofacial,	   and	   dental	  
surgery.	   	   Synthetic	   hydroxyapatite	   (HAp),	   β-­‐tricalcium	   phosphate	   (β-­‐TCP),	   and	   α-­‐tricalcium	  
phosphate	   (α-­‐TCP)	   are	   key	   materials	   for	   bone	   graft	   due	   to	   their	   potential	   biocompatibility	   and	  
osteoconductivity.	   	   Among	   synthetic	   calcium-­‐phosphate	   biomaterials,	   calcium-­‐phosphate	   cement	  
(CPC)	  has	  largely	  advantages,	  which	  can	  be	  easily	  shaped	  during	  operation	  or	  injected	  into	  cavities	  
using	  a	  syringe	  with	  minimal	  invasiveness.	  
The	   order	   in	   relative	   dissolution	   of	   the	   above	   materials	   is	   α-­‐TCP	   >	   β-­‐TCP	   >	   HAp.	   	   It	   is	  
hypothesized	   that	   CPCs	   with	   different	   biodegradability	   could	   be	   promising	   candidates	   for	  
“tailor-­‐made	   treatment”	   according	   to	   bone	  metabolism	   of	   patients.	   	   Therefore,	   the	   present	   study	  
aimed	   to	   fabricate	   novel	   CPCs	   with	   different	   biodegradability	   from	   various	   calcium-­‐phosphate	  
phases	  (HAp,	  β-­‐TCP	  and	  α-­‐TCP),	  which	  was	  set	  by	  chelate-­‐setting	  mechanism	  of	  inositol	  phosphate	  
(IP6).	   	   In	  addition,	  dissolution	  of	  resulting	  cements	   in	  vitro	  using	  Ca2+	   ion-­‐selective	  potentiometry	  
and	   biodegradability	   of	   resulting	   cements	   in	   vivo	   using	   rabbit	  models	  were	   also	   examined.	   	   This	  
thesis	  is	  consisted	  of	  6	  chapters,	  and	  findings	  from	  each	  chapter	  were	  concluded	  as	  below.	  
In	  Chapter	  1,	  general	  information	  of	  calcium	  phosphates,	  inositol	  phosphate,	  calcium-­‐phosphate	  
cements,	  and	  aim	  of	  the	  present	  study	  were	  described.	  
In	  Chapter	  2,	   it	  was	  described	  to	  investigate	  various	  types	  of	  powder	  preparation	  processes	  for	  
fabrication	   of	   chelate-­‐setting	   HAp	   (IP6-­‐HAp)	   cements	   with	   improved	   mechanical	   strength,	   and	  
handling	  and	  anti-­‐washout	  properties.	  
In	  section	  2.1,	  using	  wet	  chemical	  synthesized	  HAp,	  the	  effect	  of	  powder	  preparation	  process	  for	  
cement	  fabrication	  on	  the	  morphology,	  crystallinity,	  median	  particle	  size,	  and	  specific	  surface	  area	  of	  
the	  cement	  powders	  was	  examined	  for	  fabrication	  of	  the	  IP6-­‐HAp	  cement	  with	  enhanced	  mechanical	  
properties.	   	   It	  was	   found	   that	   the	  HAp	   powder	   obtained	   from	   ball-­‐milling	   of	   as-­‐synthesized	  HAp	  
powder	   under	   wet	   conditions	   and	   then	   freeze-­‐drying	   were	   effective	   for	   fabrication	   of	   IP6-­‐HAp	  
cement	  with	  enhance	  material	  properties.	  
In	   section	   2.2,	   a	   novel	   powder	   preparation	   process	   (hereafter,	   modified	   process)	   for	   cement	  
fabrication	   was	   established,	   whereas,	   previous	   report	   demonstrated	   preparation	   of	   the	   starting	  
cement	   powder	   for	   the	   cement	   fabrication	   by	   IP6	   surface	  modification	   after	   ball-­‐milling	   the	   HAp	  
powder	   (hereafter,	   conventional	   process).	   	   In	   the	   novel	   developed	  modified	   process,	   the	   starting	  
HAp	   powders	   were	   prepared	   by	   ball-­‐milling	   and	   simultaneously	   surface-­‐modifying	   the	  
commercially-­‐available	   HAp	   powders	   in	   the	   IP6	   solution.	   	   Afterward,	   the	   effect	   of	   the	   IP6	  
concentration	   on	   the	   material	   properties,	   such	   as	   compressive	   strength,	   setting	   time,	   handling	  
property	   (consistency),	   and	   anti-­‐washout	   property,	   of	   the	   IP6-­‐HAp	   cement	   was	   investigated,	   in	  
order	   to	   develop	   a	   paste-­‐like	   artificial	   bone	   with	   anti-­‐washout	   property.	   	   Thereby,	   the	   HAp	  
powders	   surface-­‐modified	  with	   5000	   to	   10000	   ppm	   IP6	   are	   effective	   for	   fabrication	   of	   paste-­‐like	  
IP6-­‐HAp	  cements	  with	  enhanced	  mechanical,	  handling,	  and	  anti-­‐washout	  properties.	  
Section	  2.3	  describes	  comparison	  of	  powder	  preparation	  process	  between	  the	  conventional	  and	  
modified	  processes	  using	  commercially-­‐available	  HAp	  powder.	   In	  addition,	   adsorption	  behavior	  of	  
IP6	  on	  the	  surface	  of	  HAp	  was	  investigated	  to	  clarify	  the	  chelating	  mechanism	  of	  IP6.	   	   The	  results	  
showed	  that	  the	  modified	  process	  is	  effective	  for	  preparation	  of	  highly-­‐dispersed	  fine	  HAp	  powders.	  
The	   main	   summary	   from	   the	   studies	   described	   in	   Chapter	   2	   was	   that	   highly-­‐dispersed	   HAp	  
powders	   can	   prepare	   via	   the	   modified	   process,	   which	   enable	   better	   compaction	   of	   the	   cement;	  
consequently,	  could	  fabricate	  the	  paste-­‐like	  IP6-­‐HAp	  cement	  with	  anti-­‐washout	  property.	  
Chapter	   3	   showed	   that	   improvements	   in	  mechanical,	   handling,	   anti-­‐washout	   properties	   of	   the	  
chelate-­‐setting	   β-­‐TCP	   (IP6-­‐β-­‐TCP)	   cements	   for	   clinical	   use.	   	   The	   β-­‐TCP	   is	   well	   known	   as	  
biodegradable	  bioceramics.	  
Section	  3.1	  investigated	  effect	  of	  addition	  of	  various	  polysaccharides	  into	  mixing	  solution	  on	  the	  
mechanical	  and	  handling	  properties	  of	  IP6-­‐β-­‐TCP	  cements.	   	   Use	  of	  mixing	  solutions	  containing	  the	  
additives	   resulted	   in	   improvement	   in	   the	   mechanical	   and	   handling	   properties	   of	   all	   the	   cements	  
compared	  with	  use	  of	  pure	  water	  without	  polysaccharide.	  
In	   section	   3.2,	   the	   novel	   powder	   preparation	   process,	   described	   in	   Chapter	   2,	   was	   applied	   to	  
fabrication	  of	  the	  IP6-­‐β-­‐TCP	  cement	  to	  investigate	  the	  effect	  of	  milling	  time	  and	  IP6	  concentration	  on	  
the	  material	  properties,	   in	  particular,	  anti-­‐washout	  property	  of	   the	  resulting	  cement.	   	   In	  addition,	  
biocompatibility	   and	   osteoconductivity	   of	   the	   IP6-­‐β-­‐TCP	  was	   evaluated	   in	   vitro	   and	   in	   vivo.	   	   The	  
IP6-­‐β-­‐TCP	   cement	   with	   anti-­‐washout	   property	   was	   successfully	   fabricated	   by	   mixing	   the	   β-­‐TCP	  
powder	   ball-­‐milled	   in	   3000	   ppm	   IP6	   solution	   for	   3	   h	   and	   2.5	   mass%	   Na2HPO4	   solution,	   and	  
compressive	  strength	  of	  the	  cement	  was	  13.4±0.8	  MPa.	  
Chapter	   3	   summarized	   that	   the	   β-­‐TCP	   powder	   prepared	   by	  modified	   process	  was	   effective	   for	  
fabrication	   of	   anti-­‐washout	   type	   IP6-­‐β-­‐TCP	   cement	   with	   both	   biodegradability	   and	  
osteoconductivity.	  
In	  Chapter	  4,	  the	  chelate-­‐setting	  α-­‐TCP	  (IP6-­‐α-­‐TCP)	  cement	  based	  on	  chelating	  mechanism	  of	  IP6	  
was	  fabricated	  using	  more	  soluble	  α-­‐TCP	  powder	  compared	  with	  β-­‐TCP	  powder.	   	   The	  single-­‐phase	  
α-­‐TCP	  powder	  for	  cement	  fabrication	  was	  obtained	  by	  ball-­‐milling	  α-­‐TCP	  in	  water	  for	  120	  min.	   	   The	  
resulting	   cement	   was	   composed	   of	   mainly	   single-­‐phase	   α-­‐TCP,	   and	   was	   biocompatible	   and	  
biodegradable	  in	  vivo.	  
In	   Chapter	   5,	   comparative	   study	   on	   biocompatibility	   and	   biodegradability	   of	   the	   various	  
chelate-­‐setting	   cements	   (IP6-­‐HAp,	   IP6-­‐β-­‐TCP	   and	   IP6-­‐α-­‐TCP)	   and	   commercially-­‐available	   cement	  
(Biopex®-­‐R)	  were	   carried	  out	   in	   vivo	   using	   rabbit	  models,	   in	   addition	   to	   their	  dissolution	  of	   these	  
cements	  in	  vitro.	   	   Resorption	  rate	  for	  Biopex®-­‐R,	  IP6-­‐HAp,	  IP6-­‐β-­‐TCP,	  and	  IP6-­‐α-­‐TCP	  cements	  after	  
24	  weeks	  implantation	  were	  of	  7.2,	  5.0,	  13.7,	  and	  16.2%,	  respectively,	  compared	  to	  original	  cements,	  
which	   suggest	   that	   three	   types	   of	   chelate-­‐setting	   cements	   with	   different	   biodegradability	   are	  
promising	  candidates	  for	  a	  “tailor-­‐made	  treatment”	  as	  the	  novel	  CPCs.	  
In	  Chapter	  6,	   the	  findings	  from	  the	  present	  thesis	  were	  concluded,	  and	  future	  developments	  on	  
the	  present	  study	  were	  remarked.	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Chapter	  1.	   Introduction	  
	  
	  
1.1	  Calcium	  phosphates	  
	  
Calcium	   and	   phosphorus	   are	   widely	   distributed	   elements	   on	   our	   planet.	   	   The	   surface	   of	   the	  
Earth	  contains	  about	  3.4	  mass%	  of	   calcium	  and	  0.10	  mass%	  of	  phosphorus	   [1].	   	   Combinations	  of	  
oxides	   of	   these	   two	   elements	   with	   or	   without	   incorporation	   of	   water	   give	   different	   calcium	  
phosphates.	   	   Most	   calcium	   phosphates	   are	   only	   sparingly	   soluble	   in	   water,	   and	   some	   can	   be	  
considered	  to	  be	  insoluble,	  but	  all	  dissolve	  in	  acids.	   	   Calcium	  phosphates	  are	  the	  major	  component	  
of	   all	   human	   calcified	   tissues,	   and	   natural	   calcium	   orthophosphates	   are	   the	   source	   for	  
phosphorus-­‐containing	  fertilizers	  [2-­‐4].	  
Geologically,	   natural	   calcium	   phosphates	   are	   found	   in	   different	   regions	   mostly	   as	   deposits	   of	  
apatite	  (belong	  to	  igneous	  rocks),	  mainly	  as	  natural	  fluorapatite	  (Ca10(PO4)6F2)	  or	  phosphorites	  [3-­‐6].	   	  
Natural	   calcium	  phosphates	  occur	   in	  most	   geological	   environments,	   usually	   as	   accessory	  minerals	  
(<5%).	   	   Concentrations	  sufficient	   for	  economic	  use	  (>15%)	  are	  also	  available.	   	   The	   largest	  world	  
deposits	  of	  natural	  apatites	  are	  located	  in	  Russia,	  Brazil	  and	  Zambia,	  while	  the	  largest	  world	  deposits	  
of	  natural	  phosphorites	  are	  located	  in	  Morocco,	  Russia,	  Kazakhstan,	  USA,	  China	  and	  Australia,	  as	  well	  
as	  in	  the	  oceans	  [2-­‐6].	   	   Most	  of	  natural	  calcium	  phosphates	  occur	  as	  small	  polycrystalline	  structures	  
(spherulitic	   clusters)	   and	   larger	   crystals	   are	   rare	   [7].	   	   They	   usually	   have	   the	   crystal	   structure	   of	  
apatites	  (hexagonal	  system,	  space	  group	  P63/m).	  
None	   of	   them	   are	   pure	   compounds;	   they	   always	   contain	   admixtures	   of	   other	   elements.	   	   For	  
example,	   ions	   of	   calcium	   might	   be	   partially	   replaced	   by	   Sr,	   Ba,	   Mg,	   Mn,	   K,	   Na,	   and	   Fe;	   ions	   of	  
phosphate	  may	  be	  partly	  replaced	  by	  AsO43-­‐,	  CO32-­‐	  and	  VO4	  [1];	  ions	  of	  hydroxide,	  chloride,	  bromide,	  
carbonate	  and	  oxide	  may,	  to	  a	  certain	  extent,	  substitute	  for	  fluoride	  in	  the	  crystal	   lattice	  of	  natural	  
apatites	  [8].	  
In	  biological	  systems,	  many	  organisms,	  ranging	  from	  bacteria	  and	  isolated	  cells	  to	  invertebrates	  
and	  vertebrates,	  synthesize	  calcium	  phosphates	  [9].	   	   Formation	  of	  calcium	  phosphates	  in	  primitive	  
organisms	   is	   believed	   to	   enable	   the	   storage	   and	   regulation	  of	   essential	   elements,	   such	   as	   calcium,	  
phosphorus	   and,	   possibly,	   magnesium.	   	   The	   morphology	   of	   precipitates	   in	   these	   organisms	  
complies	  with	  the	  necessity	  for	  rapid	  mobilization	  and	  intracellular	  control	  of	  the	  concentration	  of	  
these	   elements	   [10].	   	   In	   vertebrates,	   calcium	   phosphates	   occur	   as	   the	   principal	   inorganic	  
constituent	   of	   normal	   (bones,	   teeth,	   fish	   enameloid,	   deer	   antlers,	   and	   some	   species	   of	   shells)	   and	  
pathological	   (dental	   and	   urinary	   calculus	   and	   stones,	   atherosclerotic	   lesions,	   etc.)	   calcifications	  
[11-­‐17].	   	   Except	  for	  small	  portions	  of	  the	  inner	  ear,	  all	  hard	  tissue	  of	  the	  human	  body	  is	  formed	  of	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calcium	   orthophosphates.	   	   Structurally,	   they	   occur	   mainly	   in	   the	   form	   of	   poorly-­‐crystalline,	  
non-­‐stoichiometric,	   calcium-­‐deficient,	   Na-­‐,	   Mg-­‐	   and	   carbonate-­‐containing	   hydroxyapatite	   (often	  
called	  “biological	  apatite”	  [18-­‐22]).	   	   The	  main	  components	  of	  human	  bones	  are	  calcium	  phosphates	  
(~60–70	  mass%),	  collagen	  (~20–30	  mass%)	  and	  water	  (up	  to	  10	  mass%)	  [23-­‐28].	  
Calcium	  phosphates	  have	  been	  studied	  as	  bone	  repair	  materials	  for	  the	  last	  80	  years.	   	   The	  first	  
in	   vivo	   use	   of	   calcium	   phosphates	   was	   performed	   in	   1920;	   that	   time	   the	   researchers	   implanted	  
tricalcium	   phosphate	   (TCP)	   into	   animals	   to	   test	   its	   efficacy	   as	   a	   bone	   substitute	   [29].	   	   In	   the	  
following	  years,	  some	  other	  calcium	  phosphates	  were	  tested	  on	  animals	  to	  investigate	  their	  effect	  on	  
the	  healing	  of	  nonunions	  [30].	   	   However,	  it	  was	  1951,	  when	  for	  the	  first	  time	  hydroxyapatite	  (HAp)	  
was	   implanted	   in	   rats	   and	   guinea	   pigs	   [31].	   	   Those	   attempts	   might	   be	   characterized	   as	   initial	  
medical	   trials	  with	   the	   first	   generation	   of	   bone	   substitute	   biomaterials.	   	   However,	   it	  was	   already	  
the	  1970s,	  when	  other	  calcium	  phosphates	  were	  synthesized,	  characterized,	  investigated,	  and	  tried	  
in	   medicine	   [32–37,11].	   	   The	   list	   of	   various	   calcium	   phosphates,	   including	   their	   standard	  
abbreviations	   and	   the	  major	  properties,	   is	   given	   in	  Table	  1-­‐1	   [38].	   	   The	   important	  parameters	  of	  
calcium	   phosphates	   are	   the	   Ca/P	   ratio,	   basicity/acidity,	   and	   solubility.	   	   All	   these	   parameters	  
strongly	   correlate	  with	   the	   solution	   pH.	   	   The	   lower	   the	   Ca/P	  molar	   ratio	   is,	   the	  more	   acidic	   and	  
water-­‐soluble	  the	  calcium	  phosphate	  is	  [11,39,40].	   	   One	  can	  see	  that	  the	  solubility	  ranges	  from	  high	  
values	   for	   acidic	   compounds,	   such	   as	   Monocalcium	   phosphate	   monohydrate	   (Ca(H2PO4)2·H2O;	  
MCPM),	   to	   very	   low	   values	   for	   basic	   compounds,	   such	   as	   hydroxyapatite	   and	   fluorapatite,	   which	  
allows	   calcium	   orthophosphates	   to	   be	   dissolved,	   transported	   from	   one	   place	   to	   another	   and	  
precipitated	  when	  necessary.	  
The	   present	   study	   mainly	   targets	   three	   calcium	   phosphates:	   hydroxyapatite(Ca10(PO4)6(OH)2;	  
HAp),	   β-­‐tricalcium	   phosphate	   (β-­‐Ca3(PO4)2;	   β-­‐TCP),	   and	   α-­‐tricalcium	   phosphate	   (α-­‐Ca3(PO4)2;	  
α-­‐TCP),	  and	  the	  following	  is	  therefore	  described	  about	  them.	   	   The	  HAp,	  β-­‐TCP	  and	  α-­‐TCP	  have	  been	  
used	   in	   several	   clinical	   applications	   in	   dentistry,	   maxillo-­‐facial	   surgery	   and	   orthopaedics,	   due	   to	  
biocompatibility	   and	   osteoconductibity.	   	   The	   HAp	   is	   applied	   clinically	   in	   the	   following	   forms:	  
granules,	   dense	   ceramics,	   and	   porous	   ceramics	   [41].	   	   In	   contrast,	   in	   spite	   of	   having	   the	   same	  
chemical	   composition,	   β-­‐	   and	   α-­‐TCP	   differ	   considerably	   in	   their	   structure,	   density	   and	   solubility,	  
which	   in	   turn	   determine	   their	   biological	   properties	   and	   clinical	   applications.	   	   The	   β-­‐TCP	   is	   used	  
mainly	   for	  preparing	  biodegradable	  bioceramics	   shaped	  as	  dense	   and	  macro-­‐porous	   granules	   and	  
blocks,	   whereas	   the	   more	   soluble	   and	   reactive	   α-­‐TCP	   is	   used	   mainly	   as	   a	   fine	   powder	   in	   the	  
preparation	  of	  calcium-­‐phosphate	  cements	  (see,	  section	  1.3).	  
The	  order	  of	  relative	  dissolution	  is	  α-­‐TCP	  >	  β-­‐TCP	  >	  HAp	  [42-­‐44].	   	   Since	  tricalcium	  phosphates	  
exhibit	  higher	  dissolution,	  many	  researchers	  expect	  that	   it	  could	  degrade	  upon	  implantation	  in	  the	  
host	  and	  could	  be	  gradually	  replaced	  by	  the	  newly	  formed	  regenerated	  bone.	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Hydroxyapatite	  (HAp)	  
The	   HAp	   can	   be	   synthesized	   by	   a	   variety	   of	   methods	   including	   conventional	   ones,	   such	   as	  
hydrothermal	   method	   [45,46],	   sol-­‐gel	   method	   [47,48],	   hydrolysis	   method	   [49,50],	   solid-­‐state	  
reaction	   [51,52],	   co-­‐precipitation	  method	   [53,54]	   and	   so	   on.	   	   Their	   typical	   reaction	   formulae	   are	  
shown	  in	  Eqs.	  (1)-­‐(4)	  [55]:	  
	  
10Ca(OH)2	  +	  6H3PO4	  →	  Ca10(PO4)6(OH)2	  +	  18H2O	   	   	   	   	   (1)	  
10Ca(NO3)2·4H2O	  +	  6(NH4)2HPO4	  →	  Ca10(PO4)6(OH)2	  +	  12NH4NO3	  +	  8HNO3	  +	  38H2O	   	   (2)	  
6CaHPO4·2H2O	  +	  4CaCO3	  →	  Ca10(PO4)6(OH)2	  +	  4CO2	  +	  14H2O	   	   	   	   (3)	  
10Ca(NO3)2·4H2O	  +	  6(CH3O)3P(O)	  →	  Ca10(PO4)6(OH)2	  +	  By-­‐products	   	   	   (4)	  
	  
β-­‐Tricalcium	  phosphate	  (β-­‐TCP)	  
A	  wet-­‐chemical	  process	  is	  the	  most	  common	  method	  for	  synthesis	  of	  β-­‐TCP,	  which	  results	  in	  the	  
formation	   of	   a	   CDHA	   [56-­‐58].	   	   Upon	   heating	   to	   700–800	   °C,	   the	   CDHA	   transforms	   to	   the	   low	  
temperature	  polymorph	  of	  β-­‐TCP	  with	  loss	  of	  water	  as	  described	  by	  following	  reaction	  (Eq.	  (5)):	  
	  
Ca9(HPO4)(PO4)5(OH)	  →	  3Ca3(PO4)2	  +	  H2O	   	   	   	   	   	   (5)	  
	  
Mechano-­‐chemical	   synthesis	   of	   β-­‐TCP	   is	   also	   known	   as	   an	   easy	   technique	   for	   controlling	   the	  
microstructure	  and	  its	  degradable	  characteristics	  [59,60].	  
The	  β-­‐TCP	  can	  also	  be	  obtained	  by	  the	  solid-­‐state	  reaction	  of	  calcium	  and	  phosphate	  precursors	  at	  
1100	  °C	  as	  follows	  (Eq.	  (6))	  [61-­‐63]:	  
	  
CaCO3	  +	  Ca2P2O7	  →	  Ca3(PO4)2	  +	  CO2	   	   	   	   	   	   (6)	  
	  
There	   are	   reports	   that	   β-­‐TCP	   can	   be	   obtained	   at	   a	   relatively	   low	   temperature	   (150°C)	   by	  
precipitation	   in	   organic	   medium,	   such	   as	   ethylene	   glycol	   [64,65].	   	   Moreover,	   Toyama	   et	   al.	  
synthesized	  β-­‐TCP	  from	  amorphous	  calcium	  phosphate	  by	  hydrothermal	  technique	  at	  220°C	  [66].	  
In	   addition,	   β-­‐TCP	   is	   stable	   at	   room	   temperature	   and	   transforms	   reconstructively	   [67,68]	   at	  
~1125°C	  to	  α-­‐TCP,	  which	  can	  be	  retained	  during	  cooling	  to	  room	  temperature	  [39].	  
	  
α-­‐Tricalcium	  phosphate	  (α-­‐TCP)	  
The	   synthesis	   of	   α-­‐TCP	   is	   accomplished	   by	   thermal	   transformation	   of	   a	   precursor	   with	  molar	  
ratio	  Ca/P≈1.5	  (CDHA,	  amorphous	  calcium	  phosphate	  (ACP),	  or	  β-­‐TCP)	  previously	  obtained	  [69-­‐75],	  
or	  by	  solid-­‐state	  reaction	  of	  a	  mixture	  of	  solid	  precursors	  at	  high	  temperatures	  [76-­‐82].	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Camiré	   et	   al.	   [71]	   employed	   a	   CDHA	   precursor	   obtained	   by	   precipitation	   from	   a	   solution	  
containing	  Ca(NO3)2	  and	  (NH4)2HPO4	  with	  molar	  ratio	  Ca/P=1.5,	  followed	  by	  thermal	  transformation	  
into	  α-­‐TCP	  by	  heating	  at	  1250°C	  for	  2	  h.	   	   Jokic	  et	  al.	  [72]	  also	  prepared	  α-­‐TCP	  powder	  by	  thermal	  
decomposition	   of	   CDHA	   (Ca/P=1.56)	   obtained	   by	   the	   hydrothermal	  method	   according	   to	   Eq.	   (2).	   	  
CDHA	   decomposed	   into	   β-­‐TCP	   at	   T>800°C	   and	   β-­‐TCP,	   in	   turn,	   started	   to	   transform	   into	   α-­‐TCP	   at	  
T>1200°C.	  
Thermal	  decomposition	  of	  CDHA	  into	  α-­‐TCP	  is	  represented	  in	  Eq.	  (7).	  
	  
Ca9(HPO4)(PO4)5(OH)	  →	  3α-­‐Ca3(PO4)2	  +	  nH2O	   (T>1150°C)	   	   	   (7)	  
	  
Solid-­‐state	   reaction	   between	   solid	   precursors	   is	   the	   preferred	   synthetic	   route	   in	   the	   literature	  
reports.	   	   The	  solid-­‐state	  reactions	  employed	  most	  are	  listed	  in	  Eqs.	  (8)	  [76-­‐79]	  and	  (9)	  [81,82]:	  
	  
CaCO3	  +	  2CaHPO4	  →	  α-­‐Ca3(PO4)2	  +	  CO2	  +	  H2O	   	   	   	   	   (8)	  
3CaCO3	  +	  2NH4H2PO4	  →	  α-­‐Ca3(PO4)2	  +	  3CO2	  +	  3H2O	  +	  2NH3	   	   	   	   (9)	  
	  
The	   synthesis	   is	   carried	   out	   according	   to	   the	   general	   rules	   for	   solid-­‐	   state	   reactions,	   i.e.	   solid	  
precursors	   are	   milled	   together	   to	   reduce	   particle	   size,	   increase	   the	   contact	   area	   and	   mix	   them	  
intimately.	  Wet	  milling	  is	  generally	  preferred.	  After	  milling,	  the	  mixture	  of	  powders	  may	  be	  directly	  
heated	   above	   the	   transformation	   temperature	   or	   previously	   pressed	   to	   improve	   contact	   between	  
particles.	  The	  recommended	  reaction	  temperatures	  varied	  between	  1250	  and	  1500°C,	  and	  the	  dwell	  
time	  was	  between	  2	  and	  48	  h.	   	   Most	  authors	  recommend	  quenching	  to	  avoid	  the	  reversion	  of	  the	  α-­‐	  




1.2	  Inositol	  phosphate	  
	  
Myo-­‐inositol	   1,2,3,4,5,6	   hexakisphosphate	   (IP6)	   (Fig.	   1-­‐1),	  well-­‐known	   as	   phytic	   acid,	  was	   first	  
identified	   in	  1855	   [85].	   	   Salts	   of	   phytic	   acid,	   designated	   as	  phytates	   are	  widely	  present	   in	  nature	  
(plants,	   animals	   and	   soils	   [86]),	   mainly	   as	   calcium,	   magnesium	   and	   potassium	   mixed	   salts	   [87].	   	  
The	  existence	  of	  this	  compound	  in	  seeds	  was	  first	  reported	  in	  1903	  [88]	  and	  it	   is	  now	  accepted	  as	  
being	  ubiquitous	  among	  plant	  seeds	  and	  grains,	   in	  the	  range	  of	  0.5–5%	  (w/w)	  [86].	   	   On	  the	  other	  
hand,	  although	  the	  first	  report	  that	  phytate	  is	  present	  in	  animal	  cells	  appeared	  in	  1941	  [89],	  it	  only	  
became	   clear	   in	   the	   late	   1980s	   and	   1990s	   that	   it	   is	   also	   always	   present	   in	   eukaryotic	   species	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(typically	  being	  the	  most	  abundant	  inositol	  phosphate	  in	  cells)	  [90].	   	   As	  a	  result	  of	  this	  widespread	  
occurrence	  in	  nature,	  its	  important	  biological	  activity	  and	  the	  high	  number	  of	  applications	  have	  been	  
demonstrated	   amply	   by	   the	   huge	   number	   of	   papers,	   reviews	   and	   books	   [85-­‐87,89-­‐96].	   	   New	  
functions,	   properties	   and	   applications	   of	   phytate	   are	   being	   regularly	   discovered	   and	   reported	   in	  
literature	  [97-­‐101].	   	   For	  example,	  phytate	  modifies	  the	  bioavailability	  of	  several	  metal	  ions	  such	  as	  
calcium,	   iron,	   zinc,	   or	   copper	   [102–106];	   it	   is	   regarded	   as	   the	   primary	   storage	   form	   of	   both	  
phosphate	  and	  inositol	  in	  plant	  seeds	  and	  grains	  [107,108];	  it	  has	  been	  reported	  to	  be	  an	  antioxidant	  
[92,109-­‐113];	   it	   shows	   marked	   anticarcinogenic/antineoplastic	   properties	   [112,114-­‐119];	   it	   may	  
reduce	  and	  prevent	  kidney	  stone	   formation	  [120,121].	   	   Among	   its	   industrial	  and/or	  technological	  
applications,	  of	  particular	  note	  is	  the	  use	  of	  phytates	  in	  environmental	  remediation	  problems,	  such	  
as	  the	   immobilization	  and	   in	  situ	  treatment	  of	  soils	  contaminated	  by	  many	  metals	   including	  heavy	  
metals	  and	  radionuclides	  [122-­‐129].	  
Most	   of	   these	   phytate	   properties	   and	   applications	   are	   significantly	   influenced	   by	   its	   particular	  
behavior	   in	   solution	   (primarily	   aqueous	   media,	   such	   as	   biological	   fluids,	   and	   natural	   and	   waste	  
waters),	   where	   it	   strongly	   interacts	   with	   many	   metal	   and	   non-­‐metal	   ions,	   proteins	   and	   starch,	  
mainly	   by	   electrostatic	   interactions	   [85,86,89,95].	   	   Moreover,	   the	   peculiar	   characteristics	   of	   its	  
structure	  allow	  this	  ligand	  to	  assume	  two	  different	  conformations.	   	   While	  the	  hexaorthophosphate	  
structure	  of	  phytic	  acid	  proposed	  by	  Anderson	  [130]	  has	  been	  accepted	  since	  the	  late	  1960s	  [131],	  
many	   studies	   have	   been	   carried	   out	   during	   the	   last	   decades	   to	   understand	   better	   which	   phytate	  
conformational	  states	  predominate	   in	  solution	  [88,132-­‐136].	   	   It	   transpires	   that,	  depending	  on	  the	  
experimental	   conditions,	   this	   ligand	  may	  exist	   in	   solution	  either	   in	   the	  equatorial	   conformation	   in	  
which	  one	  phosphate	  group	  is	  oriented	  in	  the	  axial	  position	  and	  five	  are	  in	  the	  equatorial	  (1ax/5eq),	  
or	   in	   the	   inverted	   axial	   conformation	   (5ax/1eq).	   	   Various	   techniques,	   including	   potentiometry	  
[133],	  Raman	  spectroscopy	  [132],	  1H	  NMR	  [133-­‐136],	  13C	  NMR	  [132,133]	  and	  31P	  NMR	  spectroscopy	  
[88,132,133,136],	   and	  molecular	  modeling	   [135]	  have	  been	  used	   to	  probe	  phytate	   conformational	  
preferences.	   	   These	  works	  have	  demonstrated	  that	  the	  conformation	  in	  aqueous	  solutions	  depends	  
on	   many	   parameters,	   such	   as	   pH,	   ionic	   strength,	   ionic	   medium	   (mainly	   due	   to	   the	   nature	   of	   the	  
cation	  in	  the	  supporting	  electrolyte).	   	   According	  to	  one	  of	  these	  papers	  [135],	  in	  which	  the	  effect	  of	  
alkali	  metal	  ions	  on	  the	  conformation	  adopted	  by	  phytic	  acid	  was	  also	  investigated,	  this	  ligand	  exists	  
at	  pH<9	  in	  the	  sterically-­‐unhindered	  1ax/5eq	  form,	  and	  at	  pH>9.5	  in	  the	  sterically-­‐hindered	  5ax/1eq	  
form	   (Fig.	   1-­‐2).	   	   Moreover,	   these	   authors	   showed	   that	   at	   pH	   5.0,	   phytic	   acid	   adopts	   the	   1ax/5eq	  
form	   regardless	   of	   the	   alkali	  metal	   cation	  present	   as	   counter	   ion.	   	   On	   the	   contrary,	   at	   pH	  11,	   the	  
exclusive	  presence	  of	  the	  5ax/1eq	  form	  was	  observed	  with	  Na+,	  K+,	  Rb+,	  or	  Cs+,	  while	  with	  Li+	   ions	  
the	  two	  conformations	  are	  simultaneously	  present.	  
Regarding	  the	  study	  on	  hydroxyapatite	  and	  phytate,	  Ganesan	  and	  Epple	  [137]	  have	  reported	  that	   	  









Figure	  1-­‐2	   	   The	  conformational	  interconversion	  of	  phytic	  acid	  between	  the	  1ax/5eq	  and	  5ax/1eq	  
forms	  between	  pH	  9.0-­‐9.5	  [135]	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colloidal	   calcium	  phytate	  was	  prepared	  by	  anion-­‐exchange	  of	  phosphate	  by	  phytate,	   starting	   from	  
calcium	  phosphate	  nanoparticles,	  which	  may	  be	  used,	  e.g.,	   for	  scintigraphy,	  as	  a	  food	  additive	  or	  as	  
additive	  to	  dental-­‐care	  formulations.	  
On	  the	  other	  hand,	   in	  the	   field	  of	  dentistry,	  Hirabayashi	  et	  al.	   [138]	  have	  reported	  first	   that	   the	  
bonding	  strength	  between	   tooth	  and	  metallic	   ions	  could	  be	  enhanced	  by	  modification	  of	   the	   tooth	  
surface	  with	  IP6,	  suggesting	  that	  IP6	  coated	  on	  the	  tooth	  surface	  played	  a	  role	  as	  a	  binder	  between	  
Ca2+	  ions	  of	  the	  tooth	  surface	  and	  metallic	  ions.	  
	  
	  
1.3	  Calcium-­‐phosphate	  cements	  
	  
In	   the	  most	   general	   sense	   of	   the	  word,	   cement	   is	   a	   binder,	   a	   substance	   that	   sets	   and	   hardens	  
independently	   and	   can	   bind	   other	   materials	   together.	   	   The	   name	   ‘‘cement’’	   goes	   back	   to	   the	  
Romans	  who	   used	   the	   term	   ‘‘opus	   caementitium’’	   to	   describe	  masonry,	  which	   resembled	   concrete	  
and	  was	  made	  from	  crushed	  rock	  with	  burnt	  lime	  as	  binder.	  The	  volcanic	  ash	  and	  pulverized	  brick	  
additives,	  which	  were	  added	  to	  the	  burnt	  lime	  to	  obtain	  a	  hydraulic	  binder,	  were	  later	  referred	  to	  as	  
cementum,	  cimentum,	  cäment,	  and	  cement	  [139].	  
The	   possibility	   to	   obtain	   a	   monolithic	   calcium-­‐phosphate	   ceramics	   at	   ambient	   or	   body	  
temperature	   via	   a	   cementation	   reaction	  was	   put	   forward	   by	   LeGeros	   et	   al.	   [140]	   and	   Brown	   and	  
Chow	   [141-­‐144]	   in	   the	   early	   1980s.	   	   Currently	   this	   type	   of	   materials	   is	   known	   as	  
calcium-­‐phosphate	  cements	  (commonly	  referred	  to	  as	  CPC).	  
CPCs	  are	  blends	  of	  amorphous	  and/or	  crystalline	  calcium-­‐phosphate	  powder(s)	  with	  an	  aqueous	  
solution,	   which	   might	   be	   distilled	   water,	   an	   aqueous	   solution	   of	   sodium	   orthophosphate	   (~0.25	  
mol·dm-­‐3)	  [145],	  orthophosphoric	  acid	  [146],	  or	  0.5	  mol·dm-­‐3	  aqueous	  solution	  of	  citric	  acid	  [147].	   	  
After	   the	  powder(s)	  and	   the	   solution	  are	  mixed	   together,	   a	  viscous	  and	  moldable	  paste	   is	   formed.	   	  
The	  paste	  can	  be	  placed	  into	  a	  defect	  as	  a	  substitute	  for	  the	  damaged	  part	  of	  bone,	  where	  it	  hardens	  
in	  situ	  at	  the	  operating	  theatre.	   	   The	  powder-­‐to-­‐liquid	  (P/L)	  ratio	  is	  a	  very	  important	  characteristic	  
because	   it	   determines	   moldability	   and	   injectability.	   	   As	   the	   paste	   is	   hardened	   at	   room	   or	   body	  
temperature,	  direct	  application	  in	  treatment	  of	  bone	  defects	  became	  a	  new	  and	  innovative	  treatment	  
technique	   in	   the	   end	   of	   the	   twentieth	   century.	   	   Moreover,	   CPCs	   can	   be	   injected	   directly	   into	  
fractures	   and	   bone	   defects,	  where	   they	   adapt	   to	   the	   bone	   cavity	   regardless	   its	   shape.	   	   Injectable	  
CPCs	  also	  enable	  minimally-­‐invasive	  technique	  using	  a	  syringe	  device	  [147-­‐149].	  
The	  first	  CPC	  formulation,	  put	  forward	  by	  Brown	  and	  Chow,	  consists	  of	  the	  equimolar	  mixture	  of	  
basic	   TTCP	   and	   acidic	   dicalcium	  phosphate	   (DCPA	   or	  DCPD),	  which	   is	  mixed	  with	  water	   at	   a	   P/L	  
ratio	  of	  4:1;	  the	  paste	  hardened	  in	  about	  30	  min	  and	  formed	  HAp	  as	  Eq.	  (10)	  [142,143]	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2Ca4(PO4)2O	  +	  2CaHPO4	  →	  Ca10(PO4)6(OH)2	   	   	   	   	   	   	   	   	   	   	   	   	   (10)	  
	  
In	  1990s,	   it	  was	  established	   that	   there	  were	  about	  15	  different	  binary	  combinations	  of	  calcium	  
phosphates,	  which	  gave	  pastes	  upon	  mixing	  with	  water	  or	  aqueous	  solutions,	  so	  that	  the	  pastes	  set	  
at	  room	  or	  body	  temperature	  into	  a	  solid	  cement.	   	   The	  list	  of	  these	  combinations	  is	  given	  in	  Table	  
1-­‐2	  [150].	   	   Depending	  upon	  the	  pH	  value	  of	  a	  cement	  paste,	  after	  setting	  all	  CPCs	  can	  only	  form	  two	  
major	   end	  products:	   a	  precipitated	   low	  crystalline	  HAp	  or	  CDHA	   (under	  pH>4.2)	   [142]	   and	  DCPD	  
(also	   called	   ‘‘brushite’’)	   (under	   pH<4.2)	   [151].	   	   Therefore,	   all	   existing	   formulations	   of	   CPCs	   have	  
been	  divided	   into	   two	  major	   groups:	   “apatite	   cements”	   and	   “brushite	   cements”.	   	   The	   final	   setting	  
product	   of	   the	   cements	   is	   of	   the	   paramount	   importance	   because	   it	   determines	   the	   solubility	   and,	  
therefore,	   in	  vivo	  bioresorbability.	   	   Since	  the	  chemical	  composition	  of	  mammalian	  bones	  is	  similar	  
to	   ion-­‐substituted	   CDHA,	   apatite	   cements	   have	   been	   more	   extensively	   investigated.	   	   However,	  
many	  research	  papers	  on	  brushite	  cements	  have	  been	  published	  as	  well.	  
The	   major	   driving	   force	   for	   the	   setting	   reactions	   that	   occur	   in	   these	   cements	   is	   the	   relative	  
stability	  and	  solubility	  of	  various	  calcium	  phosphates.	   	   Therefore,	  mixing	  of	  a	  dry	  powder	  with	  an	  
aqueous	   solution	   induces	   various	   chemical	   transformations;	   crystals	   of	   the	   initial	   calcium	  
phosphate(s)	   rapidly	   dissolve	   and	   ions	   of	   calcium	   and	   phosphate	   are	   supplied	   into	   the	   solution,	  
where	   they	   chemically	   interact	   and	   precipitate	   in	   the	   form	   of	   either	   the	   end	   products	   (CDHA	   or	  
DCPD)	  with	  possible	   formation	  of	  precursor	  phases	   (e.g.,	  ACP	  and	  OCP),	  which	   causes	   the	   cement	  
setting	   [142,152].	   	   This	   setting	  mechanism	  was	   confirmed	  by	   Ishikawa	   and	  Asaoka,	  who	   showed	  
that	   when	   TTCP	   and	   DCPA	   powders	   were	   mixed	   in	   double-­‐distilled	   water,	   both	   powders	   were	  
dissolved.	   	   The	  dissolved	  calcium	  and	  phosphate	  ions	  in	  the	  solution	  were	  then	  precipitated	  in	  the	  
form	  of	  CDHA	  on	  the	  surface	  of	  the	  powders	  [153].	   	   During	  precipitation,	  the	  newly-­‐formed	  crystals	  
grow	   and	   form	   a	   web	   of	   microneedles	   or	   microplatelets	   of	   the	   final	   products;	   thus	   provide	   a	  
mechanical	   rigidity	   to	   the	  hardened	  cements.	   	   In	  other	  words,	  entanglement	  of	   the	  newly-­‐formed	  
crystals	  is	  the	  major	  reason	  of	  setting.	  
In	  contrast,	  Monma	  and	  Kanazawa	  [154]	  have	  reported	  the	  first	  discovery	  on	  hydration	  reaction	  
of	   α-­‐tricalcium	   phosphate	   (α-­‐TCP),	   which	  was	   earlier	   than	   the	   proposal	   of	   CPC	   by	   LeGeros	   et	   al.	  
[140]	  and	  Brown	  and	  Chow	  [141-­‐144]	   in	   the	  early	  1980s.	   	   The	  α-­‐TCP	  was	  shown	  to	  hydrate	   to	  a	  
CDHA	   in	   dilute	   aqueous	   solutions	   and	   at	   elevated	   temperatures	   (60-­‐100°C)	   [154].	   	   This	   calcium	  
phosphate	  is	  unique	  in	  that	  it	  can	  hydrolyze	  by	  itself	  to	  form	  a	  cement.	   	   The	  rate	  of	  α-­‐TCP	  hydration	  
has	  been	  observed	  to	  increase	  with	  temperature	  and	  decrease	  with	  increasing	  pH.	  
After	  that,	  the	  hydraulic	  properties	  of	  α-­‐TCP	  have	  been	  analyzed	  in	  detail	  by	  several	  authors.	   	   In	  
1999,	  Ginebra	  et	  al.	  [77]	  have	  reported	  that	  the	  reaction	  of	  α-­‐TCP	  was	  initially	  controlled	  by	  α-­‐TCP	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surface	   area,	   and	   then	   by	   the	   diffusion	   of	   reactants	   through	   the	   hydrated	   layer	   around	   α-­‐TCP	  
particles.	   	   Similar	   results	  were	  obtained	  by	   Sarda	   et	   al.	   [155].	   	   Ginebra	   et	   al.	   [156]	   and	  Ducuran	  
and	  Brown	  [157]	  showed	  that	  the	  setting	  reaction	  was	  accelerated	  when	  α-­‐TCP	  powder	  was	  exposed	  
to	   longer	   milling	   times.	   	   Recently,	   Gbureck	   et	   al.	   [158]	   demonstrated	   that	   prolonged	   milling	   of	  
α-­‐TCP	  led	  to	  the	  formation	  of	  an	  X-­‐ray	  amorphous	  α-­‐TCP	  which	  had	  a	  solubility	  three	  times	  that	  of	  
standard	  α-­‐TCP.	  Camiré	  et	  al.	   [159]	   related	  milling	   time	  and	  reactivity	  as	  measured	  by	   isothermal	  
calorimetry.	   	   It	  was	   found	   that	   the	   total	  heat	   released	  during	   the	   conversion	  of	  α-­‐TCP	   into	  CDHA	  
was	  increased	  two-­‐	  to	  threefold	  when	  α-­‐TCP	  was	  milled	  for	  a	  prolonged	  time.	  
In	   contrast,	   some	   problems	   on	   CPCs	   have	   been	   previously	   reported	   [145,151,160-­‐162].	   	  
Miyamoto	  et	  al.	  have	  reported	  that	  TTCP-­‐DCPA	  cement	  caused	  a	  change	  in	  pH,	  which	  resulted	  in	  an	  
inflammation	  reaction	  to	  surrounding	  tissues	  around	  the	  cement	  [160].	   	   Bohner	  et	  al.	  implied	  that	  
the	  use	  of	  orthophosphoric	  acid	  in	  β-­‐TCP-­‐H3PO4	  base	  brushite	  cement,	  which	  is	  set	  as	  Eq.	  (11),	  might	  
impair	  the	  biocompatibility	  of	  the	  cement	  formulation,	  due	  to	  low	  pH	  values	  during	  setting	  [151].	  
	  
β-­‐Ca3(PO4)2	  +	  H3PO4	  +	  6H2O	  →	  3CaHPO4·2H2O	   	   	   	   	   	   	   	   	   	   	   	   	   (11)	  
	  
Furthermore,	   washout	   property	   have	   been	   reported	   as	   one	   of	   shortcomings:	   the	   conventional	  
TTCP-­‐DCPA	   and	   commercially-­‐available	   Biopex®	   cement	   pastes	  were	  washed	   out	   if	   they	   come	   in	  
contact	  with	  body	  fluid	  before	  they	  set	  [145,160-­‐162].	  
As	   a	   solution	   for	   problems	   above-­‐mentioned,	   Aizawa	   et	   al.	   [163]	   have	   developed	   a	   novel	  
calcium-­‐phosphate	   cement,	   “chelate-­‐setting	   hydroxyapatite	   cement	   (IP6-­‐HAp)”,	   using	   IP6	   as	   a	  
chelating	   agent	   without	   acid-­‐base	   reaction,	   which	   was	   inspired	   by	   the	   above-­‐mentioned	  
fundamental	  study	  by	  Hirabayashi	  et	  al.	  [138].	   	   The	  IP6-­‐HAp	  cement	  was	  fabricated	  by	  mixing	  HAp	  
powder	  that	  was	  surface-­‐modified	  with	  IP6	  and	  pure	  water,	  and	  then	  hardened	  by	  a	  chelating	  ability	  
of	   IP6.	   	   Aizawa	   et	   al.	   also	   showed	   that	   osteoblast-­‐like	   cells	   indirectly	   cultured	  with	   the	  HAp	   and	  
IP6-­‐HAp	   cements	   using	  Transwell®	   did	   not	   show	   cytotoxicity	   till	   day	   4	   [163].	   	   However,	   it	   could	  
state	   that	  compressive	  strength	  of	   the	   IP6-­‐HAp	  cement	  (3.7	  MPa)	  and	  handling	  property	  of	   that	   is	  
not	  sufficient	  for	  clinical	  application.	  
	  
	  
1.4	  Aim	  of	  the	  present	  study	  
	  
The	  CPCs	  are	  applied	  to	  two	  surgical	  treatments:	  vertebroplasty	  and	  kyphoplasty,	  which	  recently	  
have	  been	  introduced	  to	  medically	  manage	  of	  osteoporosis-­‐induced	  vertebral	  compression	  fractures.	   	  
In	  particular,	  both	  procedures	  aim	  to	  augment	  the	  weakened	  vertebral	  body,	  stabilize	  it	  and/or	  re-­‐	   	  
	   11	  



















































































































































































































































































































































































































































































































































































































	   12	  
store	   it	   to	  as	  much	  of	   its	  normal	  height	  and	   functional	  state	  as	  possible.	   	   Both	  treatments	   involve	  
injection	  of	  a	  self-­‐setting	  paste	  of	  a	  CPC	  into	  the	  fractured	  vertebral	  body,	  which	  resulted	  in	  a	  faster	  
healing	  [164-­‐169].	  
As	   for	   HAp	   cement,	   Barralet	   et	   al.	   [170]	   and	   Lilley	   et	   al.	   [171]	   have	   reported	   that	  
brushite-­‐forming	   cement	   could	   be	   obtained	   by	  mixing	   nanocrystalline	   HAp	   (Ca/P=0.80-­‐2.00)	   and	  
orthophosphoric	  acid.	   	   Those	  are	  unique	   reports	  using	  HAp	  as	  a	  main	   cement	   reactant;	  however,	  
the	  use	  of	  orthophosphoric	  acid	  might	  impair	  the	  biocompatibility	  of	  the	  cement	  formulation,	  due	  to	  
low	  pH	  values	  during	  setting,	  as	  mentioned	  before	  [151].	   	   Due	  to	  slow	  hydrolysis	  of	  the	  crystalline	  
β-­‐TCP	  to	  CDHA	  [39],	  β-­‐TCP	   is	  mixed	  with	  orthophosphoric	  acid	   to	   form	  a	  brushite	  cement.	   	   More	  
soluble	   and	   reactive	   α-­‐TCP	   than	   β-­‐TCP	   is	   used	   mainly	   as	   a	   fine	   powder	   in	   hydraulic	   cement.	   	  
Therefore,	  it	  is	  impossible	  to	  fabricate	  HAp,	  β-­‐TCP,	  or	  α-­‐TCP	  cement	  composed	  of	  each	  single	  phase,	  
using	  neutral	  liquid	  component;	  i.e.	  setting	  cement	  with	  keeping	  starting	  reactant	  phase.	  
In	  contrast,	  as	  above-­‐mentioned,	  the	  order	  of	  relative	  dissolution	  is	  α-­‐TCP	  >	  β-­‐TCP	  >	  HAp	  [42-­‐44],	  
which	   suggests	   that	   there	   is	   a	   possibility	   that	   the	   chelate-­‐setting	   CPCs	   with	   different	  
biodegradability	   could	   be	   fabricated	   using	   different	   calcium	   phosphate	   phases:	   HAp,	   β-­‐TCP,	   and	  
α-­‐TCP.	   	   These	  cements	  with	  different	  biodegradability	  will	  be	  promising	  candidates	  for	  application	  
as	  novel	  paste-­‐like	  artificial	  bones,	  which	  will	  also	  enable	  “tailor-­‐made	  treatment”	  according	  to	  bone	  
metabolism	  of	  patients.	  
Therefore,	  the	  present	  study	  investigated	  fabrication	  process	  of	  novel	  chelate-­‐setting	  CPCs	  with	  
different	   biodegradability	   using	   various	   calcium-­‐phosphate	   phases:	   HAp,	   β-­‐TCP	   and	   α-­‐TCP.	   	  
Moreover,	   dissolution	   of	   resulting	   cements	   in	   vitro	   using	   Ca2+	   ion-­‐	   selective	   potentiometry	   and	  
biodegradability	  of	  resulting	  cements	  in	  vivo	  using	  rabbit	  models	  were	  also	  examined.	  
Chapter	  2,	  3,	  and	  4	  were	  described	  about	  fabrication	  of	  chelate-­‐setting	  HAp	  (IP6-­‐HAp)	  cements,	  
chelate-­‐setting	   β-­‐TCP	   (IP6-­‐β-­‐TCP)	   cements,	   and	   chelate-­‐setting	   α-­‐TCP	   (IP6-­‐α-­‐TCP)	   cements,	  
respectively.	   	   In	   Chapter	   5,	   comparative	   study	   on	   biocompatibility	   and	   biodegradability	   of	   the	  
various	   chelate-­‐setting	   cements	   (IP6-­‐HAp,	   IP6-­‐β-­‐TCP	   and	   IP6-­‐α-­‐TCP)	   and	   commercially-­‐available	  
cement	  (Biopex®-­‐R)	  were	  carried	  out	  in	  vivo	  using	  rabbit	  models,	  in	  addition	  to	  their	  dissolution	  of	  
these	   cements	   in	   vitro.	   	   Chapter	   6	   concluded	   the	   findings	   from	   the	   present	   thesis,	   and	   remarked	  
future	  developments	  on	  the	  present	  study.	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Novel	   calcium-­‐phosphate	   cement,	   “chelate-­‐setting	   hydroxyapatite	   cement	   (IP6-­‐HAp)”,	   using	  
inositol	  phosphate	  (IP6)	  as	  a	  chelating	  agent	  has	  been	  developed	  for	  the	  first	  time	  by	  Aizawa	  et	  al.	  
[1].	   	   In	  Chapter	  2,	  various	  types	  of	  powder	  preparation	  processes	  for	  the	  cement	  fabrication	  were	  
examined	  to	  improve	  mechanical	  strength,	  and	  handling	  and	  anti-­‐washout	  properties	  of	  the	  IP6-­‐HAp	  
cement.	  
In	   section	   2.1,	   the	   effect	   of	   the	   powder	   preparation	   process	   on	   the	   morphology,	   crystallinity,	  
median	  particle	  size,	  and	  specific	  surface	  area	  of	  the	  cement	  powders	  was	  investigated	  to	   fabricate	  
the	   IP6-­‐HAp	   cement	   with	   enhanced	   mechanical	   properties	   using	   wet	   chemical	   synthesized	  
hydroxyapatite	  (HAp)	  [2].	   	   The	  starting	  cement	  powder	  for	  the	  cement	  fabrication	  was	  previously	  
prepared	   by	   surface-­‐modification	   with	   IP6	   after	   ball-­‐milling	   of	   the	   HAp	   powder	   (hereafter,	  
conventional	  process)	  [1-­‐4].	  
In	  section	  2.2,	  a	  novel	  powder	  preparation	  process	  (hereafter,	  modified	  process)	  for	  the	  cement	  
fabrication	  was	  established,	   in	  which	  the	  starting	  HAp	  powders	  were	  prepared	  by	  ball-­‐milling	  and	  
simultaneously	  surface-­‐modifying	  the	  commercially-­‐	  available	  HAp	  powders	  in	  the	  IP6	  solution	  [5].	   	  
Afterward,	   the	   effect	   of	   the	   IP6	   concentration	   on	   the	   material	   properties,	   such	   as	   compressive	  
strength,	  setting	  time,	  handling	  property	  (consistency),	  and	  anti-­‐washout	  property,	  of	   the	  IP6-­‐HAp	  
cement	   was	   investigated,	   with	   the	   aim	   to	   develop	   paste-­‐like	   artificial	   bone	   with	   anti-­‐washout	  
property.	  
Section	  2.3	  describes	  that	  comparison	  of	  powder	  preparation	  process	  between	  the	  conventional	  
and	  modified	  processes	  using	  commercially-­‐available	  HAp	  powder	  [6].	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In	   the	   previous	   study,	   Horiguchi	   et	   al.	   have	   reported	   that	   the	  morphology	   and	   SSA	   of	   starting	  
cement	  powder	  affected	  the	  compressive	  strength	  of	   the	  chelate-­‐setting	  hydroxyapatite	   (IP6-­‐HAp)	  
cements:	   fine	   IP6-­‐HAp	   powder	   with	   higher	   SSA	   and	   lower	   crystallinity	   was	   effective	   for	   the	  
fabrication	   of	   the	   higher	   compressive	   strength	   of	   IP6-­‐HAp	   cement.	   	   In	   section	   2.1,	   using	   wet	  
chemical	  synthesized	  HAp,	  effect	  of	  the	  powder	  preparation	  process	  on	  the	  morphology,	  crystallinity,	  
median	  particle	  size,	  and	  specific	  surface	  area	  of	  the	  cement	  powders	  was	  investigated	  to	   fabricate	  
the	   IP6-­‐HAp	   cement	  with	   enhanced	  mechanical	   properties	   [2].	   	   In	   addition,	   Biocompatibility	   and	  




2.1.1	  Materials	  and	  methods	  
	  
2.1.1.1	  Preparation	  of	  HAp	  powders	  
A	  500	  cm3	  suspension	  of	  Ca(OH)2	  (0.5	  mol･dm-­‐3,	  Wako	  Pure	  Chemical	  Industries,	  Ltd.,	  Japan)	  in	  
distilled	  water	  was	  stirred	  (200	  rpm)	  at	  37°C	  while	  500	  cm3	  of	  0.3	  mol･dm-­‐3	  H3PO4	  solution	  (Wako	  
Pure	  Chemical	  Industries,	  Ltd.)	  was	  added	  dropwise	  into	  the	  suspension,	  according	  to	  the	  report	  by	  
Akao	   et	   al.	   [7].	   	   The	   pH	   of	   the	   mixed	   suspension	   was	   maintained	   at	   10	   by	   the	   addition	   of	   25%	  
NH4OH	  solution	  (Wako	  Pure	  Chemical	  Industries,	  Ltd.).	   	   The	  mixture	  was	  stirred	  for	  1	  h	  and	  aged	  at	  
37°C	  for	  24	  h.	   	   The	  resulting	  slurry	  was	  filtrated	  using	  a	  glass	  microfiber	  filter	  with	  0.7	  μm	  pore	  size	  
(GF/F,	  Whatman,	  UK),	  and	   the	   filter	  cake	  was	  washed	  with	  pure	  water	  and	  dried	  by	   the	   following	  
methods	  to	  obtain	  six	  types	  of	  synthesized	  HAp	  powders:	  (i)	  freeze-­‐drying,	  (ii)	  drying	  at	  110°C	  in	  air,	  
and	   (iii)	   calcining	   at	   600,	   800,	   1000	   and	   1200°C	   in	   air.	   	   A	   schematic	   of	   the	   powder	   preparation	  
process	  is	  shown	  in	  Fig.	  2-­‐1-­‐1.	  
	  
2.1.1.2	  Surface-­‐modification	  of	  HAp	  particles	  with	  inositol	  phosphate	  
Inositol	   phosphate	   (IP6)	   solution	   with	   concentrations	   of	   1000	   ppm	   was	   prepared	   using	   50	  
mass%	   phytic	   acid	   (Wako	   Pure	   Chemical	   Industries,	   Ltd.),	   and	   adjusting	   to	   pH	   7.3	   with	   NaOH	  
solution	   (0.1	  mol·dm-­‐3).	   	   Ten	  grams	  of	  each	  HAp	  powder	  prepared	  via	  processes	   (i),	   (ii),	   and	   (iii)	  
was	  added	  into	  the	  IP6	  solution	  (200	  cm3),	  and	  then	  stirred	  (400	  rpm)	  at	  37°C	  for	  5	  h.	   	   The	  slurry	  
mixtures	  were	  filtrated	  using	  a	  glass	  microfiber	  filter	  with	  0.7	  μm	  pore	  size,	  and	  the	  filter	  cake	  was	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washed	  with	   pure	  water	   and	   freeze-­‐dried	   for	   24	   h	   to	   obtain	   IP6	   surface-­‐modified	   HAp	   powders,	  
which	  are	  denoted	  hereafter	  according	  to	  the	  abbreviations	  given	  in	  Table	  2-­‐1-­‐1.	  
The	   HAp	   powders	   prepared	   via	   the	   process	   (i)	   were	   ball-­‐milled	   using	   a	   planetary	   mill	  
(Pulverisette	  6,	  Fritsch,	  Germany)	  for	  5	  min	  at	  a	  rotation	  rate	  of	  300	  rpm	  in	  a	  ZrO2	  pot	  with	  fifty	  10	  
mm	  diameter	  ZrO2	  beads	  under	  wet	  (40	  cm3	  of	  pure	  water)	  and	  dry	  conditions.	   	   After	  ball-­‐milling,	  
the	   filter	   cake	  was	   surface-­‐modified	  with	   IP6,	   as	   above-­‐mentioned.	   	   Consequently,	   eight	   types	   of	  
IP6-­‐HAp	  powders	  were	  prepared	  via	  various	  routes	  to	  fabricate	  various	  IP6-­‐HAp	  cements.	  
	  
2.1.1.3	  Characterization	  of	  prepared	  powders	  
X-­‐ray	  diffraction	  (XRD;	  MiniFlex,	  Rigaku,	   Japan)	  analysis	  of	   the	  powders	  was	  conducted	  using	  a	  
CuKα	  radiation	  source.	   	   Data	  were	  collected	  in	  the	  range	  of	  2θ=5-­‐50°	  with	  a	  step	  size	  of	  0.04°	  and	  
count	   time	   of	   4°·min-­‐1.	   	   The	   crystallite	   phase	  was	   identified	  with	   respect	   to	   the	   JCPDS	   reference	  
patterns	  for	  HAp	  (#09-­‐0432)	  and	  β-­‐tricalcium	  phosphate	  (#09-­‐0169).	   	   The	  half	  width	  at	  2θ=25.9°	  
(hkl=002)	  was	  calculated	  using	  JADE	  software	  (Materials	  Data	  Inc.,	  USA).	  
The	  crystallite	  size	  of	  the	  HAp	  was	  calculated	  using	  Scherrer’s	  equation:	  
	  
Crystallite	  size	  (nm)	  =	  Kλ/βcosθ	  	   	   	   	   	   	   (1)	  
	  
where	  K	  is	  the	  shape	  coefficient	  (K=0.9),	  λ	  is	  the	  wavelength	  (λ=0.15405	  nm),	  and	  β	  is	  the	  half	  width	  
at	  2θ=25.9°.	  
The	   particle	   morphology	   of	   the	   IP6-­‐HAp	   powder	   was	   observed	   using	   scanning	   electron	  
microscopy	   (SEM;	   JSM-­‐6390LA,	   JEOL,	   Japan).	   	   The	   specific	   surface	   area	   (SSA)	   of	   the	   IP6-­‐HAp	  
powders	  was	  determined	  by	   the	  Brunauer-­‐Emmett-­‐Teller	   (BET)	  method	  using	  a	  BET	  surface	  area	  
analyzer	   (Flowsorb	   III,	   Shimadzu,	   Japan)	   and	   the	  median	  particle	   size	  was	  measured	  with	   a	   laser	  
particle	   size	  analyzer	   (LA-­‐300,	  Horiba,	   Japan).	   	   The	  Ca/P	   ratio	  of	   the	  HAp	  powder	  was	  measured	  
with	  an	  X-­‐ray	   fluorescence	  analyser	   (RIX3100,	  Rigaku,	   Japan).	   	   The	   zeta-­‐potential	   of	   the	   IP6-­‐HAp	  
powders	  were	  measured	  at	  25°C	  using	  a	   laser-­‐Doppler	  velocimeter	  (ELS-­‐6000,	  Otsuka	  Electronics,	  
Japan)	  in	  a	  10	  mmol·dm-­‐3	  NaCl	  solution.	  
	  
2.1.1.4	  Fabrication	  and	  evaluation	  of	  IP6-­‐HAp	  cements	  
The	   cement	   specimen	   was	   fabricated	   by	   mixing	   the	   IP6-­‐HAp	   powder	   and	   pure	   water	   at	  
powder/liquid	  (P/L)	  ratios	  of	  1/0.35-­‐1/0.55	  [g/cm3]	  and	  packing	  into	  a	  5	  mm	  diameter	  cylindrical	  
stainless	  mold.	   	   The	  resulting	  cement	  specimens	  (5	  mm	  in	  diameter,	  7±0.5	  mm	  in	  height)	  were	  kept	  
at	  room	  temperature	  in	  air	  for	  24	  h.	  
The	  compressive	  strength	  (CS)	  of	  the	  cement	  specimens	  was	  measured	  using	  a	  universal	  testing	   	  










Fig.	  2-­‐1-­‐1	   	   Schematic	  diagram	  of	  the	  powder	  preparation	  process.	  
	  
	   	  
















	   	  
Abbreviation	   Drying	  method	   Ball-­‐milling	  
HAp	   Freeze-­‐drying	   -­‐	  
IP6-­‐HAp	   Freeze-­‐drying	   -­‐	  
Wet	  milled	  IP6-­‐HAp	   Freeze-­‐drying	   5	  min	  (wet	  ball-­‐milling)	  
Dry	  milled	  IP6-­‐HAp	   Freeze-­‐drying	   5	  min	  (dry	  ball-­‐milling)	  
IP6-­‐HAp/110°C	   Drying	  at	  110°C	  in	  oven	   -­‐	  
IP6-­‐HAp/600°C	   Calcining	  at	  600°C	   -­‐	  
IP6-­‐HAp/800°C	   Calcining	  at	  800°C	   -­‐	  
IP6-­‐HAp/1000°C	   Calcining	  at	  1000°C	   -­‐	  
IP6-­‐HAp/1200°C	   Calcining	  at	  1200°C	   -­‐	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machine	   (Autograph	   AGS-­‐J,	   Shimadzu,	   Japan)	   with	   a	   5	   kN	   load	   cell	   at	   crosshead	   speed	   of	   500	  
μm·min-­‐1.	   	   The	  bulk	  density	  of	   the	  cylindrical	  cement	  specimens	  was	  calculated	  by	  measuring	  the	  
diameter,	  height,	  and	  weight	  of	  the	  cement.	   	   The	  relative	  density	  (RD)	  of	  the	  cement	  specimens	  was	  
calculated	  from	  the	  bulk	  density	  divided	  by	  theoretical	  density	  of	  HAp	  (3.16	  g･cm-­‐3).	   	   The	  relative	  
porosity	  of	  the	  cement	  specimens	  was	  calculated	  using	  Eq.	  (2).	  
	  
Relative	  porosity	  (%)	  =	  100	  –	  (relative	  density)	   	   	   	   	   (2)	  
	  
The	   microstructure	   of	   the	   fractured	   cement,	   sputter-­‐coated	   with	   Au,	   was	   observed	   by	   SEM	  
(VE-­‐9800,	  Keyence,	  Japan)	  at	  an	  accelerating	  voltage	  of	  10	  kV.	  
	  
2.1.1.5.	  In	  vitro	  evaluation	  of	  IP6-­‐HAp	  cements	  
The	   cement	   specimens	   for	   in	   vitro	   evaluation	  were	   prepared	   by	  mixing	   the	  HAp	   powder	   (wet	  
milled	  HAp	  and	  wet	  milled	  IP6-­‐HAp	  powders	  were	  selected)	  and	  pure	  water	  at	  a	  P/L	  ratio	  of	  1/0.3	  
[g/cm3].	   	   The	   resulting	   cements	   were	   packed	   into	   a	   cylindrical	   stainless	   mold.	   	   The	   resulting	  
cement	   specimens	  were	  22	  mm	   in	  diameter	  and	  2	  mm	   in	   thickness,	   and	  were	  kept	   in	  air	  at	   room	  
temperature	  for	  24	  h.	   	   Ethylene	  oxide	  gas	  (EOG)	  was	  used	  to	  sterilize	  the	  cement	  specimens.	  
Osteoblast-­‐like	  cells	   (MC3T3-­‐E1)	  were	  cultured	  on	  the	  cement	  specimens	   in	  growth	  medium	  at	  
37°C,	  5%	  CO2,	  and	  100%	  humidity.	   	   The	  number	  of	  proliferated	  cells	  was	  counted	  after	  seeding	  for	  
1,	  3,	  5,	  and	  7	  days.	   	   The	  cells	  cultured	  on	  the	  cement	  specimens	  for	  1,	  3,	  5,	  and	  7	  days	  were	  rinsed	  
with	   phosphate	   buffered	   saline	   (PBS),	   fixed	   with	   4%	   paraformaldehyde/PBS,	   and	   permeabilized	  
with	   0.25%	   Triton	   X-­‐100/PBS	   (pH7.4)	   for	   15	   min.	   	   The	   cells	   were	   washed	   with	   PBS	   and	   then	  
stained	  with	  Alexa	  Fluor®488-­‐labeled	  phalloidin	   for	  F-­‐actin.	   	   After	  washing	  with	  PBS,	   the	   cement	  
specimens	  were	  examined	  using	  an	  epifluorescence	  microscope	  (IX71,	  Olympus,	  Japan).	  
	  
2.1.1.6.	  In	  vivo	  evaluation	  of	  IP6-­‐HAp	  cements	  
To	   evaluate	   the	   biocompatibility	   and	   osteoconductivity	   of	   the	   wet	   milled	   IP6-­‐HAp	   cement	  
specimens,	   in	  vivo	  studies	  were	  performed	  using	  16	  weeks	  old	  male	  rabbits	  (average	  weight;	  3	  kg)	  
according	  to	  the	  guidelines	  of	  the	  laboratory	  animal	  center	  at	  Keio	  University.	   	   The	  IP6-­‐HAp	  cement	  
specimens	  were	  fabricated	  by	  mixing	  the	  wet	  milled	  IP6-­‐HAp	  powder	  and	  pure	  water	  at	  a	  P/L	  ratio	  
of	   1/0.35	   [g/ml],	   and	   packing	   into	   a	   cylindrical	   stainless	  mold.	   	   The	   resulting	   cement	   specimens	  
were	  4	  mm	   in	  diameter	   and	  8	  mm	   in	  height,	   and	  were	   kept	   in	   air	   at	   room	   temperature	   for	   24	  h.	   	  
EOG	  was	  used	  to	  sterilize	  the	  cement	  specimens.	  
The	  tibia	  of	  a	  rabbit	  was	  exposed	  and	  cylindrical	  defects	  (4.4	  mm	  in	  diameter)	  were	  drilled	  in	  the	  
epiphysis	  of	   the	   tibia.	   	   The	   IP6-­‐HAp	  cement	   specimens	  were	   then	   implanted	   into	   the	  defect	   for	  4	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and	   24	  weeks.	   	   After	   implantation,	   the	   rabbit	  was	   sacrificed	   using	   sodium	  pentobarbital	   and	   the	  
tibia	   was	   removed.	   	   Undecalcified	   sections	   stained	   with	   toluidine	   blue	   (TB)	   were	   prepared	   for	  
histological	   evaluation.	   	   The	   histological	   sections	   were	   observed	   using	   an	   epifluorescence	  





2.1.2.1	  Characterization	  of	  various	  HAp	  powders	  surface-­‐modified	  with	  IP6	  
Figure	   2-­‐1-­‐2	   shows	   XRD	   patterns	   of	   the	   as-­‐synthesized	   HAp	   powder	   and	   various	   IP6-­‐HAp	  
powders.	   	   Some	   of	   the	   IP6-­‐HAp	   powders,	   as-­‐synthesized	  HAp	   and	   IP6-­‐HAp,	  wet	  milled	   IP6-­‐HAp,	  
dry	   milled	   IP6-­‐HAp,	   IP6-­‐HAp/110°C,	   and	   IP6-­‐HAp/600°C,	   were	   composed	   of	   single	   phase	   HAp.	   	  
However,	   in	   the	   IP6-­‐HAp/800°C,	   IP6-­‐HAp/1000°C,	   and	   IP6-­‐HAp/1200°C	   powders,	   the	   peaks	  
corresponding	  to	  both	  HAp	  and	  β-­‐TCP	  were	  detected,	  suggesting	  that	  these	  powders	  were	  partially	  
decomposed	  into	  β-­‐TCP	  during	  the	  calcining	  process,	  and	  that	  a	  small	  amount	  of	  β-­‐TCP	  was	  included	  
in	  the	  HAp	  powders	  as	  an	  impurity.	  
The	   Ca/P	   ratio	   of	   the	   as-­‐synthesized	   HAp	   powder	   was	   1.69,	   which	   was	   higher	   than	   the	  
stoichiometric	   value	   (Ca/P=1.67).	   	   The	   zeta-­‐potential	   of	   the	   as-­‐synthesized	   HAp	   powder	   was	  
−6.2±0.7	  mV	  in	  10	  mmol·dm-­‐3	  NaCl	  solution,	  while	   that	  of	   the	   IP6-­‐HAp	  powder	  was	  −23.0±0.6	  mV	  
under	  the	  same	  condition.	  
Table	  2-­‐1-­‐2	  presents	  the	  crystallite	  size,	  median	  particle	  size,	  and	  SSA	  of	  the	  prepared	  powders.	   	  
There	  was	  no	  significant	  difference	  in	  the	  crystallite	  size	  between	  as-­‐synthesized	  HAp	  and	  IP6-­‐HAp.	   	  
The	   crystallite	   size	   of	   the	   wet	   milled	   IP6-­‐HAp	   powder	   (22.7±1.4	   nm)	   was	   decreased	   slightly	  
compared	  to	  that	  of	  as-­‐synthesized	  HAp	  (24.5±1.1	  nm).	   	   As	  a	  result,	  the	  median	  particle	  size	  of	  the	  
wet	  milled	   IP6-­‐HAp	  was	  decreased	  and	   the	  SSA	  was	   increased,	  which	  suggests	   that	  wet	  milling	  of	  
HAp	  is	  effective	  for	  the	  preparation	  of	  small	  particles	  with	  high	  SSA.	   	   In	  contrast,	  the	  crystallite	  size	  
of	   the	   dry	  milled	   IP6-­‐HAp	   (24.6±0.7	   nm)	   did	   not	   change	   significantly	   from	   that	   of	   as-­‐synthesized	  
HAp	   (24.5±1.1	   nm),	   although	   dry	   milling	   of	   IP6-­‐HAp	   was	   effective	   in	   increasing	   the	   SSA.	   	   The	  
crystallite	  and	  median	  particle	  sizes	  and	  SSA	  of	  the	  IP6-­‐HAp/110°C	  powder	  were	  almost	  the	  same	  as	  
those	  of	  as-­‐synthesized	  HAp.	   	   The	  calcining	  process	  led	  to	  an	  increase	  in	  the	  crystallite	  and	  median	  
particle	  sizes,	  and	  a	  decrease	  in	  the	  SSA	  due	  to	  the	  sintering	  of	  particles.	  
The	  particle	  morphologies	  of	  the	  as-­‐synthesized	  HAp	  powder	  and	  various	  IP6-­‐HAp	  powders	  are	  
shown	  in	  Fig.	  2-­‐1-­‐3.	   	   Each	  powder	  was	  composed	  of	   irregular-­‐shaped	  microcrystals.	   	   No	  obvious	  
difference	  in	  particle	  morphology	  was	  evident	  in	  Figs.	  2-­‐1-­‐3a-­‐e.	   	   However,	  Figs.	  2-­‐1-­‐3f-­‐g	  show	  that	  
large	   sized	  grains	  were	   formed,	   in	   contrast	   to	   those	   in	  Figs.	   2-­‐1-­‐3a-­‐e,	   indicating	   that	   the	   calcining	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process	  caused	  sintering	  of	  the	  powder	  particles.	  
	  
2.1.2.2	  Material	  properties	  of	  the	  IP6-­‐HAp	  cements	  
Figure	   2-­‐1-­‐4	   shows	   the	   compressive	   strength	   of	   the	   HAp	   and	   IP6-­‐HAp	   cement	   specimens	   as	   a	  
function	  of	  the	  P/L	  ratio.	   	   The	  poor	  handling	  property	  of	  the	  IP6-­‐HAp/1000°C	  and	  IP6-­‐HAp/1200°C	  
powders	  made	  it	  difficult	  to	  fabricate	  cement	  specimens.	   	   The	  compressive	  strength	  of	  the	  cement	  
specimens	  decreased	  with	  a	  reduction	  of	   the	  P/L	  ratio.	   	   The	  maximum	  compressive	  strength	  was	  
obtained	   for	   the	   wet	   milled	   IP6-­‐HAp	   cement	   (P/L=1/0.35	   [g/cm3])	   at	   23.1±2.1	   MPa,	   which	   was	  
higher	   than	   that	   of	   the	   HAp	   cement	   specimens	   without	   IP6	   surface-­‐modification	   (18.9±2.3	   MPa,	  
P/L=1/0.35).	  
To	   clarify	   the	   relationship	   between	   compressive	   strength	   and	   relative	   porosity,	   the	   natural	  
logarithm	  of	  the	  compressive	  strength	  is	  plotted	  as	  a	  function	  of	  the	  relative	  porosity	  in	  Fig.	  2-­‐1-­‐5,	  
where	   a	   linear	   relation	   was	   obtained.	   	   The	   porosity	   in	   the	   wet-­‐milled	   IP6-­‐HAp	   cement	   with	   the	  
maximum	  compressive	  strength	  (23.1±2.1	  MPa,	  P/L=1/0.35	  [g/	  cm3])	  was	  relatively	  lower	  than	  that	  
among	  the	  cement	  specimens.	  
The	  microstructures	  of	   the	  cement	   fracture	  surfaces	  were	  observed	  using	   the	  SEM	  (Fig.	  2-­‐1-­‐6).	   	  
The	   relative	  porosities	  of	   the	  observed	   cement	   specimens	   (P/L=1/0.35	   [g/	   cm3])	  were	  57.0±1.7%	  
for	  HAp,	   54.7±0.9%	   for	   IP6-­‐HAp,	   and	  56.1±0.5%	   for	  wet	  milled	   IP6-­‐HApHAp,	   respectively.	   	   In	   all	  
the	   cement	   specimens,	   the	   cement	   particles	  were	   tightly	   packed	  with	   each	   other,	   and	   no	   obvious	  
difference	   in	   the	  microstructure	  was	   observed.	   	   Because	   difference	   in	   the	   relative	   porosities	  was	  
little	  among	  three	  types	  of	  cement	  specimens.	  
Figure	  2-­‐1-­‐7	   shows	   that	   the	   compressive	   strength	  of	   the	   cement	   specimens	   tended	   to	   increase	  
with	  the	  SSA	  of	  the	  cement	  powders.	  
	  
2.1.2.3.	  In	  vitro	  evaluation	  of	  IP6-­‐HAp	  cements	  
Osteoblast-­‐like	  cells	  cultured	  on	  the	  wet	  milled	  HAp	  and	  wet	  milled	  IP6-­‐HAp	  cement	  specimens	  
increased	  till	  day	  7,	  and	  no	  significant	  difference	  in	  the	  number	  of	  cells	  was	  confirmed	  between	  the	  
wet	   milled	   HAp	   and	   wet	   milled	   IP6-­‐HAp	   cement	   specimens	   (Fig.	   2-­‐1-­‐8).	   	   The	   cell	   morphology	  
showed	  that	  cells	  attached,	  spread	  and	  grew	  on	  both	  the	  cement	  specimens	  (Fig.	  2-­‐1-­‐9),	  which	  was	  
in	  agreement	  with	  the	  result	  in	  Fig.	  2-­‐1-­‐8.	  
	  
2.1.2.4.	  In	  vivo	  evaluation	  of	  IP6-­‐HAp	  cements	  
The	   osteoconductivity	   of	   the	   cement	   specimens	   was	   evaluated	   by	   implanted	   the	   wet	   milled	  
IP6-­‐HAp	   cement	   specimens	   into	   rabbit	   tibiae.	   	   The	   wet	   milled	   IP6-­‐HAp	   cement	   specimens	   were	  
selected,	  because	  no	  significant	  difference	  in	  the	  cell	  proliferation	  between	  the	  wet	  milled	  HAp	  ce-­‐	   	  











Fig.	   2-­‐1-­‐2	   	   XRD	  pattern	  of	   the	  as-­‐synthesized	  HAp	  and	  various	   IP6-­‐HAp	  powders.	   	   White	   circles	  
and	  black	  triangles	  indicate	  typical	  HAp	  and	  β-­‐TCP	  peaks,	  respectively.	  
	   	  










Table	  2-­‐1-­‐2	   	   Crystallite	  size,	  median	  particle	  size,	  and	  SSA	  of	  various	  IP6-­‐HAp	  powders.	  
	  
	  








HAp	   24.5±1.1	   8.1±0.3	   97.8±0.7	  
IP6-­‐HAp	   23.8±2.8	   8.5±0.3	   102.6±0.3	  
Wet	  milled	  IP6-­‐HAp	   22.7±1.4	   7.3±0.1	   110.0±0.2	  
Dry	  milled	  IP6-­‐HAp	   24.6±0.7	   8.1±0.2	   102.1±0.2	  
IP6-­‐HAp/110°C	   25.6±1.6	   8.3±0.2	   97.6±0.4	  
IP6-­‐HAp/600°C	   29.7±0.4	   8.5±0.1	   46.5±0.7	  
IP6-­‐HAp/800°C	   50.7±3.8	   14.1±0.7	   20.7±0.1	  
IP6-­‐HAp/1000°C	   65.2±6.5	   20.1±2.3	   3.0±0.1	  
IP6-­‐HAp/1200°C	   77.3±7.6	   26.5±2.0	   0.5±0.1	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ments	  with	  and	  without	  IP6	  surface-­‐modification	  was	  observed	   in	  vitro	  evaluation	  (Figs.	  2-­‐1-­‐8	  and	  
2-­‐1-­‐9).	  
Histological	  observation	  of	   the	  wet	  milled	   IP6-­‐HAp	  cement	  specimens	  was	  performed	  using	  TB	  
staining	   (Fig.	   2-­‐1-­‐10).	   	   A	   low-­‐magnification	   image	   after	   4	   weeks	   implantation	   (Fig.	   2-­‐1-­‐10a)	  
showed	  that	  the	  cement	  specimen	  (C)	  was	  partially	  in	  direct	  contact	  with	  the	  host	  and	  newly	  formed	  
bones,	  without	  the	  formation	  of	  fibrous	  tissue	  layers.	   	   The	  high-­‐magnification	  image	  in	  Fig.	  2-­‐1-­‐10b	  
shows	   newly	   formed	   bones	   (N)	   stained	   with	   dark	   purple	   around	   the	   cement	   specimen.	   	   A	  
low-­‐magnification	   image	   after	   24	   weeks	   implantation	   (Fig.	   2-­‐1-­‐10c)	   showed	   that	   the	   cement	  
specimen	  was	   also	   partially	   in	   direct	   contact	  with	   the	   host	   and	   newly	   formed	   bones,	  without	   the	  
formation	  of	  fibrous	  tissue	  layers,	  regardless	  of	  the	  tissue	  reaction	  in	  the	  bone-­‐marrow	  cavity.	   	   The	  
high-­‐magnification	   image	   in	   Fig.	   2-­‐1-­‐10d	   revealed	   that	   newly	   formed	   bones	   reached	   maturity	   as	  
mature	  bones	   (M),	   as	   indicated	  by	   the	   light	  purple	   areas,	   and	   continued	   to	  be	   formed	  around	   the	  
mature	  bones	  shown	  by	  dark	  purple	  areas	  (N).	   	   These	  results	   indicate	  that	  the	  cement	  specimens	  
are	   osteoconductive	   materials	   and	   that	   IP6	   surface	   modification	   of	   HAp	   did	   not	   affect	   the	  





In	  the	  present	  study,	  optimization	  of	  the	  powder	  preparation	  process	  for	  cement	  fabrication	  was	  
investigated	   to	   develop	   IP6-­‐HAp	   cement	   with	   enhanced	   mechanical	   properties.	   	   The	   IP6-­‐HAp	  
powder	  prepared	  via	  wet	  milling	  and	  freeze-­‐drying	  had	  the	  smallest	  crystallite	  and	  median	  particle	  
sizes,	  and	  the	  largest	  SSA.	  
Lu	  et	  al.	  showed	  that	  the	  freeze-­‐drying	  method	  could	  produce	  highly	  homogeneous,	  fine-­‐grained	  
HAp	  powders	  (mean	  particle	  size:	  33	  nm)	  compared	  to	  heat-­‐dried	  HAp	  powders	  (mean	  particle	  size:	  
40	   nm)	   [8],	   whereas	   Hansen	   et	   al.	   reported	   that	   HAp	   particles	   tend	   to	   aggregate	   each	   other	   [9].	   	  
Although	  the	  IP6-­‐HAp	  powder	  prepared	  via	  the	  wet	  milling	  process	  had	  the	  smallest	  crystallite	  and	  
median	   particle	   sizes,	   and	   the	   largest	   SSA	   among	   the	   examined	   samples,	   the	   IP6-­‐HAp	   powders	  
themselves	  prepared	  via	  freeze-­‐drying	  process	  (HAp,	  IP6-­‐HAp,	  wet	  milled	  IP6-­‐HAp,	  and	  dry	  milled	  
IP6-­‐HAp)	  were	   slightly	   agglomerated.	   	   Thus,	   no	   obvious	   difference	   in	   the	   particle	  morphology	   of	  
the	  powders	  was	  observed	  in	  Figs.	  2-­‐1-­‐3a-­‐d.	   	   The	  crystallite	  size	  of	  the	  heat-­‐dried	  IP6-­‐HAp/110°C	  
powder	   was	   more	   than	   that	   of	   the	   freeze-­‐dried	   HAp	   powder,	   which	   was	   in	   agreement	   with	   the	  
results	   by	   Lu	   et	   al.	   [8].	   	   In	   the	   case	   of	   the	   calcining	   process,	   the	   IP6-­‐HAp	   powders	   were	   partly	  
decomposed	   into	   the	   β-­‐TCP	   phase	   between	   600	   and	   800°C.	   	   These	   phenomena	   were	   consistent	  
with	  the	  results	  of	  Marković	  et	  al.	  and	  Kannan	  et	  al.	  [10,11].	   	   Marković	  et	  al.	  demonstrated	  that	  HAp	   	  










Fig.	   2-­‐1-­‐3	   	   Particle	  morphologies	   of	   the	   as-­‐synthesized	  HAp	   and	   IP6-­‐HAp	   powders:	   (a)	  HAp,	   (b)	  
IP6-­‐HAp,	  (c)	  wet	  milled	  IP6-­‐HAp,	  (d)	  dry	  milled	  IP6-­‐HAp,	  (e)	  IP6-­‐HAp/110°C,	  (f)	  IP6-­‐HAp/600°C,	  (g)	  
IP6-­‐HAp/800°C,	  (h)	  IP6-­‐HAp/1000°C,	  and	  (i)	  IP6-­‐HAp/1200°C.	  
	  
	  
	   	  













	   	  









Fig.	   2-­‐1-­‐5	   	   Natural	   logarithm	   of	   the	   compressive	   strength	   as	   a	   function	   of	   the	   relative	   porosity.	   	  
Data	  were	  plotted	  using	  the	  values	  in	  Fig.	  4.	  
	  
	   	  










Fig.	  2-­‐1-­‐6	   	   The	  microstructures	  of	  the	  cement	  fracture	  surfaces:	  (a)	  HAp	  (P/L=1/0.35	  [g/cm3]),	  (b)	  
IP6-­‐HAp	  cement	  (P/L=1/0.35),	  and	  (c)	  wet	  milled	  IP6-­‐HAp	  cement	  (P/L=1/0.35).	  
	  
	   	  










Fig.	  2-­‐1-­‐7	   	   Relationship	  between	  the	  compressive	  strength	  and	  SSA	  of	  cement	  powders	  fabricated	  
at	  a	  P/L	  ratio	  of	  1/0.35	  [g/cm3].	  
	  
	   	  










Fig.	  2-­‐1-­‐8	   	   Comparison	  of	  cell	  proliferation	  on	  (a)	  wet	  milled	  HAp	  (P/L=1/0.3	  [g/cm3])	  and	  (b)	  wet	  
milled	  IP6-­‐HAp	  (P/L=1/0.3)	  cement	  specimens.	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Fig.	   2-­‐1-­‐10	   	   Histological	   observations	  of	  wet	  milled	   IP6-­‐HAp	   cement	   specimens	   stained	  with	  TB.	   	  
At	  4	  weeks	  implantation	  (a	  and	  b),	  newly	  formed	  bones	  (N)	  were	  partially	  in	  direct	  contact	  with	  the	  
cement	  specimens	  (C).	   	   At	  24	  weeks	  implantation	  (c	  and	  d),	  newly	  formed	  bones	  reached	  maturity	  
as	   mature	   bones	   (M).	   	   Figures	   10(b)	   and	   (d)	   are	   highly	   magnified	   images	   of	   (a)	   and	   (c),	  
respectively.	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containing	  1	  wt%	  of	  carbonate	  decomposed	  from	  HAp	  to	  β-­‐TCP	  at	  nearly	  790°C	  [10],	  and	  Kannan	  et	  
al.	   reported	   that	   calcium-­‐deficient	   apatite	   partially	   transformed	   from	  HAp	   to	   β-­‐TCP	   between	   700	  
and	   800°C	   [11].	   	   The	   present	   HAp	   powder	   synthesized	   via	   a	   wet	   chemical	   process	   was	  
carbonate-­‐containing	  HAp,	  and	  the	  Ca/P	  ratio	  of	  the	  HAp	  powder	  (Ca/P=1.69)	  was	  higher	  than	  the	  
stoichiometric	  value	  (Ca/P=1.67).	   	   Therefore,	   the	   IP6-­‐HAp	  powders	  were	  partly	  decomposed	   into	  
β-­‐TCP	  between	  600	  and	  800°C	  during	  the	  calcining	  process.	  
Aizawa	   et	   al.	   reported	   that	   adsorption	   of	   IP6	   on	   the	   surface	   of	   commercially-­‐available	   HAp	  
powders	   using	   zeta-­‐potential	   measurements	   [1].	   	   The	   zeta-­‐potential	   of	   the	   present	   IP6-­‐HAp	  
powder	   (−23.0±0.6	   mV)	   was	   less	   than	   that	   of	   the	   as-­‐synthesized	   HAp	   powder	   (−6.2±0.7	   mV).	   	  
Ganesan	   and	   Epple	   reported	   that	   the	   zeta-­‐potential	   of	   a	   prepared	   calcium-­‐phytate	   complex	   was	  
negatively	   charged	   (−52	   to	   −6	   mV)	   [12],	   which	   suggests	   that	   the	   IP6	   chelates	   Ca2+	   ions	   of	   HAp	  
particle	  surfaces.	  
The	  highest	   compressive	   strength	  among	   the	  examined	  cement	   specimens	   (23.1±2.1	  MPa)	  was	  
obtained	   from	   the	  wet	  milled	   IP6-­‐HAp	   cement	   (P/L=1/0.35	   [g/cm3]),	  which	  was	   higher	   than	   our	  
target	   compressive	   strength	   (more	   than	   15	   MPa)	   for	   clinical	   application	   such	   as	   osteoporotic	  
vertebral	   fracture,	   because	  normal	   compressive	   strength	  of	   a	   vertebral	   body	   is	   about	  6	  MPa	   [13].	   	  
Therefore,	  it	  is	  considered	  that	  the	  wet	  milled	  IP6-­‐HAp	  powder	  would	  be	  effective	  for	  the	  fabrication	  
of	  cement	  specimens	  with	  enhanced	  mechanical	  properties.	  
Ishikawa	   and	   Asaoka	   reported	   that	   an	   increase	   in	   the	   P/L	   ratio	   leads	   to	   an	   increase	   in	   the	  
compressive	  strength	  of	  the	  cement	  specimen	  [14],	  which	  was	  also	  confirmed	  in	  the	  present	  study,	  
as	   shown	   in	   Fig.	   2-­‐1-­‐4.	   	   Therefore,	   one	   of	   the	   reasons	   why	   the	   maximum	   compressive	   strength	  
(23.1±2.1	  MPa)	  was	  obtained	  from	  the	  wet	  milled	  IP6-­‐HAp	  powder	  was	  an	  increase	  in	  the	  P/L	  ratio	  
(P/L=1/0.35	  [g/cm3]).	  
The	  strength	  of	  ceramics	  has	  a	  strong	  correlation	  with	  porosity,	  in	  accordance	  with	  the	  relation	  
reported	  by	  Duckworth	  [15]:	  
	  
S	  =	  S0exp(−KP)	   	   	   	   	   	   	   	   (3)	  
	  
where	  S	   is	  the	  compressive	  strength	  of	  the	  porous	  material,	  S0	   is	  the	  ideal	  compressive	  strength	  of	  
the	  material,	  K	   is	   a	   constant,	   and	  P	   is	   the	   porosity.	   	   Equation	   (4)	   can	   be	   obtained	   by	   taking	   the	  
natural	  logarithm	  of	  Eq.	  (3).	  
	  
lnS	  =	  lnS0－KP	   	   	   	   	   	   	   	   (4)	  
	  
Figure	  2-­‐1-­‐5	  shows	  a	  linear	  relation	  between	  the	  natural	  log	  of	  the	  compressive	  strength	  and	  the	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relative	   porosity,	   which	   corresponds	   with	   the	   linear	   relation	   for	   the	   same	   cement	   powders,	   as	  
reported	   by	   Ishikawa	   and	   Asaoka	   [14],	   and	   Barralet	   et	   al.	   [16].	   	   To	   determine	   the	   maximum	  
compressive	   strength	   of	   the	   calcium-­‐phosphate	   cement	   (CPC)	   in	   the	   TTCP-­‐DCPA	   system,	   they	  
demonstrated	   the	   linear	   relationship	   between	   the	   compressive	   strength	   of	   CPC	   and	   the	   porosity	  
using	   different	   compression	   pressures	   with	   one	   type	   of	   calcium-­‐phosphate	   powder.	   	   However,	  
some	   of	   the	   present	   data	   for	   the	   cement	   powders	   were	   scattered	   around	   the	   approximate	   line.	   	  
Seven	  types	  of	  HAp	  powders	  were	  used	  for	  cement	   fabrication	   in	  the	  present	  study;	   therefore,	   the	  
variety	  of	  the	  cement	  powders	  with	  different	  powder	  properties	  may	  be	  the	  reason	  for	  the	  scatter	  of	  
data	  for	  all	  powders	  around	  the	  approximated	  linear	  relation.	  
Horiguchi	   et	   al.	   previously	   reported	   that	   the	   compressive	   strength	   of	   a	   chelate-­‐setting	   HAp	  
cement	   fabricated	  using	  commercially-­‐available	  HAp	  powders	  was	  enhanced	  by	   lower	  crystallinity	  
and	   higher	   SSA	   than	   those	   of	   the	   starting	   HAp	   powders	   [3].	   	   The	   increase	   in	   the	   compressive	  
strength	   with	   the	   SSA	   of	   the	   cement	   powders	   (Fig.	   2-­‐1-­‐7)	   suggests	   that	   IP6-­‐HAp	   powders	   with	  
higher	   SSA	   could	   not	   only	   provide	  many	   chelating	   sites	   on	   the	  HAp	  particles,	   but	   also	   have	   small	  
particle	  size,	  which	  would	  lead	  to	  the	  better	  compaction	  of	  the	  cement	  particles.	   	   Consequently,	  the	  
compressive	  strength	  of	  cement	  specimens	  was	  enhanced.	   	   This	  hypothesis	  supports	  the	  maximum	  
compressive	  strength	  of	  the	  wet	  milled	  IP6-­‐HAp	  cement	  specimen,	  because	  the	  wet	  milled	  IP6-­‐HAp	  
powder	   has	   the	   highest	   SSA	   and	   the	   smallest	  median	   particle	   size	   among	   the	   examined	   IP6-­‐HAp	  
powders.	   	   Thus,	   it	   is	   considered	   that	   the	   enhancement	   in	   the	   compressive	   strength	   of	   the	   wet	  
milled	   IP6-­‐HAp	   cement	   was	   archived	   by	   higher	   SSA	   and	   smaller	   particle	   size	   of	   the	   IP6-­‐HAp	  
powders.	  
Regarding	  in	  vitro	  evaluation	  of	  IP6-­‐HAp	  cements,	  Aizawa	  et	  al.	  reported	  that	  osteoblast-­‐like	  cells	  
indirectly	   cultured	   with	   the	   HAp	   and	   IP6-­‐HAp	   cements	   using	   Transwell®	   kit	   did	   not	   show	  
cytotoxicity	   till	   day	   4	   [1].	   	   In	   the	   present	   study,	   even	   though	   the	   cells	   were	   directly	   seeded	   and	  
cultured	   on	   the	   cement	   specimens,	   no	   significant	   differences	   in	   the	   number	   of	   cells	   and	   the	  
morphology	   were	   observed	   between	   the	   wet	   milled	   HAp	   cements	   with	   and	   without	  
surface-­‐modification	  of	  IP6	  (Fig.	  2-­‐1-­‐8).	   	   The	  results	  clarify	  that	  IP6	  surface	  modification	  of	  the	  wet	  
milled	  HAp	  did	  not	  affect	  the	  biocompatibility	  of	  the	  cement	  specimen.	  
HAp	  bioceramics	  are	  osteoconductive	  and	  HAp	  makes	  direct	  contact	  with	  host	  bones	  and	  newly	  
formed	  bones	  [17,18]	  via	  apatite	  layers	  formed	  on	  the	  surface	  of	  implanted	  HAp	  bioceramics	  [17,19].	   	  
The	   present	   in	   vivo	   histological	   studies	   revealed	   that	   the	   wet	   milled	   IP6-­‐HAp	   cement	   specimens	  
were	  also	  osteoconductive	  materials.	   	   However,	  it	  is	  unclear	  whether	  apatite	  layers	  were	  formed	  on	  
the	   interface	  between	   the	  bones	  and	   IP6-­‐HAp	  cement;	   therefore,	   further	   in	   vivo	   studies	  and	  detail	  
analyses	  will	  be	  necessary.	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2.1.4	  Summary	  
	  
The	  effect	  of	   the	  powder	  preparation	  process	  on	  the	  morphology,	  particle	  size,	  and	  SSA	  of	  HAp	  
cement	  powders	  was	  examined,	  and	  the	  mechanical	  properties	  of	  resultant	  cement	  specimens	  were	  
evaluated	  with	  an	  aim	  to	  fabricate	  the	  IP6-­‐HAp	  cement	  with	  enhanced	  mechanical	  properties.	   	   The	  
smallest	  crystallite	  and	  median	  particle	  sizes,	  and	  the	  highest	  SSA	  were	  obtained	  from	  the	  wet	  milled	  
IP6-­‐HAp	  powder.	   	   The	  resulting	  cement	  specimens	  had	  the	  maximum	  compressive	  strength	  among	  
the	   cement	   specimens	   examined	   at	   23.1±2.1	   MPa	   for	   a	   P/L	   ratio	   of	   1/0.35	   [g/cm3],	   which	   was	  
achieved	   by	   a	   reduction	   in	   porosity	   of	   the	   cement	   specimens	   and	   the	   better	   compaction	   of	   the	  
smallest	   wet	   milled	   IP6-­‐HAp	   powders.	   	   No	   significant	   difference	   in	   the	   cell	   proliferation	   and	  
morphology	  between	   the	  wet	  milled	  HAp	  cements	  with	  and	  without	   IP6	   surface	  modification	  was	  
observed	   in	   vitro	   evaluation.	   	   In	   vivo	   histological	   studies	   revealed	   that	   the	   IP6-­‐HAp	   cement	  
specimens	  were	   in	  direct	   contact	  with	  host	  bones	  and	  newly	   formed	  bones	  as	  an	  osteoconductive	  
material.	   	   Thus,	  the	  wet	  milled	  IP6-­‐HAp	  powder	  is	  effective	  for	  the	  fabrication	  of	  the	  chelate-­‐setting	  
HAp	  cement	  with	  enhanced	  mechanical	  properties.	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2.2	  Fabrication	  of	  chelate-­‐setting	  cements	  using	  hydroxyapatite	  powder	  prepared	  




The	   starting	   cement	   powder	   for	   the	   cement	   fabrication	   was	   previously	   prepared	   by	  
surface-­‐modification	  with	  IP6	  after	  ball-­‐milling	  of	  the	  HAp	  powder	  (hereafter,	  conventional	  process)	  
[1-­‐4].	   	   In	   section	   2.2,	   a	   novel	   powder	   preparation	   process	   (hereafter,	   modified	   process)	   for	   the	  
cement	   fabrication	   was	   established,	   in	   which	   the	   starting	   HAp	   powders	   were	   prepared	   by	  
ball-­‐milling	  and	  simultaneously	  surface-­‐modifying	  the	  commercially-­‐	  available	  HAp	  powders	  in	  the	  
IP6	  solution	  [5].	   	   Afterward,	  the	  effect	  of	  the	  IP6	  concentration	  on	  the	  material	  properties,	  such	  as	  
compressive	  strength,	  setting	  time,	  handling	  property	  (consistency),	  and	  anti-­‐washout	  property,	  of	  




2.2.1	  Materials	  and	  methods	  
	  
2.2.1.1	  Preparation	  of	  HAp	  powder	  surface-­‐modified	  with	  IP6	  
Inositol	  phosphate	  (IP6)	  solutions	  with	  concentrations	  of	  0,	  1000,	  5000,	  7000,	  10000,	  and	  20000	  
ppm	   were	   prepared	   using	   50	   mass%	   phytic	   acid	   (Wako	   Pure	   Chemical	   Industries,	   Ltd.),	   and	  
adjusting	  to	  pH	  7.3	  with	  NaOH	  solution	  (0.1	  mol·dm-­‐3).	   	   Ten	  grams	  of	  commercially-­‐available	  HAp	  
powder	   (HAp-­‐100,	   Taihei	   Chemical	   Industrial	   Co.,	   Ltd.,	   Japan)	   was	   ground	   and	   its	   surface	   was	  
simultaneously	  modified	  by	  milling	  with	  50	  cm3	  of	  IP6	  solution	  using	  a	  planetary	  mill	  (Pulverisette	  6,	  
Fritsch,	  Germany)	  for	  2	  h	  at	  a	  rotation	  rate	  of	  300	  rpm	  in	  a	  ZrO2	  pot	  with	  fifty	  of	  ZrO2	  beads	  with	  10	  
mm	   in	   diameter.	   	   After	   ball-­‐milling,	   the	   slurry	  mixture	  was	   filtrated	   and	   freeze-­‐dried	   for	   24	   h	   to	  
obtain	  IP6	  surface-­‐modified	  HAp	  powders.	   	   Hereafter,	  sample	  labels	  are	  employed;	  for	  example,	  the	  
HAp	  powder	  surface-­‐modified	  with	  10000	  ppm	  IP6	  is	  denoted	  “10000-­‐IP6-­‐HAp”.	  
	  
2.2.1.2	  Characterization	  of	  IP6-­‐HAp	  powder	  
Inductively	  coupled	  plasma-­‐atomic	  emission	  spectroscopy	  (ICP-­‐AES;	  SPS7800,	  Hitachi	  High-­‐Tech	  
Science,	   Japan)	   was	   used	   to	  measure	   the	   amount	   of	   IP6	   adsorbed	   on	   the	   surface	   of	   the	   IP6-­‐HAp	  
powders.	   	   The	   slurry	  was	   centrifuged	   after	   ball-­‐milling	   and	   the	   supernatant	  was	   collected.	   	   The	  
concentration	   of	   phosphorus	   (P)	   in	   each	   supernatant	   was	   measured	   using	   the	   ICP-­‐AES.	   	   The	  
amount	  of	  IP6	  adsorbed	  on	  the	  surface	  of	  the	  HAp	  powder	  was	  calculated	  from	  the	  difference	  in	  the	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concentrations	  of	  P	  before	  and	  after	  ball	  milling.	  
The	  ζ-­‐potential	  of	  the	  IP6-­‐HAp	  powders	  was	  measured	  at	  25°C	  using	  a	  laser-­‐Doppler	  velocimeter	  
(ELS-­‐6000,	  Otsuka	  Electronics,	  Japan)	  in	  a	  10	  mmol·dm-­‐3	  NaCl	  solution.	  
The	   median	   particle	   size	   of	   the	   IP6-­‐HAp	   powders	   was	   measured	   with	   a	   laser	   particle	   size	  
analyzer	   (LA-­‐300,	  Horiba,	   Japan).	   	   Approximately	   1	  mg	   of	   the	   IP6-­‐HAp	  powder	  was	   dispersed	   in	  
distilled	  water	  by	  ultrasonication	  for	  3	  min.	  
The	   surface	  morphology	   of	   the	   IP6-­‐HAp	  powders,	   sputter-­‐coated	  with	  Au,	  was	   observed	   using	  
scanning	  electron	  microscopy	  (SEM;	  VE-­‐9800,	  Keyence,	  Japan)	  at	  an	  accelerating	  voltage	  of	  1.3	  kV.	  
The	   IP6-­‐HAp	   particles	   were	   also	   observed	   using	   transmission	   electron	   microscopy	   (TEM;	  
JEM-­‐2100F,	  JEOL,	  Japan)	  at	  an	  accelerating	  voltage	  of	  200	  kV.	   	   Samples	  were	  dispersed	  in	  ethanol	  
and	  collecting	  them	  onto	  carbon-­‐coated	  copper	  grids	  (300	  mesh,	  Agar	  Scientific,	  UK).	  
The	   specific	   surface	   area	   (SSA)	   of	   the	   IP6-­‐HAp	   powders	   was	   determined	   by	   the	  
Brunauer-­‐Emmett-­‐Teller	  (BET)	  method	  (Flowsorb	  III,	  Shimadzu,	  Japan).	  
The	   elution	   of	   calcium	   (Ca)	   and	   phosphorus	   (P)	   from	   the	   IP6-­‐HAp	   powders	  was	  measured	   by	  
shaking	   0.25	   g	   of	   each	   IP6-­‐HAp	   powder	   in	   5	   cm3	   of	   pure	   water	   for	   desired	   periods.	   	   After	   the	  
shaking,	  the	  supernatant	  was	  collected	  by	  centrifuging	  the	  mixtures	  and	  the	  concentration	  of	  Ca	  and	  
P	  was	  examined	  by	  the	  ICP-­‐AES.	  
	  
2.2.1.3	  Preparation	  of	  IP6-­‐HAp	  cement	  paste	  and	  its	  evaluation	  
The	   IP6-­‐HAp	  cement	  paste	  was	  prepared	  by	  mixing	   the	   IP6-­‐HAp	  powder	  and	  distilled	  water	  at	  
various	  powder/liquid	  ratios	  (P/L=[g/cm3]).	   	   The	  consistency	  of	  the	  resulting	  cement	  paste,	  as	  an	  
indicator	  of	  handling	  property,	  was	  evaluated	  by	  the	  following	  method.	   	   Glass	  plates	  (120	  g)	  were	  
placed	  on	  the	  cement	  paste	  (0.5	  cm3)	  and	  the	  spread	  area	  was	  measured	  after	  5	  min	  using	  the	  Image	  
J	  software	  (public	  domain	  software	  by	  National	  Institute	  of	  Health,	  USA).	  
Specimens	  for	  compressive	  strength	  (CS)	  measurements	  were	  prepared	  by	  hardening	  the	  cement	  
paste	   in	   a	   cylindrical	   Teflon®	   mold	   (6	   mm	   in	   diameter	   and	   12	   mm	   in	   height)	   for	   24	   h	   at	   room	  
temperature.	   	   The	   CS	   was	   measured	   using	   a	   universal	   testing	   machine	   (Autograph	   AGS-­‐X,	  
Shimadzu,	  Japan)	  with	  a	  5	  kN	  load	  cell	  at	  a	  crosshead	  speed	  of	  500	  μm·min-­‐1.	  
The	  fracture	  surface	  microstructure	  of	  the	  cement	  was	  investigated	  using	  the	  SEM.	  The	  relative	  
density	  (RD)	  of	  the	  cements	  was	  calculated	  from	  the	  measured	  density	  of	  the	  cylindrical	  specimen	  
divided	  by	  the	  theoretical	  density	  of	  HAp	  (3.16	  g·cm-­‐3).	  
After	  preparation	  of	   the	  cement	  pastes,	   the	  setting	  time	  of	   the	  cement	  paste	  packed	  in	  a	  plastic	  
mold	   (8	  mm	   in	   diameter	   and	   2	  mm	   in	   height)	   was	  measured	   at	   the	   desired	   period	   using	   a	   light	  
Gillmore	  needle	  (113.4	  g).	  
The	  anti-­‐washout	  property	  of	  the	  cement	  pastes	  was	  tested	  according	  to	  the	  literature	  [20]	  with	  
	   44	  
some	  modifications.	   	   A	  spherical	  cement	  paste	  (about	  1	  cm	  in	  diameter)	  was	  immersed	  in	  distilled	  
water,	  instead	  of	  a	  saliva-­‐like	  solution,	  at	  0.5,	  1,	  3,	  6,	  and	  24	  h	  after	  cement	  preparation.	   	   After	  each	  
immersion,	  the	  sample	  was	  judged	  by	  naked-­‐eye	  observation.	   	   The	  test	  cement	  was	  deemed	  to	  pass	  





2.2.2.1	  Characterization	  of	  prepared	  IP6-­‐HAp	  powder	  
Figures	  2-­‐2-­‐1A	  and	  B	  show	  the	  amounts	  of	  IP6	  adsorbed	  on	  the	  HAp	  powder	  and	  the	  ζ-­‐potential	  
as	   functions	   of	   the	   IP6	   concentration,	   respectively.	   	   The	   amount	   of	   IP6	   adsorbed	   on	   the	   HAp	  
powder	   was	   normalized	   according	   to	   the	   SSA	   value.	   	   The	   amounts	   of	   IP6	   adsorbed	   on	   the	   HAp	  
powder	   increased	   with	   the	   IP6	   concentration	   (Fig.	   2-­‐2-­‐1A),	   and	   the	   ζ-­‐potential	   decreased	   (Fig.	  
2-­‐2-­‐1B).	   	   The	  adsorption	  of	  IP6	  to	  the	  HAp	  powder	  resulted	  in	  a	  negative	  ζ-­‐potential,	  because	  IP6	  
has	  twelve	  negative	  hydroxyl	  groups.	   	   The	  ζ-­‐potential	  almost	  reached	  a	  plateau	  at	  more	  than	  10000	  
ppm;	  however,	  the	  amount	  of	  IP6	  adsorbed	  on	  the	  HAp	  powder	  did	  not	  reach	  the	  total	  saturation.	  
Figures	   2-­‐2-­‐2	   shows	   correlation	   between	   ζ-­‐potential	   and	   amount	   of	   IP6	   adsorbed	   on	   the	   HAp	  
powder.	   	   Linear	   relation	   between	   ζ-­‐potential	   and	   adsorbed	   amount	   of	   IP6	   was	   obtained,	   and	  
ζ-­‐potential	  decreased	  with	  increasing	  adsorbed	  amount	  of	  IP6.	  
The	  median	  particle	  size	  of	  the	  IP6-­‐HAp	  powder	  decreased	  with	  increasing	  IP6	  concentration;	  7.6	  
μm	  for	  1000-­‐IP6-­‐HAp	  and	  4.2	  μm	  for	  20000-­‐IP6-­‐HAp	  (Fig.	  2-­‐2-­‐3).	  
Figure	  2-­‐2-­‐4	  shows	   the	  SEM	  micrographs	  of	   the	   IP6-­‐HAp	  powders.	   	   In	  Fig.	  2-­‐2-­‐4a,	  20	  μm	  HAp	  
particle	   agglomerates	   are	   evident,	   as	   indicated	   by	   the	   arrows.	   	   Figures	   2-­‐2-­‐4b-­‐f	   show	   that	   the	  
number	  of	  the	  HAp	  particle	  agglomerates	  decreased	  with	  increasing	  IP6	  concentration;	  IP6	  surface	  
modification	  of	  HAp	  inhibits	  the	  agglomeration	  of	  HAp	  particles.	   	   These	  results	  are	  consistent	  with	  
the	  decrease	  in	  the	  median	  size	  of	  the	  prepared	  powders.	   	   Highly-­‐magnified	  SEM	  images	  revealed	  
no	  significant	  difference	  in	  the	  surface	  morphology	  of	  each	  powder.	  
The	  morphology	  of	  the	  IP6-­‐HAp	  particles	  was	  examined	  in	  detail	  using	  the	  TEM.	   	   Figure	  2-­‐2-­‐5a	  
shows	   that	   without	   IP6	   surface-­‐modification,	   the	   HAp	   primary	   particles	   are	   agglomerated.	   	   In	  
contrast,	   an	   increase	   of	   the	   IP6	   concentration	   led	   to	   improved	   dispersion	   of	   the	   HAp	   primary	  
particles	   (Fig.	   2-­‐2-­‐5b-­‐d),	  which	  may	  be	   ascribed	   to	   the	  mutual	   repulsion	   of	   their	   negative	   surface	  
charges.	  
To	  confirm	  the	  stability	  of	  the	  IP6	  adsorbed	  on	  the	  prepared	  powder,	  the	  elution	  of	  Ca	  and	  P	  from	  
each	   IP6-­‐HAp	   powder	   was	   measured	   using	   the	   ICP-­‐AES	   (Fig.	   2-­‐2-­‐6).	   	   Calcium	   and	   phosphorus	  
elution	  was	  detected	  for	  the	  5000,	  7000	  and	  10000-­‐IP6-­‐HAp	  powders,	  but	  was	  barely	  significant	  for	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the	   0	   and	   1000-­‐IP6-­‐HAp	   powders.	   	   The	   Ca	   elution	   was	   detected	   in	   the	   5000,	   7000	   and	  
10000-­‐IP6-­‐HAp	  powders,	  which	  suggests	  that	  these	  powders	  may	  be	  partially	  dissolved.	  
	  
2.2.2.2	  Evaluation	  of	  some	  properties	  of	  IP6-­‐HAp	  cement	  
The	  handling	  property	  of	  the	  cement	  pastes	  was	  evaluated	  by	  measuring	  the	  consistency.	   	   The	  
consistency	  of	   the	  cement	  pastes	   increased	  with	  decreasing	  P/L	  ratio	   (Fig.	  2-­‐2-­‐7).	   	   Moreover,	   the	  
P/L	  ratios	  of	   the	  5000	  and	  10000-­‐IP6-­‐HAp	  cement	  pastes	  (1/0.5-­‐1/0.7)	  were	  higher	  than	  those	  of	  
the	  0	  and	  1000-­‐IP6-­‐HAp	  cement	  pastes	  (1/0.9-­‐1/1.2).	  
Figures	   2-­‐2-­‐8a	   and	   b	   show	   the	   compressive	   strength	   (CS)	   and	   relative	   density	   (RD)	   of	   the	  
resulting	  cement	  specimens,	   respectively.	   	   The	  CS	  generally	  has	  a	   strong	  correlation	  with	  RD	  and	  
the	  P/L	  ratio;	  reduction	  of	  the	  P/L	  ratio	  leads	  to	  a	  decrease	  in	  the	  RD	  of	  the	  cement	  specimen,	  and	  
consequently	  to	  a	  low	  CS	  [14,16,21].	   	   As	  expected,	  CS	  and	  RD	  decreased	  with	  a	  reduction	  of	  the	  P/L	  
ratio.	   	   The	   CS	   and	   RD	   of	   the	   5000	   and	   10000-­‐IP6-­‐HAp	   cement	   specimens	   (P/L=1/0.5-­‐1/0.7	  
[g/cm3])	   were	   much	   higher	   than	   the	   corresponding	   values	   for	   the	   0	   and	   1000-­‐IP6-­‐HAp	   cement	  
specimens	   (1/0.9-­‐1/1.2).	   	   The	  maximum	   CS	   obtained	   from	   the	   examined	   cement	   specimens	  was	  
9.9±1.9	  MPa	  for	  the	  10000-­‐IP6-­‐HAp	  cement	  (1/0.5).	  
The	  setting	  times	  of	  the	  cement	  pastes	  is	  given	  in	  Table	  2-­‐2-­‐1.	   	   The	  setting	  time	  was	  shortened	  
with	   the	   increase	   of	   the	   P/L	   ratio,	   and	   that	   for	   the	   5000	   and	   10000-­‐IP6-­‐HAp	   cement	   pastes	  was	  
approximately	  30	  min.	  
Figure	  2-­‐2-­‐9	  show	  relationship	  between	  compressive	  strength	  and	  relative	  density	  of	  the	  cement	  
specimens	   fabricated	   at	   various	   P/L	   ratios.	   	   The	   CS	   of	   the	   cement	   specimens	   increased	  
exponentially	  with	  RD	  of	  the	  cement	  specimens.	  
The	   CS,	   RD,	   setting	   time,	   and	   anti-­‐washout	   property	   of	   the	   cement	   pastes	   prepared	   from	   four	  
different	  IP6-­‐HAp	  powders	  are	  compared	  in	  the	  following,	  where	  the	  cement	  pastes	  have	  almost	  the	  
same	   level	   of	   consistency:	   0-­‐IP6-­‐HAp	   (P/L=1/1.2	   [g/cm3]),	   1000-­‐IP6-­‐HAp	   (1/1.2),	   5000-­‐IP6-­‐HAp	  
(1/0.5)	  and	  10000-­‐IP6-­‐HAp	  (1/0.6).	  
Figure	  2-­‐2-­‐10	  shows	  comparison	  of	  CS	   for	   these	  cement	  specimens.	   	   Despite	   the	  same	   level	  of	  
consistency,	  the	  CS	  for	  the	  5000	  and	  10000-­‐IP6-­‐HAp	  cement	  specimens	  was	  much	  higher	  than	  that	  
for	   the	  0	  and	  1000-­‐IP6-­‐HAp	  cement	   specimens.	   	   The	  RD	  of	   the	  5000	  and	  10000-­‐IP6-­‐HAp	  cement	  
specimens	  was	  more	  than	  10%	  higher	  than	  those	  of	  the	  0	  and	  1000-­‐IP6-­‐HAp	  cement	  specimens,	  as	  
shown	  in	  Figure	  2-­‐2-­‐8b.	  
Figure	  2-­‐2-­‐11	  showing	  the	  microstructure	  of	  the	  fracture	  surfaces	  reveals	  that	  many	  micropores	  
were	   present	   between	   the	   particles	   in	   the	   fractured	   cement	   surfaces	   of	   the	   0	   and	   1000-­‐IP6-­‐HAp	  
cement	  specimens,	  as	   indicated	  by	   the	  arrows.	   	   In	  contrast,	   the	   fracture	  surfaces	  of	   the	  5000	  and	  
10000-­‐IP6-­‐HAp	  cement	  specimens	  had	  quite	  smooth	  surfaces.	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The	   results	   of	   the	   anti-­‐washout	   property	   testing	   are	   shown	   in	   Fig.	   2-­‐2-­‐12.	   	   At	   6	   h	   after	   the	  





Although	   the	  ζ-­‐potential	  almost	  reached	  a	  plateau	  at	  more	   than	  10000	  ppm,	   the	  amount	  of	   IP6	  
adsorbed	  on	  the	  HAp	  powder	  did	  not	  reach	  the	  total	  saturation	  (Fig.	  2-­‐2-­‐1),	  which	  explains	  why	  the	  
powder	  could	  not	  be	  completely	  washed	  after	   filtration,	  and	   thus,	   the	  prepared	  powder	  contained	  
physically	   trapped	   IP6.	   	   The	   trapped	   IP6	   molecules	   were	   released	   during	   the	   ζ-­‐potential	  
measurement,	  causing	  the	  ζ-­‐potential	  to	  reach	  a	  plateau.	  
In	  previous	  studies,	  sodium	  citrate	  or	  sodium	  hexametaphosphate	  were	  employed	  for	  the	  surface	  
modification	  of	  calcium-­‐phosphate	  cement	  (CPC)	  particles	  [22-­‐25];	  the	  surface	  of	  the	  CPC	  reactants	  
was	   modified	   by	   adsorption	   of	   sodium	   citrate	   or	   sodium	   hexametaphosphate,	   improving	   the	  
dispersion	   of	   the	   CPC	   reactants	   as	   a	   result	   of	   the	   increased	   negative	   surface	   charge.	   	   Fig.	   2-­‐2-­‐3	  
indicated	  that	  all	  the	  prepared	  IP6-­‐HAp	  powders	  were	  weakly	  agglomerated;	  however,	  the	  negative	  
surface	   charge	   of	   IP6-­‐HAp	   particles	   inhibited	   the	   agglomeration	   of	   individual	   particles	   due	   to	  
electrostatic	   repulsion	   [22,23].	   	   Consequently,	   the	  median	   particle	   size	   of	   the	   prepared	   powders	  
decreased	  with	  increasing	  IP6	  concentration,	  which	  are	  consistent	  with	  the	  increase	  in	  dispersion	  of	  
IP6-­‐HAp	  particles	  with	  the	  IP6	  concentration	  (Figs.	  2-­‐2-­‐4	  and	  2-­‐2-­‐5).	  
Most	   of	   the	   eluted	   P	   from	   each	   IP6-­‐HAp	   powder	   probably	   originates	   from	   IP6,	   because	  
physically-­‐adsorbed	  IP6	  on	  the	  surface	  of	  HAp	  particles	  could	  be	  eluted	  during	  shaking	  (Fig.	  2-­‐2-­‐6).	   	  
The	   elution	   of	   Ca	   detected	   in	   the	   5000,	   7000	   and	   10000-­‐IP6-­‐HAp	   powders	   suggests	   that	   these	  
powders	  may	   be	   partially	   dissolved.	   	   The	   HAp	   is	   generally	   regarded	   as	   the	  most	   stable	  material	  
among	  calcium	  phosphates.	   	   However,	  as	  Oonishi	  et	  al.	  [18]	  reported,	  low	  crystallinity	  HAp	  is	  more	  
soluble	   than	   highly	   crystalline	   HAp.	   	   The	   degree	   of	   crystallinity	   of	   the	   IP6-­‐HAp	   powders	   was	  
lowered	  with	  increasing	  IP6	  concentration	  (data	  not	  shown);	  therefore,	  a	  small	  amount	  of	  Ca	  and	  P	  
was	  eluted	  from	  the	  powders	  surface-­‐modified	  with	  high	  IP6	  concentrations,	  such	  as	  the	  5000,	  7000	  
and	   10000-­‐IP6-­‐HAp	   powders.	   	   In	   addition,	   elution	   of	   Ca	   may	   lead	   to	   a	   decrease	   in	   the	   median	  
particle	  size	  of	  the	  prepared	  powder;	  in	  the	  5000,	  7000	  and	  10000-­‐IP6-­‐HAp	  powders,	  the	  Ca2+	  ions	  
chelated	  by	  IP6	  were	  eluted	  from	  HAp	  particles	  during	  shaking,	  which	  resulted	  in	  a	  decrease	  of	  the	  
median	   particle	   size	   of	   the	   prepared	   powder.	   	   This	   result	   is	   consistent	   with	   the	   decrease	   in	   the	  
degree	  of	  crystallinity	  of	  the	  prepared	  powders.	  
The	  relation	  between	  the	  consistency	  and	  the	  P/L	  ratio	  is	  similar	  to	  that	  reported	  by	  Ishikawa	  et	  
al.	  [26];	  the	  increase	  in	  consistency	  of	  the	  cement	  pastes	  with	  decreasing	  P/L	  ratio	  (Fig.	  2-­‐2-­‐7).	   	  





Fig.	  2-­‐2-­‐1	   	   Amount	  of	  IP6	  adsorbed	  on	  the	  HAp	  powder	  (A)	  and	  ζ-­‐potential	  (B)	  as	  a	  function	  of	  the	  
IP6	  concentration.	  
	  
	   	  











Fig.	  2-­‐2-­‐2	   	   Correlation	  between	  ζ-­‐potential	  and	  amount	  of	  IP6	  adsorbed	  on	  the	  HAp	  powder.	  
	  
	  
	   	  










Fig.	  2-­‐2-­‐3	  Median	  particle	  size	  of	  the	  IP6-­‐HAp	  powders	  as	  a	  function	  of	  the	  IP6	  concentration.	  
	   	  







Fig.	  2-­‐2-­‐4	   	   SEM	  images	  showing	  the	  particle	  morphology	  of	  the	  IP6-­‐HAp	  powders:	  (a)	  0-­‐IP6-­‐HAp,	  
(b)	  1000-­‐IP6-­‐HAp,	  (c)	  5000-­‐IP6-­‐HAp,	  (d)	  7000-­‐IP6-­‐HAp,	  (e)	  10000-­‐IP6-­‐HAp,	  and	  (f)	  20000-­‐IP6-­‐HAp.	   	  
Arrows	  indicate	  aggregates.	  
	  
	   	  









Fig.	   2-­‐2-­‐5	   	   TEM	  micrographs	  providing	   the	  particle	  morphologies	  of	   IP6-­‐HAp:	   (a)	  0-­‐IP6-­‐HAp,	   (b)	  
1000-­‐IP6-­‐HAp,	  (c)	  5000-­‐IP6-­‐HAp,	  and	  (d)	  10000-­‐IP6-­‐HAp.	  
	  
	   	  






Fig.	  2-­‐2-­‐6	  Elution	  of	  Ca	  (A)	  and	  P	  (B)	  from	  the	  IP6-­‐HAp	  powders.	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Fig.	   2-­‐2-­‐7	   	   Consistency	   of	   the	   cement	   pastes	   prepared	   at	   various	   P/L	   ratios:	   (a)	   0-­‐IP6-­‐HAp,	   (b)	  
1000-­‐IP6-­‐HAp,	  (c)	  5000-­‐IP6-­‐HAp,	  and	  (d)	  10000-­‐IP6-­‐HAp.	  
	   	  















	   	  








1/0.5	   -­‐	   -­‐	   31±2	   34±2	  
1/0.6	   -­‐	   -­‐	   69±2	   72±3	  
1/0.7	   -­‐	   -­‐	   97±3	   125±9	  
1/0.8	   -­‐	   53±4	   -­‐	   -­‐	  
1/0.9	   104±8	   91±7	   -­‐	   -­‐	  
1/1.0	   141±5	   131±5	   -­‐	   -­‐	  
1/1.1	   158±4	   153±9	   -­‐	   -­‐	  
1/1.2	   170±4	   163±3	   -­‐	   -­‐	  





Fig.	  2-­‐2-­‐8	   	   Compressive	  strength	  (A)	  and	  relative	  density	  (B)	  of	  the	  cement	  specimens	  fabricated	  at	  
various	  P/L	  ratios:	  (a)	  0-­‐IP6-­‐HAp,	  (b)	  1000-­‐IP6-­‐HAp,	  (c)	  5000-­‐IP6-­‐HAp,	  and	  (d)	  10000-­‐IP6-­‐HAp.	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Fig.	  2-­‐2-­‐9	  Relationship	  between	  compressive	  strength	  and	  relative	  density	  of	  the	  cement	  specimens	  
fabricated	   at	   various	   P/L	   ratios:	   (a)	   0-­‐IP6-­‐HAp,	   (b)	   1000-­‐IP6-­‐HAp,	   (c)	   5000-­‐IP6-­‐HAp,	   and	   (d)	  
10000-­‐IP6-­‐HAp.	  
	  
	   	  










Fig.	  2-­‐2-­‐10	   	   Compressive	  strength	  of	  the	  cement	  specimens	  prepared	  with	  almost	  the	  same	  level	  of	  
consistency:	   (a)	   compressive	   strength,	   (b)	   consistency,	   0-­‐IP6-­‐HAp	   (P/L=	   1/1.2	   [g/cm3]),	  
1000-­‐IP6-­‐HAp	  (1/1.2),	  5000-­‐IP6-­‐HAp	  (1/0.5),	  and	  10000-­‐IP6-­‐HAp	  (1/0.6).	  
	   	  










Fig.	   2-­‐2-­‐11	   	   Microstructure	   of	   the	   fracture	   surface	   of	   the	   cement	   specimens:	   (a)	   0-­‐IP6-­‐HAp	  
(P/L=1/1.2	  [g/cm3]),	  (b)	  1000-­‐IP6-­‐HAp	  (1/1.2),	  (c)	  5000-­‐IP6-­‐HAp	  (1/0.5),	  and	  (d)	  10000-­‐IP6-­‐HAp	  
(1/0.6).	   	   Arrows	  indicate	  micropores.	  
	  
	   	  












Fig.	   2-­‐2-­‐12	   	   Overview	  of	   the	   results	   for	   the	   anti-­‐washout	  property	   test	   of	   typical	   cement	  pastes:	  
0-­‐IP6-­‐HAp	  (P/L=1/1.2	  [g/cm3]),	  1000-­‐IP6-­‐HAp	  (1/1.2),	  5000-­‐IP6-­‐HAp	  (1/0.5),	  and	  10000-­‐IP6-­‐HAp	  
(1/0.6).	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However,	   the	  5000	  and	  10000-­‐IP6-­‐HAp	  powders	  with	  negative	  charge	   less	   than	  −20	  mV	  provided	  
the	  workable	  cement	  pastes	  with	  a	  small	  amount	  of	  mixing	  solution,	   i.e.,	  at	  higher	  P/L	  ratio.	   	   The	  
cement	   pastes	   prepared	  with	   a	   smaller	   amount	   of	  mixing	   solution	   resulted	   in	   cement	   specimens	  
with	  higher	  RD,	  and	  this	  may	  be	  the	  main	  reason	  for	  the	  higher	  CS	  of	  the	  5000	  and	  10000-­‐IP6-­‐HAp	  
cement	  specimens	  than	  those	  of	  the	  0-­‐	  and	  1000-­‐IP6-­‐HAp	  cement	  specimens.	   	   The	  fracture	  surfaces	  
of	  the	  5000	  and	  10000-­‐IP6-­‐HAp	  cement	  specimens	  had	  quite	  smooth	  surfaces	  with	  less	  micropores,	  
which	  reflect	  the	  RD	  results	  (Fig.	  2-­‐2-­‐8).	  
The	  shorter	  setting	   times	   for	   the	  5000	  and	  10000-­‐IP6-­‐HAp	  cement	  pastes	   than	  those	   for	  0	  and	  
1000-­‐IP6-­‐HAp	   cement	   pastes	   was	   due	   to	   the	   difference	   in	   the	   P/L	   ratios;	   the	   5000	   and	  
10000-­‐IP6-­‐HAp	  cement	  pastes	  were	  prepared	  from	  mixtures	  with	  almost	  half	  the	  water	  content	  of	  
the	  0	  and	  1000-­‐IP6-­‐HAp	  cement	  pastes	  (1/1.2	  [g/cm3]).	  
Regarding	  the	  setting	  time	  and	  anti-­‐washout	  time,	  those	  may	  be	  too	  long	  for	  clinical	  application.	   	  
This	   is	   presumably	   due	   to	   the	   use	   of	   distilled	   water	   as	   a	   mixing	   solution,	   which	   is	   not	   explicitly	  
involved	   in	   the	  setting	   reaction	  of	   the	  cement.	   	   Therefore,	   as	  previously	   reported,	  when	  cohesion	  
promoters	  such	  as	  chitosan	  [27],	  hydroxypropyl	  methylcellulose	  [28]	  and	  sodium	  alginate	  [29]	  are	  
used	  in	  this	  cement	  system,	  it	  is	  expected	  that	  the	  setting	  time	  and	  the	  anti-­‐washout	  time	  would	  be	  
shortened.	   	   However,	   we	   did	   not	   examine	   cohesion	   promoters	   in	   the	   present	   study,	   but	   instead	  
focused	  on	  the	  effect	  of	  IP6	  concentration	  on	  the	  material	  properties	  of	  the	  cement.	  
The	   handling	   property	   of	   the	   cement	   paste	   is	   an	   important	   factor	   for	   clinical	   application.	   	  
Several	   attempts	   have	   been	   made	   to	   improve	   the	   handling	   feasibility	   of	   cement	   pastes	   by	   (i)	  
changing	   viscosity	   or	   (ii)	   the	   interactions	   between	   the	   CPC	   reactant	   surfaces.	   	   Sodium	   citrate	  
[22-­‐24]	  and	  sodium	  hexametaphosphate	  [25]	  can	  be	  used	  to	  change	  the	  viscosity	  by	  modification	  of	  
the	   surface	   of	   the	   CPC	   reactants,	  which	   leads	   to	   a	   liquefying	   effect	   in	   the	   cement	   paste	   due	   to	   an	  
increase	  in	  the	  negative	  surface	  charge.	   	   The	  liquefying	  effect	  was	  macroscopically	  observed	  in	  the	  
5000	  and	  10000-­‐IP6-­‐HAp	  cement	  pastes.	   	   Figure	  2-­‐2-­‐7	   clearly	   shows	   that	   the	   liquefying	  effect	   of	  
the	  5000	  and	  10000-­‐IP6-­‐HAp	  cement	  pastes	  enables	  low	  water	  content	  and	  workable	  cements	  to	  be	  
prepared	  with	  much	  higher	  CS	  than	  cements	  prepared	  from	  the	  0	  and	  1000-­‐IP6-­‐HAp	  cement	  pastes.	   	  
It	  was	  confirmed	  that	  IP6	  surface	  modification	  (by	  adsorption)	  could	  change	  electrostatic	  interaction	  
between	   HAp	   particle	   surfaces;	   mutual	   repulsion	   of	   individual	   particles	   in	   the	   cement	   paste.	   	  
Incidentally,	  the	  liquefying	  effect	  of	  cement	  paste	  is	  well-­‐known	  as	  a	  mean	  to	  reduce	  water-­‐induced	  
porosity	  [23,30].	  
One	   of	   the	   most	   important	   factors	   for	   controlling	   the	   CS	   of	   a	   cement	   specimen	   is	   RD	   [22].	   	  
Increasing	   RD	   allows	   fabrication	   of	   higher	   CS	   cement	   specimens.	   	   The	   RD	   of	   the	   5000	   and	  
10000-­‐IP6-­‐HAp	  cement	   specimens	  was	  much	  higher	   than	   that	  of	   the	  0	  and	  1000-­‐IP6-­‐HAp	  cement	  
specimens	   as	   the	   result	   of	   the	   liquefying	   effect	   in	   the	   cement	   paste.	   	   Thus,	   the	   CS	   of	   the	   cement	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specimens	  is	  enhanced	  as	  a	  result	  of	  an	  increase	  in	  RD.	   	   In	  addition,	  the	  results	  for	  the	  elution	  of	  Ca	  
and	  P	  (Fig.	  2-­‐2-­‐6)	  suggest	  that	  dissolution-­‐precipitation	  reactions	  of	  the	  IP6-­‐HAp	  powder	  may	  also	  
contribute	   to	   the	   setting	   of	   the	   cement,	   where	   the	   precipitation	   of	   HAp	   is	   assumedly	   caused	   by	  
eluted	  Ca	  and	  P.	  
The	   surface	   modification	   during	   ball-­‐milling	   in	   the	   present	   study	   may	   also	   be	   effective	   for	   a	  
dicalcium	  phosphate	  anhydrous	  (CaHPO4;	  DCPA)-­‐TTCP	  cement	  system.	   	   To	  adjust	  the	  particle	  size	  
in	   the	   DCPA-­‐TTCP	   cement	   system,	   the	   DCPA	   powder	   is	   generally	   ground	   in	   ethanol	   to	   prevent	  
agglomeration	   [23,31].	   	   If	   a	   liquefying	   agent	   such	   as	   sodium	   citrate	   [22-­‐24]	   or	   sodium	  
hexametaphosphate	  [25]	  is	  used	  in	  the	  milling	  solvent	  instead	  of	  ethanol,	  the	  agent	  may	  be	  adsorbed	  
onto	   the	   surface	   of	   DCPA,	   which	   would	   result	   in	   deagglomerated	   particles	   with	   negative	   surface	  
charges.	   	   Thus,	   the	   liquefying	  effect	  of	  DCPA-­‐TTCP	  cement	  could	  be	  accomplished	  as	  described	   in	  
some	  reports	  [22-­‐25].	  
Furthermore,	   from	   a	   clinical	   perspective,	   injectable	   CPC	   is	   required	   for	   minimally-­‐invasive	  
treatment;	  however,	  conventional	  CPC	  is	  not	  injectable,	  but	  is	  disturbed	  by	  the	  filter-­‐pressing	  effect	  
during	  injection,	  which	  causes	  liquid-­‐solid	  phase	  separation	  [32].	   	   Gbureck	  et	  al.	  have	  reported	  that	  
the	  liquefying	  effect	  also	  improves	  the	  injection	  properties	  of	  CPC	  [22].	   	   Thus,	  chelate-­‐setting	  HAp	  
cements	   fabricated	   from	   the	   5000	   to	   10000-­‐IP6-­‐HAp	   powders,	   in	  which	   the	   liquefying	   effect	  was	  





The	  effect	  of	   IP6	  concentration,	  used	   for	  surface-­‐modification,	  on	   the	  CS,	   setting	   time,	  consistency,	  
and	   anti-­‐washout	   property	   of	   the	   resulting	   chelate-­‐setting	   HAp	   cement	   was	   investigated.	   	   The	  
amount	   of	   IP6	   adsorbed	   on	   the	   surface	   of	   the	   HAp	   powders	   increased	   with	   increasing	   IP6	  
concentration,	   which	   led	   to	   more	   negative	   charge	   on	   the	   powder	   surface.	   	   Dispersion	   of	   the	  
IP6-­‐HAp	   powders	   was	   improved	   with	   increasing	   IP6	   concentration	   due	   to	   mutual	   electrostatic	  
repulsion	   as	   a	   result	   of	   the	   negative	   surface	   charges.	   	   A	  workable	   cement	   paste	  with	   a	   high	   P/L	  
ratio	  was	   prepared	   from	   the	   IP6-­‐HAp	   powder	  with	   negative	   surface	   charge	   of	   less	   than	   −20	  mV.	   	  
The	   surface	   modification	   with	   5000	   and	   10000	   ppm	   IP6	   improved	   the	   handling	   property	   of	   the	  
cement	   paste,	   which	   could	   be	   used	   as	   paste-­‐like	   artificial	   bone.	   	   The	   CS	   of	   the	   resulting	   cement	  
specimens	  increased	  from	  1.4	  MPa	  to	  8.3	  MPa	  with	  the	  RD.	   	   Thus,	  HAp	  powders	  surface-­‐modified	  
with	   5000	   to	   10000	   ppm	   IP6	   are	   effective	   for	   the	   fabrication	   of	   IP6-­‐HAp	   cements	  with	   enhanced	  
material	   properties.	   	   The	   chelate-­‐setting	   HAp	   cement	   with	   controlled	   IP6	   concentration	   is	  
promising	  for	  application	  as	  an	  injectable	  artificial	  bone	  using	  a	  minimally-­‐invasive	  technique.	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In	   section	   2.2,	   a	   novel	   powder	   preparation	   process	   (modified	   process)	   was	   successfully	  
developed.	   	   However,	   the	   adsorption	   behavior	   of	   IP6	   on	   the	   surface	   of	   HAp	   in	   conventional	   and	  
modified	   processes	   is	   not	   studied	   in	   detail.	   	   In	   section	   2.3,	   comparison	   of	   powder	   preparation	  
process	   between	   the	   conventional	   and	   modified	   processes	   using	   commercially-­‐available	   HAp	  
powder	  was	  examined	  [6].	   	   In	  addition,	  the	  adsorption	  behavior	  of	  IP6	  on	  the	  surface	  of	  HAp	  was	  
circumstantially	  examined	  to	  clarify	  the	  chelating	  mechanism	  of	  IP6.	  
	  
	  
2.3.1	  Materials	  and	  methods	  
	  
2.3.1.1	  Preparation	  of	  HAp	  powders	  
Inositol	   phosphate	   (IP6)	   solutions	  with	   concentrations	   of	   1000,	   3000,	   5000,	   7000,	   10000,	   and	  
20000	  ppm	  were	  prepared	  using	  phytic	  acid	  (50	  mass%	  phytic	  acid,	  Wako,	  Japan),	  and	  adjusted	  to	  
pH	  7.3	  with	  NaOH	  solution.	  
In	  order	  to	  prepare	  the	  HAp	  powders	  surface-­‐modified	  with	  IP6	  at	  the	  conventional	  process,	  ten	  
grams	  of	  commercially-­‐available	  HAp	  powder	  (HAp-­‐100,	  Taihei	  Chemical	  Industrial	  Co.,	  Ltd.,	  Japan)	  
was	  ground	  with	  50	  cm3	  of	  pure	  water	  using	  a	  planetary	  mill	  (Pulverisette	  6,	  Fritsch,	  Germany)	  for	  2	  
h	  at	  a	  rotation	  rate	  of	  300	  rpm	  in	  a	  ZrO2	  pot	  with	  fifty	  of	  ZrO2	  beads	  with	  10	  mm	  in	  diameter.	   	   After	  
ball-­‐milling,	   the	   slurry	  was	   filtrated	   and	   freeze-­‐dried	   for	   24	   h	   to	   obtain	   ball-­‐milled	  HAp	  powders.	   	  
One	  gram	  of	  ball-­‐milled	  HAp	  powder	  was	  surface-­‐modified	  with	  1000-­‐10000	  ppm	  IP6	  (40	  cm3)	  by	  
shaking	  for	  5	  h	  at	  37°C,	  filtrated,	  and	  then	  freeze-­‐dried.	   	   Hereafter,	  sample	  labels	  are	  employed;	  for	  
example,	  the	  HAp	  powder	  surface-­‐modified	  with	  10000	  ppm	  IP6	  at	  conventional	  process	  is	  denoted	  
as	  “10000-­‐c-­‐IP6-­‐HAp”.	  
In	  order	  to	  prepare	  HAp	  powders	  surface-­‐modified	  with	  IP6	  at	  the	  modified	  process,	  ten	  grams	  of	  
commercially-­‐available	  HAp-­‐100	  powder	  was	  ground	  and	   its	  surface	  was	  simultaneously	  modified	  
by	   milling	   with	   50	   cm3	   of	   IP6	   solution	   (1000-­‐20000	   ppm)	   using	   a	   planetary	   mill	   for	   2	   h	   at	  
above-­‐mentioned	   same	   conditions.	   	   After	   ball-­‐milling,	   the	   slurry	   was	   filtrated	   and	   freeze-­‐dried.	   	  
Hereafter,	  sample	  labels	  are	  employed;	  for	  example,	  the	  HAp	  powder	  surface-­‐modified	  with	  10000	  
ppm	  IP6	  at	  modified	  process	  is	  denoted	  as	  “10000-­‐m-­‐IP6-­‐HAp”.	  
	  
2.3.1.2	  Characterization	  of	  the	  prepared	  powders	  and	  their	  cements	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Inductively-­‐coupled	  plasma-­‐atomic	  emission	  spectroscopy	  (ICP-­‐AES;	  SPS7800,	  Hitachi	  High-­‐Tech	  
Science,	  Japan)	  was	  used	  to	  measure	  the	  amount	  of	  IP6	  adsorbed	  on	  the	  surface	  of	  the	  HAp	  powders.	  
The	  surface	  of	  c-­‐IP6-­‐HAp	  disc	  (10	  mm	  in	  diameter,	  1	  mm	  in	  thickness)	  was	  analyzed	  using	  X-­‐ray	  
photoelectron	   spectroscopy	   (XPS;	   JPS-­‐9010,	   JEOL,	   Japan),	   with	   MgKα	   radiation	   (1253.6	   eV)	  
operating	  at	  10	  kV.	   	   Spectrum	  between	  0	  and	  1100	  eV	  was	  recorded,	  and	  the	  binding	  energy	  was	  
referenced	  to	  the	  C1s	  hydrocarbon	  peak.	  
The	  median	  particle	  size	  and	  specific	  surface	  area	  (SSA)	  of	  the	  IP6-­‐HAp	  powders	  were	  measured	  
with	  a	  laser	  particle	  size	  analyzer	  (LA-­‐300,	  Horiba,	  Japan)	  and	  by	  a	  Brunauer-­‐Emmett-­‐Teller	  (BET)	  
method	  using	  a	  BET	  surface	  area	  analyzer	  (Flowsorb	  III,	  Shimadzu,	  Japan),	  respectively.	  
The	   particle	  morphology	   of	   the	   IP6-­‐HAp	   powders,	   sputter-­‐coated	  with	   Au,	   was	   observed	   by	   a	  
scanning	  electron	  microscopy	  (SEM;	  VE-­‐9800,	  Keyence,	  Japan).	  
The	  elution	  of	  IP6	  and	  calcium	  ions	  (Ca2+)	  from	  the	  prepared	  powders	  at	  the	  both	  processes	  was	  
measured	   by	   shaking	   0.5	   g	   of	   each	   IP6-­‐HAp	  powder	   prepared	   at	   the	   both	   processes	   in	   20	   cm3	   of	  
2-­‐[4-­‐(2-­‐Hydroxyethyl)-­‐	   1-­‐piperazinyl]	   ethanesulfonic	   acid	   (HEPES,	   pH	   7.0)	   for	   desired	   periods.	   	  
After	   the	   shaking,	   the	   supernatant	  was	   collected	  by	   centrifuging	   and	   then	   the	   concentration	  of	  Ca	  
and	  P	  in	  the	  supernatant	  was	  examined	  by	  the	  ICP-­‐AES.	   	   The	  elution	  of	  IP6	  and	  calcium	  ions	  (Ca2+)	  
from	  the	  cements	  was	  measured	  by	  immersing	  each	  IP6-­‐HAp	  cement	  with	  10	  mm	  in	  diameter	  and	  3	  





Figure	  2-­‐3-­‐1	  shows	  the	  amounts	  of	  IP6	  adsorbed	  on	  the	  surface	  of	  HAp	  powder	  as	  a	  function	  of	  
the	  amount	  IP6	  used.	   	   The	  amount	  of	  IP6	  adsorbed	  on	  the	  HAp	  powder	  was	  normalized	  for	  the	  SSA	  
value.	   	   In	   the	   conventional	   process,	   the	   amounts	   of	   IP6	   adsorbed	   on	   the	   HAp	   powder	   increased	  
with	  the	   IP6	  concentration,	  and	  reached	  the	  total	  saturation	  at	  more	  than	  3000	  ppm	  (Fig.	  2-­‐3-­‐1a).	   	  
In	   the	  modified	  process,	   the	   amounts	  of	   IP6	   adsorbed	  on	   the	  HAp	  powder	  did	  not	   reach	   the	   total	  
saturation	  even	  at	  20000	  ppm	  (Fig.	  2-­‐3-­‐1b).	  
The	  surface	  of	   IP6-­‐HAp	  was	  analyzed	  using	   the	  XPS.	   	   The	  XPS	  peaks	   from	  C1s	   core	   level	   in	   the	  
HAp	  with	  and	  without	  surface	  modification	  are	  shown	  in	  Fig.	  2-­‐3-­‐2A.	   	   Whereas	  the	  broad	  peaks	  at	  
286.7	  eV	  in	  the	  IP6-­‐HAp	  were	  detected,	  those	  were	  not	  detected	  in	  the	  0-­‐c-­‐HAp	  without	  IP6	  surface	  
modification.	   	   The	   peak	   separation	   of	   the	   10000-­‐c-­‐IP6-­‐HAp	   spectrum	   was	   fitted	   with	   Gaussian–
Lorentzian	  function	  (Fig.	  2-­‐3-­‐2B).	   	   The	  peak	  at	  286.7	  eV	  corresponded	  to	  C-­‐O	  bonding	  of	  IP6	  [33].	  
The	  median	  particle	  size	  of	  the	  IP6-­‐HAp	  powders	  was	  measured	  (Fig.	  2-­‐3-­‐3).	   	   The	  median	  size	  of	  
the	  IP6-­‐HAp	  powders	  decreased	  with	  increase	  in	  the	  IP6	  concentration:	  13.9	  μm	  for	  1000-­‐c-­‐IP6-­‐HAp	  	   	  











Fig.	   2-­‐3-­‐1	   	   Amounts	   of	   IP6	   adsorbed	   on	   the	   surface	   of	   HAp	   powder	   as	   a	   function	   of	   the	   used	  
amount	  of	  IP6:	  (a)	  conventional	  process	  and	  (b)	  modified	  process.	  
	   	  






Fig.	  2-­‐3-­‐2	   	   XPS	  spectrum	  at	  C1s	  core	  level:	  (A)	  the	  HAp	  with	  and	  without	  surface	  modification,	  (B)	  
peak	  separation	  of	  typical	  10000-­‐c-­‐IP6-­‐HAp	  spectrum.	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Fig.	  2-­‐3-­‐3	   	   Median	  particle	  size	  of	  the	  IP6-­‐HAp	  powders:	  (a)	  conventional	  process	  and	  (b)	  modified	  
process.	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to	  10.1	  μm	  for	  10000-­‐c-­‐IP6-­‐HAp	  at	  the	  conventional	  process,	  and	  7.6	  μm	  for	  1000-­‐m-­‐IP6-­‐HAp	  to	  4.2	  
μm	   for	   20000-­‐m-­‐IP6-­‐HAp	   at	   the	   modified	   process.	   	   The	   median	   particle	   size	   of	   the	   IP6-­‐HAp	  
powders	  at	  the	  modified	  process	  was	  lower	  than	  that	  at	  the	  conventional	  process.	  
Figure	   2-­‐3-­‐4	   shows	   the	   typical	   SEM	   micrographs	   of	   the	   IP6-­‐HAp	   powders	   prepared	   at	  
conventional	  process	  (Figs.	  2-­‐3-­‐4a-­‐d)	  and	  modified	  process	  (Figs.	  2-­‐3-­‐4e-­‐h).	   	   In	  Figs.	  4a	  and	  e,	  HAp	  
particle	  agglomerates	  more	  than	  20	  μm	  are	  evident.	   	   Figures	  3b-­‐d	  and	  f-­‐h	  show	  that	  the	  number	  of	  
the	   HAp	   particle	   agglomerates	   decreased	   with	   an	   increase	   in	   the	   IP6	   concentration;	   IP6	   surface	  
modification	  of	  HAp	  inhibits	  the	  agglomeration	  of	  HAp	  particles.	   	   These	  results	  are	  consistent	  with	  
the	  decrease	  in	  the	  median	  particle	  size	  of	  the	  prepared	  powders.	   	   However,	  difference	  in	  degree	  of	  
agglomeration	   between	   the	   conventional	   and	   modified	   processes	   could	   not	   be	   observed.	   	  
Highly-­‐magnified	   SEM	   images	   revealed	   no	   obvious	   difference	   in	   the	   surface	   morphology	   of	   each	  
powder.	  
Figure	  2-­‐3-­‐5	  shows	  elution	  of	  IP6	  and	  Ca2+	  ions	  from	  the	  IP6-­‐HAp	  powders.	   	   Elution	  of	  IP6	  from	  
the	  IP6-­‐HAp	  powders	  prepared	  at	  both	  the	  processes	  increased	  with	  the	  IP6	  concentration.	   	   Elution	  
of	  IP6	  from	  7000-­‐	  and	  10000-­‐m-­‐IP6-­‐HAp	  powders	  (Fig.	  2-­‐3-­‐5B)	  was	  more	  than	  that	  from	  the	  7000-­‐	  
and	  10000-­‐c-­‐IP6-­‐HAp	  powders	  (Fig.	  2-­‐3-­‐5	  A),	  whereas	  that	  from	  0-­‐,	  1000-­‐,	  3000-­‐	  and	  5000-­‐IP6-­‐HAp	  
powders	  prepared	  at	  the	  both	  processes	  was	  the	  same	  level	  (0-­‐4	  mg/g).	   	   Elution	  of	  Ca2+	  ions	  from	  
IP6-­‐HAp	  powders	  prepared	  at	  the	  both	  processes	  was	  less	  than	  that	  of	  IP6	  (Figs.	  2-­‐3-­‐5C	  and	  D).	  
Elution	  of	  IP6	  and	  Ca2+	  ions	  from	  the	  IP6-­‐HAp	  cements	  was	  measured	  (Figure	  2-­‐3-­‐6).	   	   Elution	  of	  IP6	  
from	   the	   IP6-­‐HAp	   cements	   prepared	   at	   both	   the	   processes	   increased	   with	   the	   IP6	   concentration	  
(Figs.	  2-­‐3-­‐6A	  and	  B),	  whereas	  that	  from	  IP6-­‐HAp	  cements	  prepared	  at	  the	  both	  processes	  was	  less	  
than	  that	  from	  IP6-­‐HAp	  powders	  prepared	  at	  the	  both	  processes.	   	   In	  contrast,	  elution	  of	  Ca2+	  ions	  
from	  IP6-­‐HAp	  cements	  prepared	  at	  the	  both	  processes	  decreased	  with	  increasing	  IP6	  concentration,	  





The	  adsorption	  efficiency	  of	  IP6	  in	  the	  modified	  process	  was	  lower	  than	  that	  in	  the	  conventional	  
process	   (Fig.	  2-­‐3-­‐1).	   	   The	  ball-­‐milling	  of	  HAp	  powder	  and	  surface	  modification	  of	   its	   surface	  with	  
IP6	  was	  simultaneously	  conducted	  at	  the	  modified	  process;	  thus,	  IP6	  once	  adsorbed	  on	  the	  surface	  
of	  HAp	  particles	  may	  desorb	  from	  the	  surfaces	  during	  ball-­‐milling.	  
As	  mentioned	  in	  section	  2.2,	  the	  IP6	  adsorption	  to	  the	  HAp	  powder	  results	  in	  a	  negative	  ζ-­‐potential,	  
because	  IP6	  has	  six	  negative	  phosphate	  groups.	   	   In	  the	  present	  study,	  the	  IP6-­‐HAp	  powder	  surfaces	  
at	  both	  the	  processes	  thought	  to	  be	  negative	  charge,	  as	  the	  amount	  of	  IP6	  adsorbed	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on	  the	  surface	  of	  HAp	  increased.	  
The	  XPS	  analyses	  reveal	  that	  the	  adsorption	  of	  IP6	  on	  the	  surface	  of	  HAp	  (Fig.	  2-­‐3-­‐2).	   	   Martin	  et	  
al.	  reported	  that	  IP6	  could	  chelate	  with	  Ca2+	  ions	  [34],	  whereas	  Kaufman	  reported	  that	  IP6	  had	  high	  
affinity	   for	  HAp	   [35].	   	   These	  reports	  also	  support	  on	   the	  adsorption	  of	   IP6	  on	   the	  surface	  of	  HAp	  
particles;	  however,	  it	  is	  still	  not	  clear	  that	  the	  chelation	  of	  Ca2+	  ions	  on	  the	  surface	  of	  HAp	  via	  single	  
IP6	  molecule	  could	  occur.	  
Yang	  et	  al.	  clarified	  by	  Raman	  spectroscopic	  study	  that	  IP6	  molecule	  adsorbed	  chemically	  on	  the	  
copper	  substrate	  surface	  via	  two	  coplanar	  phosphate	  groups	  in	  the	  single	  IP6	  molecule	  [36].	   	   These	  
imply	  that	  IP6	  also	  could	  adsorb	  with	  Ca2+	  ions	  on	  the	  surface	  of	  HAp	  via	  two	  phosphate	  groups	  in	  
the	   single	   IP6	   molecule,	   and	   the	   residual	   four	   phosphate	   groups	   can	   adsorb	   with	   Ca2+	   ions	   on	  
another	  surface	  of	  HAp	  particles.	  
We	  have	  previously	  reported	   that	   the	   increase	   in	   the	   IP6	  concentration	  of	  surface	  modification	  
improved	  dispersion	  of	   the	  HAp	  particles,	  which	  was	  caused	  by	  mutual	  repulsion	  of	   their	  negative	  
surface	   charges	   [5].	   	   The	   decrease	   in	  median	   particle	   size	   and	   the	   agglomerates	   of	   HAp	   powder	  
indicate	  that	  the	  dispersion	  of	  the	  HAp	  particle	  was	  improved	  by	  increase	  in	  amount	  of	  IP6	  adsorbed	  
on	   the	   surface	   of	   HAp.	   	   With	   compared	   to	   the	   median	   particle	   size	   between	   conventional	   and	  
modified	  processes,	  the	  degree	  in	  dispersion	  of	  the	  HAp	  particles	  at	  the	  modified	  process	  was	  higher	  
than	  that	  at	  conventional	  process.	   	   These	  results	  are	  because	  the	  IP6	  surface	  modification	  of	  HAp	  
was	  conducted	  during	  ball-­‐milling	  in	  IP6	  solution	  at	  the	  modified	  process,	  whereas	  the	  HAp	  powders	  
were	  surface-­‐modified	  after	  ball-­‐milling	  of	  the	  HAp	  at	  conventional	  process.	  
Despite	  of	   lower	  adsorbed	  amount	  of	  IP6	  at	  conventional	  process	  compared	  to	  that	  at	  modified	  
process,	   elution	  of	   IP6	   from	  7000-­‐	  and	  10000-­‐m-­‐IP6-­‐HAp	  powders	  was	  higher	   than	   that	   from	   the	  
7000-­‐	   and	   10000-­‐c-­‐IP6-­‐HAp	   powders	   prepared	   at	   the	   conventional	   process.	   	   The	   7000-­‐	   and	  
10000-­‐m-­‐IP6-­‐HAp	   powders	   could	   not	   be	   completely	   washed	   after	   filtration	   and	   the	   prepared	  
powders	   contained	   physically	   trapped	   IP6;	   thus,	   trapped	   IP6	   on	   those	   powders	   were	   released	  
during	  elution	  test.	   	   Moreover,	  as	  the	  trapped	  IP6	  increased	  with	  the	  IP6	  concentration,	  the	  elution	  
of	  IP6	  also	  increased	  with	  the	  IP6	  concentration.	   	   As	  for	  elution	  of	  Ca2+	  ions,	  that	  was	  mostly	  caused	  
by	   elution	   of	   IP6,	   because	   the	   eluted	   IP6	   during	   shaking	   presumably	   decalcified	   Ca2+	   ions	   on	   the	  
surface	   of	   IP6-­‐HAp.	   	   Indeed,	   the	   initial	   elution	   of	   IP6	   was	   different	   levels;	   however,	   the	   initial	  
elution	   of	   Ca2+	   ions	  was	   almost	   the	   same	   levels,	   which	   indicate	   that	   the	   elution	   of	   Ca2+	   ions	  was	  
caused	  by	  the	  elution	  of	  IP6.	  
Elution	  of	  IP6	  and	  Ca2+	  ions	  from	  the	  cements	  may	  occur	  from	  the	  surface	  of	  the	  cements;	  thus,	  
elution	  of	  IP6	  and	  Ca2+	  ions	  from	  the	  IP6-­‐HAp	  cements	  was	  lower	  than	  that	  from	  IP6-­‐HAp	  powders	  
prepared	  at	  the	  both	  processes.	   	   Increase	  in	  the	  elution	  of	  IP6	  with	  the	  IP6	  concentration	  was	  due	  
to	  trapped	  IP6	  on	  IP6-­‐HAp	  powders.	   	   In	  contrast,	  decrease	  in	  the	  elution	  of	  Ca2+	  ions	  with	  increas-­‐-­‐	   	  





Fig.	   2-­‐3-­‐4	   	   SEM	  micrographs	   of	   the	   IP6-­‐HAp	   powders:	   (a)-­‐(d)	   conventional	   process	   and	   (e)-­‐(h)	  
modified	  process,	   (a)	  0-­‐c-­‐IP6-­‐HAp,	   (b)	  1000-­‐c-­‐IP6-­‐HAp,	   (c)	  5000-­‐c-­‐IP6-­‐HAp,	   (d)	  10000-­‐c-­‐IP6-­‐HAp,	  
(e)	  0-­‐m-­‐IP6-­‐HAp,	  (b)	  1000-­‐m-­‐IP6-­‐HAp,	  (c)	  5000-­‐m-­‐IP6-­‐HAp,	  (d)	  10000-­‐m-­‐IP6-­‐HAp.	  
	  
	   	  









Fig.	   2-­‐3-­‐5	   	   Elution	   of	   IP6	   (A,	   B)	   and	   Ca2+	   ion	   (C,	   D)	   from	   the	   IP6-­‐HAp	   powders:	   (A)	   and	   (C)	  
conventional	  process	  and	  (B)	  and	  (D)	  modified	  process.	  
	  
	  
	   	  









Fig.	   2-­‐3-­‐6	   	   Elution	   of	   IP6	   (A,	   B)	   and	   Ca2+	   ion	   (C,	   D)	   from	   the	   IP6-­‐HAp	   cements:	   (A)	   and	   (C)	  
conventional	  process	  and	  (B)	  and	  (D)	  modified	  process.	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ing	   IP6	  concentration	  was	  due	  to	  chelating	  of	  Ca2+	   ions	  by	  the	  eluted	  IP6.	   	   In	   the	  case	  of	   IP6-­‐HAp	  
powders,	  the	  eluted	  IP6	  chelated	  the	  Ca2+	  ions,	  however,	  those	  were	  released	  during	  shaking.	   	   The	  
eluted	  IP6	  from	  the	  cements	  chelated	  the	  Ca2+	  ions,	  and	  those	  were	  removed	  by	  centrifugation	  after	  
elution	  test.	   	   Thus,	  the	  elution	  of	  Ca2+	  ions	  decreased	  with	  increasing	  IP6	  concentration	  in	  the	  case	  





Comparison	   of	   powder	   preparation	   process	   between	   the	   conventional	   and	  modified	   processes	  
using	   commercially-­‐available	   HAp	   powder	   was	   performed,	   together	   with	   investigation	   on	  
adsorption	  behavior	  of	   IP6	  on	   the	   surface	  of	  HAp	   to	   clarify	   the	   chelating	  mechanism	  of	   IP6.	   	   The	  
adsorbed	  amount	  of	   IP6	   increased	  with	   the	   IP6	  concentration	  at	  both	   the	  processes;	  however,	   the	  
adsorption	  efficiency	  of	  IP6	  at	  the	  modified	  process	  was	  lower	  than	  that	  at	  the	  conventional	  process.	   	  
The	  XPS	  study	  clearly	  revealed	  that	  the	  IP6	  adsorbed	  on	  the	  surface	  of	  HAp	  powders.	   	   The	  degree	  in	  
dispersion	  of	  the	  HAp	  particles	  at	  the	  modified	  process	  was	  higher	  than	  that	  at	  conventional	  process.	   	  
The	  elution	  of	  IP6	  from	  the	  7000-­‐	  and	  10000-­‐m-­‐IP6-­‐HAp	  powders	  prepared	  at	  the	  modified	  process	  
was	  less	  than	  that	  of	  the	  7000-­‐	  and	  10000-­‐c-­‐IP6-­‐HAp	  powders	  at	  the	  conventional	  process.	   	   Elution	  
of	   IP6	   from	   the	   IP6-­‐HAp	   cements	   prepared	   at	   both	   the	   processes	   increased	   with	   the	   IP6	  
concentration.	   	   The	  modified	  process	  is	  effective	  for	  preparation	  of	  highly-­‐dispersed	  HAp	  powders,	  
which	  are	  potentially	  applicable	  to	  fabrication	  of	  the	  chelate-­‐setting	  HAp	  cement.	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Chapter	  3.	   Fabrication	   of	   biodegradable	   β-­‐tricalcium	   phosphate	  
cements	  with	  anti-­‐washout	  properties	  and	  their	  evaluation	  
	  
	  
Due	   to	   slow	   hydrolysis	   of	   the	   crystalline	   β-­‐tricalcium	   phosphate	   (β-­‐TCP)	   to	   calcium-­‐deficient	  
hydroxyapatite	  (CDHA)	  [1],	  there	  is	  difficulty	  to	  create	  the	  biodegradable	  β-­‐TCP	  based	  cement	  using	  
neutral	   mixing	   solution.	   	   To	   break	   through	   the	   problem,	   Takahashi	   et	   al.	   [2]	   have	   previously	  
developed	  a	  prototype	  of	  chelate-­‐setting	  β-­‐TCP	  cement	  (IP6-­‐β-­‐TCP)	  using	  a	  chelating	  mechanism	  of	  
inositol	   phosphate	   (IP6),	   and	   Nishiyama	   et	   al.	   [3]	   have	   reported	   the	   biocompatibility	   and	  
osteoconductivity	  of	   the	   IP6-­‐β-­‐TCP	  cement.	   	   However,	   low	  mechanical	  and	  handling	  properties	  of	  
IP6-­‐β-­‐TCP	  cement	  made	  it	  impossible	  to	  apply	  it	  for	  a	  clinical	  use.	  
In	  Chapter	  3,	   improvements	  of	  mechanical,	   handling,	   anti-­‐washout	  properties	  of	   the	   IP6-­‐β-­‐TCP	  
cements	   were	   examined,	   together	   with	   cell-­‐culture	   test	   of	   the	   cements.	   	   In	   section	   3.1,	   effect	   of	  
addition	   of	   various	   polysaccharides	   such	   as	   sodium	   alginate,	   sodium	   dextran	   sulfate,	   sodium	  
chondroitin	  sulfate,	  and	  chitosan	  into	  mixing	  solution	  on	  the	  handling	  and	  mechanical	  properties	  of	  
IP6-­‐β-­‐TCP	   cements	   was	   investigated	   [4].	   	   In	   section	   3.2,	   the	   novel	   powder	   preparation	   process,	  
described	  in	  section	  2.2,	  Chapter	  2,	  was	  applied	  to	  fabrication	  of	  the	  IP6-­‐β-­‐TCP	  cement	  to	  investigate	  
the	  effect	  of	  milling	  time	  and	  IP6	  concentration	  on	  the	  material	  properties	  the	  resulting	  cement,	   in	  
particular,	   anti-­‐washout	   property	   [5].	   	   Moreover,	   the	   in	   vitro	   dissolution	   using	   a	   potentiometric	  
method	  and	  biocompatibility	  of	  the	  cement	   in	  vitro	  using	  osteoblasts	  and	   in	  vivo	  using	  a	  pig	  model	  
was	  examined.	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3.1	  Fabrication	  of	   chelate-­‐setting	  β-­‐tricalcium	  phosphate	   cements	  using	  various	  
polysaccharides	  as	  liquid	  components	  
	  
	  
In	   section	   3.1,	   effect	   of	   addition	   of	   various	   polysaccharides	   such	   as	   sodium	   alginate,	   sodium	  
dextran	  sulfate,	  sodium	  chondroitin	  sulfate,	  and	  chitosan	   into	  mixing	  solution	  on	  the	  handling	  and	  
mechanical	   properties	   of	   chelate-­‐setting	   β-­‐tricalcium	   phosphate	   (IP6-­‐β-­‐TCP)	   cements	   was	  
investigated	   [4].	   	   In	   cell-­‐culture	   test,	   resulting	   cement	   specimens	   were	   co-­‐cultured	   with	   the	  
osteoblast	  cells	  to	  evaluate	  biocompatibility	  of	  the	  cement.	  
	  
	  
3.1.1	  Materials	  and	  methods	  
	  
3.1.1.1	  Preparation	  of	  the	  ball-­‐milled	  β-­‐TCP	  powder	  
β-­‐tricalcium	  phosphate	  (β-­‐TCP)	  powder	  was	  purchased	  from	  Taihei	  Chemical	  Industrial	  Co.,	  Ltd	  
(Japan).	   	   The	  as-­‐received	  β-­‐TCP	  powder	  was	  ground	  for	  4	  h	  using	  a	  planetary	  ball-­‐mill	  (Pulverisette	  
6,	   Fritsch,	   Germany)	   to	   prepare	   the	   ball-­‐milled	   β-­‐TCP	   powder	   (hereafter,	   β-­‐TCP-­‐4h).	   	   The	  
ball-­‐milling	  conditions	  were	  as	  follows:	  a	  zirconia	  pot,	  zirconia	  beads	  with	  10	  mm	  in	  diameter,	  10	  g	  
of	  β-­‐TCP	  powder,	  40	  cm3	  of	  distilled	  water,	  and	  rotation	  rate	  of	  300	  rpm.	  
	  
3.1.1.2	  Surface	  modification	  of	  the	  ball-­‐milled	  β-­‐TCP	  powder	  with	  IP6	  and	  its	  characterization	  
Inositol	   phosphate	   (IP6)	   solution	   with	   concentrations	   of	   3000	   ppm	   was	   prepared	   using	   50	  
mass%	   phytic	   acid	   (Wako	   Pure	   Chemical	   Industries,	   Ltd.),	   and	   adjusting	   to	   pH	   7.3	   with	   NaOH	  
solution	  (0.1	  mol·dm-­‐3).	   	   Ten	  grams	  of	  ball-­‐milled	  β-­‐TCP	  powder	  (β-­‐TCP-­‐4h)	  was	  added	  into	  the	  IP6	  
solution	  (400	  cm3),	  and	  then	  stirred	  at	  400	  rpm	  for	  24	  h.	   	   The	  slurry	  mixture	  was	  freeze-­‐dried	  for	  
24	  h	  to	  prepare	  the	  β-­‐TCP	  powder	  surface-­‐modified	  with	  IP6	  (hereafter,	  IP6/β-­‐TCP-­‐4h).	  
An	  X-­‐ray	  diffractometer	  (XRD;	  MiniFlex,	  Rigaku,	  Japan),	  equipped	  with	  a	  CuKα	  radiation	  source,	  
was	   used	   to	  measure	   the	   diffraction	   pattern	   of	   the	   powder.	   	   Data	  were	   collected	   in	   the	   range	   of	  
2θ=10-­‐50°	  with	  a	  step	  size	  of	  0.04°	  and	  counting	  time	  of	  4	  s/step.	   	   The	  crystal	  phase	  was	  identified	  
by	  means	  of	  the	  JCPDS	  reference	  patterns	  for	  β-­‐TCP	  (#09-­‐0169)	  and	  HAp	  (#09-­‐0432).	  
The	   particle	   morphology	   of	   the	   powder	   was	   observed	   using	   a	   scanning	   electron	   microscope	  
(SEM;	  JSM-­‐6390LA,	  JEOL,	  Japan)	  at	  an	  accelerating	  voltage	  of	  10	  kV.	  
	  
3.1.1.3	  Preparation	  of	  IP6/β-­‐TCP-­‐4h	  cement	  paste	  and	  its	  evaluation	  
Six	   kinds	   of	   the	  mixing	   solutions	  with	   and	  without	   polysaccharides	  were	   prepared	   as	   given	   in	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Table	   3-­‐1-­‐1.	   	   Sodium	   alginate,	   sodium	   dextran	   sulfate,	   and	   sodium	   chondroitin	   sulfate	   were	  
purchased	  from	  Wako	  Pure	  Chemical	  Industries,	  Ltd.	  (Japan).	   	   Daichitosan-­‐coat	  GL	  (Chito	  GL)	  and	  
daichitosan	  W10	   (Chito	  W10)	   were	   received	   from	   Dainichiseika	   Color	   &	   Chemicals	   Mfg.	   Co.,	   Ltd.	  
(Japan).	   	   Chito	  GL	  was	  10%	   low-­‐molecular-­‐weight	   chitosan	  dissolved	   in	   1.4%	   lactic	   acid	   solution	  
(pH	  5.3).	   	   Chito	  W10	  was	  10%	  chitosan	  derivative	  dissolved	  in	  5.0%	  lactic	  acid	  solution	  (pH	  4.1).	  
To	   prepare	   the	   cement	   paste,	   IP6/β-­‐TCP-­‐4h	   powder	   was	   mixed	   with	   the	   mixing	   solutions	   at	  
various	  powder/liquid	  (P/L)	  ratios	  (P/L=	  1/0.45-­‐1/0.55	  [g/cm3]).	   	   For	  compressive	  strength	  (CS)	  
test,	  the	  resulting	  cement	  paste	  was	  packed	  in	  a	  cylindrical	  Teflon®	  mold	  (6	  mm	  in	  diameter	  and	  12	  
mm	  in	  height)	  and	  kept	  at	  37°C	  at	  100%	  humidity	  for	  about	  24	  h.	   	   The	  CS	  test	  was	  performed	  on	  
the	   cement	   specimens	   using	   a	   universal	   testing	   machine	   (Autograph	   AGS-­‐J,	   Shimadzu,	   Japan)	  
according	   to	   JIS	  T6602	  (Dental	  zinc	  phosphate	  cement).	   	   The	  crosshead	  speed	  was	  0.5	  mm·min-­‐1,	  
and	  a	   load	  cell	   of	  5	  kN	  was	  used.	   	   Six	   cement	   specimens	  were	   tested	   to	  obtain	   the	  average	  value	  
with	   the	   standard	   deviation.	   	   The	   relative	   density	   (RD)	   of	   the	   cement	   specimens	   was	   calculated	  
from	  the	  bulk	  density	  divided	  by	  the	  theoretical	  density	  of	  β-­‐TCP	  (3.07	  g/cm3).	  
To	   clarify	   the	   crystalline	   phase	   of	   the	   cement	   specimens	   after	   setting,	   the	   XRD	   pattern	   was	  
measured	  as	  mentioned	  above.	  
The	  microstructure	  of	  fractured	  cement	  surface	  fabricated	  at	  P/L=1/0.50	  [g/cm3]	  was	  observed	  
by	  the	  SEM	  at	  an	  accelerating	  voltage	  of	  10	  kV.	  
For	   measurement	   of	   consistency,	   the	   cement	   paste	   was	   prepared	   as	   mentioned	   above.	   	   The	  
resulting	  cement	  paste	  was	  evaluated	  according	  to	   JIS	  T6602	  as	   follows.	  Glass	  plates	  (200	  g)	  were	  
placed	  on	  the	  cement	  paste	  (0.2	  g)	  and	  the	  spread	  area	  was	  measured	  after	  2	  min.	  
The	   initial	   setting	   time	  was	  measured	   using	   a	   light	   Gillmore	   needle	   (113.4	   g)	   according	   to	   JIS	  
T6602.	   	   After	  preparation	  of	   the	   cement	  paste,	   the	   cement	  paste	  was	  packed	   in	  a	  plastic	  mold	   (8	  
mm	  in	  diameter	  and	  2	  mm	  in	  height).	   	   The	  setting	  time	  was	  measured	  at	  the	  desired	  period	  until	  
the	  cement	  paste	  was	  set.	  
	  
3.1.1.4	  In	  vitro	  evaluation	  of	  IP6/β-­‐TCP-­‐4h	  cement	  specimens	  
In	  order	  to	  examine	  the	  cytotoxicity	  of	  the	  cement	  specimens,	  a	  cell-­‐culture	  test	  of	  the	  IP6/β-­‐TCP	  
cement	  was	  performed.	   	   The	  cement	  specimens	   fabricated	  using	  Chond,	  Chito	  GL,	  and	  Chito	  W10	  
were	   chosen	   and	   sterilized	   by	   ethylene	   oxide	   gas.	   	   The	   used	   cell	   was	   an	   osteoblast-­‐like	   cell	  
(MC3T3-­‐E1).	   	   First,	  the	  MC3T3-­‐E1	  cells	  were	  seeded	  into	  12	  well	  tissue	  culture	  plates	  at	  a	  density	  
of	  6×104	  cells/well	  and	  cultured	  for	  1	  day.	   	   The	  cement	  specimens	  were	  then	  set	  on	  a	  membrane	  of	  
Transwell®	  kit	  (Corning,	  USA)	  to	  culture	  the	  cells	  in	  a	  humidified	  5%	  CO2	  balanced-­‐air	  incubator	  at	  
37°C	  for	  5	  days.	   	   Cell	  proliferation	  was	  examined	  by	  counting	  using	  an	  erythro-­‐cytometer.	  
	   	  











Table	  3-­‐1-­‐1	   	   Mixing	  solutions	  for	  cement	  fabrication.	  
	  
Abbreviation	   Concentration	  
(mass%)	  
Additive	   Solvent	  
Water	   0	   -­‐	   -­‐	  
Alg	   2	   Sodium	  alginate	   3000	  ppm	  IP6	  
Dex	   20	   Sodium	  dextran	  sulfate	   3000	  ppm	  IP6	  
Chond	   20	   Sodium	  chondroitin	  sulfate	   3000	  ppm	  IP6	  
Chito	  GL	   10	   Chitosan	   Lactic	  acid	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3.1.2	  Results	  
	  
3.1.2.1	  Characterization	  of	  IP6/β-­‐TCP	  powders	  
Figure	  3-­‐1-­‐1	  shows	  the	  typical	  XRD	  patterns	  of	  (a)	  commercially	  available	  β-­‐TCP	  powder	  before	  
ball-­‐milling	   (hereafter,	   β-­‐TCP-­‐0h),	   (b)	   β-­‐TCP-­‐0h	   powder	   ball-­‐milled	   for	   4	   h	   (β-­‐TCP-­‐4h)	   and	   (c)	  
β-­‐TCP-­‐4h	  powder	  surface-­‐modified	  with	  IP6	  (IP6/β-­‐TCP-­‐4h).	   	   The	  XRD	  pattern	  of	  β-­‐TCP-­‐0h	  shows	  
a	  typical	  β-­‐TCP	  single	  phase	  and	  high	  crystallinity	  (Fig.	  3-­‐1-­‐1a).	   	   The	  XRD	  patterns	  of	  β-­‐TCP-­‐4h	  and	  
IP6/β-­‐TCP-­‐4h	  also	  show	  the	  β-­‐TCP	  single	  phase	  (Figs.	  3-­‐1-­‐1b	  and	  c).	   	   These	  results	  show	  that	  each	  
powder	  maintains	  the	  β-­‐TCP	  single	  phase	  even	  after	  ball-­‐milling	  in	  water.	   	   Moreover,	  no	  changes	  in	  
the	  crystal	  phases	  could	  be	  detected	  before	  and	  after	  surface	  modification	  with	  IP6.	  
To	   examine	   the	   particle	   morphologies	   of	   β-­‐TCP-­‐4h	   powder	   before	   and	   after	   IP6	   surface	  
modification,	  SEM	  observation	  was	  carried	  out.	   	   Figure	  3-­‐1-­‐2	  reveals	  that	  the	  particle	  morphology	  
of	  the	  two	  powders	  is	  not	  influenced	  by	  the	  IP6	  surface	  modification.	  
Table	   3-­‐1-­‐2	   gives	  median	   particle	   size,	   specific	   surface	   area	   (SSA),	   and	   zeta-­‐potential	   of	   β-­‐TCP	  
powders	  [2].	   	   The	  median	  particle	  size	  of	  β-­‐TCP-­‐4h	  and	  IP6/β-­‐TCP-­‐4h	  decreased	  after	  ball-­‐milling	  
and	   IP6	   surface	  modification	   of	   β-­‐TCP-­‐0h,	   and	   the	   SSA	   of	   β-­‐TCP-­‐4h	   and	   IP6/β-­‐TCP-­‐4h	   increased.	   	  
The	  zeta-­‐potential	  of	  IP6/β-­‐TCP-­‐4h	  decreased	  by	  IP6	  surface	  modification.	  
	  
3.1.2.2	  Preparation	  of	  IP6/β-­‐TCP-­‐4h	  cement	  paste	  and	  its	  evaluations	  
In	  order	  to	  evaluate	  the	  handling	  property	  of	  cement	  paste,	  consistency	  of	  the	  cement	  paste	  was	  
examined	   (Fig.	   3-­‐1-­‐3).	   	   The	   consistency	   of	   the	   cement	   paste	   using	   water	   was	   much	   higher	   than	  
those	  of	   the	  cement	  pastes	  using	  mixing	  solutions	  containing	  various	  polysaccharides	  as	  additives.	   	  
Difference	  in	  consistency	  among	  the	  P/L	  ratios	  could	  not	  be	  confirmed.	   	   These	  results	  suggest	  that	  
the	   consistencies	   of	   the	   cement	   pastes	   using	  mixing	   solutions	   containing	   additives	   have	   a	   higher	  
viscosity	   than	   the	   cement	   pastes	   using	   water.	   	   Furthermore,	   when	   five	   types	   of	   additives	   in	   the	  
present	  study	  were	  used,	  the	  cement	  paste	  with	  the	  same	  level	  of	  consistency	  could	  be	  obtained.	  
Next,	   the	   setting	   time	   of	   IP6/β-­‐TCP-­‐4h	   cement	   paste	   using	   Chito	   W10	   was	   measured.	   	   The	  
setting	   time	   of	   cement	   paste	   at	   P/L=1/0.50	   and	   1/0.55	   [g/cm3]	   was	   8.0±1.0	   and	   20±1.0	   min,	  
respectively.	   	   The	  setting	  time	  of	  P/L=1/0.50	  was	  shorter	  compared	  with	  that	  of	  P/L=1/0.55.	  
	  
3.1.2.3	  Evaluations	  of	  IP6/β-­‐TCP-­‐4h	  cement	  specimens	  
Figure	  3-­‐1-­‐4	  shows	  typical	  XRD	  patterns	  of	  the	  IP6/β-­‐TCP-­‐4h	  cement	  specimens	  fabricated	  with	  
water	   and	   the	   mixing	   solutions	   containing	   various	   polysaccharides	   as	   additives.	   	   These	   cement	  
specimens	   were	   fabricated	   at	   P/L	   ratio	   of	   1/0.50	   [g/cm3].	   	   The	   XRD	   patterns	   indicate	   that	   the	  
β-­‐TCP	  single	  phase	  was	  maintained	  after	  setting.	   	   The	  crystalline	  phase	  of	  β-­‐TCP	  was	  not	  changed	   	  










Fig.	  3-­‐1-­‐1	   	   XRD	  pattern	  of	  β-­‐TCP	  powder:	  (a)	  starting	  β-­‐TCP,	  (b)	  β-­‐TCP-­‐4h,	  and	  (c)	  IP6/β-­‐TCP-­‐4h.	   	  
Black	  circles	  indicate	  typical	  β-­‐TCP	  peaks.	  
	  
	   	  












Fig.	   3-­‐1-­‐2	   	   Particle	   morphology	   of	   β-­‐TCP	   powder	   before	   and	   after	   IP6	   surface	   modification:	   (a)	  
β-­‐TCP-­‐4h,	  (b)	  IP6/β-­‐	  TCP-­‐4h.	  
	  
	   	  











Table	  3-­‐1-­‐2	   	   Median	  particle	  size,	  specific	  surface	  area,	  and	  zeta-­‐potential	  of	  β-­‐TCP	  powders	  [2].	  
	  
Sample	   Median	  particle	  size	  
(µm)	  




β-­‐TCP-­‐0h	   5.1	   2.5	   −19.7	  
β-­‐TCP-­‐4h	   1.5	   20.3	   −7.73	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by	  the	  addition	  of	  five	  types	  of	  polysaccharides.	  
The	  relationship	  between	  the	  CS	  of	  the	  cement	  specimens	  and	  the	  P/L	  ratio	  is	  shown	  in	  Fig.	  3-­‐1-­‐5.	   	  
The	   cement	   specimens	   were	   fabricated	   by	   mixing	   IP6/β-­‐TCP-­‐4h	   powder	   and	   water	   or	   mixing	  
solutions	  containing	  various	  polysaccharides	  at	  the	  P/L	  ratios	  of	  1/0.45,	  1/0.50	  and	  1/0.55	  [g/cm3].	   	  
The	  CSs	  of	  typical	  cement	  specimens	  fabricated	  at	  a	  P/L	  ratio	  of	  1/0.45	  were	  as	  follows:	  0.6±0.1	  MPa	  
(Water),	  4.6±1.0	  MPa	  (Alg),	  3.7±1.1	  MPa	  (Dex),	  7.3±2.2	  MPa	  (Chond),	  10.4±1.7	  MPa	  (Chito	  GL),	  and	  
17.4±1.8	  MPa	  (Chito	  W10).	   	   The	  highest	  CS	  was	  17.4±1.8	  MPa	  (P/L=1/0.45)	  when	  Chito	  W10	  was	  
added	  (Fig.	  3-­‐1-­‐3f).	   	   The	  CS	  of	   the	  cement	  specimen	   fabricated	  using	  Chito	  W10	  was	  significantly	  
higher	  than	  that	  of	  cement	  specimen	  fabricated	  using	  water.	  
Figure	  3-­‐1-­‐6	  shows	  the	  relationship	  between	  the	  CS	  and	  RD	  of	  the	  cement	  specimens.	   	   The	  RDs	  
of	   the	   typical	   cement	   specimens	   at	   a	   P/L	   ratio	   of	   1/0.45	   [g/cm3]	   were	   as	   following:	   43.9±1.5%	  
(Water),	   45.9±1.4%	   (Alg),	   47.8±1.7%	   (Dex),	   49.2±1.4%	   (Chond),	   50.5±0.8%	   (Chito	   GL),	   and	  
51.7±0.9%	  (Chito	  W10).	   	   The	  data	  plots	  in	  Fig.	  3-­‐1-­‐5	  indicate	  that	  CS	  tended	  to	  be	  enhanced	  with	  an	  
exponential	  increase	  of	  RD	  of	  the	  cement	  specimens.	  
To	  examine	  the	  difference	  of	  RD	  among	  cement	  specimens,	  the	  microstructures	  of	  the	  fractured	  
cement	  surfaces	  were	  observed	  by	  SEM	  (Fig.	  3-­‐1-­‐7).	   	   The	  typical	  IP6/β-­‐TCP-­‐4h	  cement	  specimens	  
were	  fabricated	  at	  a	  P/L	  ratio	  of	  1/0.50	  [g/cm3].	   	   IP6/β-­‐TCP-­‐4h	  cement	  fabricated	  using	  water	  was	  
composed	   of	   grains	  with	   a	   diameter	   of	   of	   approximately	   1-­‐2	   μm	   (Fig.	   3-­‐1-­‐7a).	   	   In	   Figs.	   3-­‐1-­‐7b-­‐d,	  
significant	   differences	   among	   the	  microstructures	   are	   not	   observed	   compared	  with	   that	   of	  water.	   	  
In	  contrast,	  as	  shown	  in	  Figs.	  3-­‐1-­‐7e	  and	  f,	  the	  surface	  morphologies	  of	  the	  grains	  slightly	  changed	  to	  
rough	  compared	  with	  the	  smooth	  surface	  of	  grains	  in	  Figs.	  3-­‐1-­‐7a-­‐d.	  
	  
3.1.2.4	  In	  vitro	  evaluation	  of	  IP6/β-­‐TCP-­‐4h	  cement	  specimens	  
To	  examine	  the	  cytotoxicity	  of	  the	  cement	  specimens	  in	  vitro,	  a	  cell-­‐culture	  test	  using	  Transwell®	  
kit	   was	   performed	   (Fig.	   3-­‐1-­‐8).	   	   Cement	   specimens	   fabricated	   with	   water,	   Chond,	   Chito	   GL,	   and	  
Chito	  W10	  at	  P/L=1/0.20	  [g/cm3]	  were	  selected.	   	   The	  number	  of	  cells	  co-­‐cultured	  with	  the	  cement	  
specimen	  fabricated	  with	  water	  increased	  at	  the	  same	  rate	  as	  the	  control	  (plate)	  (Figs.	  3-­‐1-­‐8a	  and	  b).	   	  
In	  contrast,	  the	  number	  of	  cells	  co-­‐cultured	  with	  the	  cement	  specimens	  fabricated	  with	  Chond,	  Chito	  
GL,	  and	  Chito	  W10	  decreased	  on	  the	  first	  day	  (Figs.	  3-­‐1-­‐8c-­‐e).	   	   However,	  the	  number	  of	  cells	  then	  
gradually	  increased	  until	  the	  fifth	  day.	   	   These	  results	  suggest	  that	  the	  cement	  specimens	  fabricated	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3.1.3	  Discussion	  
	  
The	   effect	   of	   addition	   of	   various	   polysaccharides:	   sodium	   alginate,	   sodium	   dextran	   sulfate,	  
sodium	   chondroitin	   sulfate,	   and	   chitosan,	   into	   mixing	   solution	   on	   the	   handling	   and	   mechanical	  
properties	  of	  IP6-­‐β-­‐TCP	  cements	  was	  investigated.	  
The	  handling	  property	  of	  the	  cement	  pastes	  was	  improved	  by	  addition	  of	  various	  polysaccharides	  
into	  mixing	   solutions.	   	   To	   improve	   the	   handling	   property	   of	   cement	   paste,	   various	   additives	   are	  
described	   in	   the	   literature,	   including	   chitosan	   [6,7],	   hydroxypropyl	   methylcellulose	   [8],	   carboxyl	  
methylcellulose	   [8],	   and	   sodium	   alginate	   [9,10].	   	   Sodium	   alginate	   and	   chitosan	   form	   a	  
water-­‐insoluble	  gel	   in	   the	  presence	  of	  calcium	   ion	   [6,7,9,10].	   	   Sodium	  dextran	  sulfate	  and	  sodium	  
chondroitin	   sulfate	   have	   functional	   groups	   such	   as	   a	   sulfate	   group	   and	   a	   carboxyl	   group	   in	   their	  
structure,	  and	  they	  interact	  electrostatically	  with	  calcium	  ion	  [11,12].	  
Thus,	  it	  is	  considered	  that	  when	  Alg,	  Dex,	  Chond,	  Chito	  GL,	  and	  Chito	  W10	  were	  used	  for	  cement	  
fabrication,	  formation	  of	  a	  water-­‐insoluble	  gel	  or	  electrostatic	  interaction	  with	  calcium	  ion	  increased	  
the	   viscosity	   of	   the	   cement	   pastes.	   	   As	   a	   result,	   the	   handling	   property	   of	   the	   cement	   paste	   was	  
improved.	  
The	  setting	   time	   is	  generally	   related	   to	   the	  P/L	   ratio;	   an	   increase	  of	   the	  P/L	   ratio	   shortens	   the	  
setting	   time.	   	   As	   expected,	   the	   setting	   time	   of	   P/L=1/0.50	   was	   shorter	   compared	   with	   that	   of	  
P/L=1/0.55.	  
One	   of	   the	   problems	   of	   the	   conventional	   calcium	  phosphate	   cement	   (CPC)	   is	   long	   setting	   time	  
(30-­‐60	  min)	  [9].	   	   The	  setting	  time	  of	  the	  cement	  paste	  prepared	  with	  Chito	  W10	  was	  about	  8	  to	  20	  
min,	  and	  this	  setting	  time	  might	  be	  short	  enough	  to	  apply	  in	  clinical	  use.	  
The	  grains	  of	  the	  fractured	  cement	  surfaces	  fabricated	  with	  Chito	  GL	  and	  W10	  slightly	  changed	  to	  
rough	  compared	  with	  the	  grains	  of	  smooth	  surface	  in	  Figs.	  3-­‐1-­‐7a-­‐d.	   	   The	  following	  two	  reasons	  are	  
considered	  to	  explain	  the	  above	  observations.	   	   The	  first	  is	  IP6/β-­‐TCP-­‐4h	  grains	  were	  covered	  with	  
chitosan	  by	  forming	  a	  water-­‐insoluble	  gel	  with	  calcium	  ion	  of	  IP6/β-­‐TCP-­‐4h	  particles.	   	   The	  second	  
is	   the	   pH	   of	   Chito	   GL	   and	   W10	   was	   5.3	   and	   4.1,	   respectively,	   and	   the	   surface	   of	   IP6/β-­‐TCP-­‐4h	  
particles	  slightly	  dissolved.	  
The	  changes	  of	  RD	  correlate	  with	  a	  change	  in	  packing	  density	  of	  the	  grains	  as	  shown	  in	  the	  SEM	  
micrographs;	   however,	   the	   increase	   in	   RD	   as	   shown	   in	   Fig.	   6	   was	   not	   confirmed	   from	   the	   SEM	  
micrographs.	   	   We	  calculated	  RD	  from	  bulk	  density	  divided	  by	  the	  theoretical	  density	  of	  β-­‐TCP	  (3.07	  
g/cm3).	   	   As	   the	   results	   did	   not	   take	   the	   specific	   gravity	   of	   additives	   into	   account,	   the	   changes	   in	  
packing	  density	  of	  the	  grains	  might	  not	  be	  detected	  in	  SEM.	  
As	  mentioned	  above,	  sodium	  alginate	  and	  chitosan	  form	  a	  water-­‐insoluble	  gel	  in	  the	  presence	  of	  
calcium	  ion	  [6,7,9].	   	   Sodium	  dextran	  sulfate	  and	  sodium	  chondroitin	  sulfate	  interact	  electro-­‐	   	  










Fig.	  3-­‐1-­‐3	   	   Consistency	  of	  the	  cement	  paste:	  (a)	  Water,	  (b)	  Alg,	  (c)	  Dex,	  (d)	  Chond,	  (e)	  Chito	  W10.	  
	  
	   	  









Fig.	   3-­‐1-­‐4	   	   XRD	   patterns	   of	   IP6/β-­‐TCP-­‐4h	   cement	   specimens	   at	   P/L	   ratio	   of	   1/0.50	   [g/cm3]:	   (a)	  
Water,	  (b)	  Alg,	  (c)	  Dex,	  (d)	  Chond,	  (e)	  Chito	  GL,	  and	  (f)	  Chito	  W10.	   	   Black	  circles	  indicate	  the	  typical	  
β-­‐TCP	  peaks.	  
	  
	   	  










Fig.	   3-­‐1-­‐5	   	   Compressive	  strength	  of	   IP6/β-­‐TCP-­‐4h	  cement	  specimens:	   (a)	  Water,	   (b)	  Alg,	   (c)	  Dex,	  
(d)	  Chond,	  (e)	  Chito	  GL,	  and	  (f)	  Chito	  W10.	  
	  
	   	  









Fig.	   3-­‐1-­‐6	   	   Relationship	  between	   the	  compressive	  strength	  (MPa)	  and	   the	  relative	  density	   (%)	  at	  
the	  P/L	   ratio	  of	  1/0.45	   [g/cm3]:	   (a)	  Water,	   (b)	  Alg,	   (c)	  Dex,	   (d)	  Chond,	   (e)	  Chito	  GL,	   and	   (f)	  Chito	  
W10.	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Fig.	  3-­‐1-­‐8	   	   Cell	  proliferation	  co-­‐cultured	  with	  IP6/β-­‐TCP-­‐4h	  cement:	  (a)	  Control	  (plate),	  (b)	  Water,	  
(c)	  Chond,	  (d)	  Chito	  GL,	  and	  (e)	  Chito	  W10.	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statically	  with	  calcium	  ion	  [11,12].	   	   Formation	  of	  the	  water-­‐insoluble	  gel	  or	  electrostatic	  interaction	  
with	   calcium	   ion	   enhanced	   RDs	   of	   the	   cement	   specimens.	   	   Consequently,	   the	   CS	   of	   the	   cement	  
specimens	  is	  also	  enhanced.	   	   In	  particular,	  in	  the	  case	  of	  the	  cement	  fabricated	  using	  Chito	  GL	  and	  
W10,	   the	   surface	   of	   IP6/β-­‐TCP-­‐4h	   particles	  was	   slightly	   dissolved	   by	   chitosan,	   and	   then	   chitosan	  
might	   form	   water-­‐insoluble	   gels	   with	   dissolved	   calcium	   ions.	   	   Therefore,	   the	   CS	   of	   cement	  
specimens	  was	  higher	  than	  that	  of	  other	  additives.	  
Regarding	   the	   cell-­‐culture	   test	   (Fig.	   3-­‐1-­‐8),	   the	   number	   of	   cells	   co-­‐cultured	   with	   the	   cement	  
specimens	  fabricated	  with	  Chond,	  Chito	  GL,	  and	  Chito	  W10	  decreased	  on	  the	  first	  day;	  however,	  that	  
then	   increased	   gradually	   until	   the	   fifth	   day.	   	   The	   results	   suggest	   that	   the	   cement	   specimens	  
fabricated	  with	  additives	  (Chond,	  Chito	  GL,	  and	  ChitoW10)	  affect	  the	  viability	  of	  cells.	  
Some	  authors	  have	   reported	   that	  a	   chitosan	   is	  a	  biocompatible	  polysaccharide	   [13,14].	   	   In	   the	  
cell-­‐culture	   tests	   using	   Chito	   GL	   and	   W10	   (Figs.	   3-­‐1-­‐8d	   and	   e),	   however,	   the	   cement	   specimens	  
slightly	  showed	  cytotoxicity	  on	  the	  first	  day.	   	   These	  may	  be	  due	  to	  the	  slight	  elution	  of	  lactic	  acid	  in	  
Chito	   GL	   and	  W10	   on	   the	   first	   day	   and	   following	   the	   decrease	   in	   pH.	   	   It	   is	   considered	   that	   the	  
decrease	   in	   the	   number	   of	   cells	   is	   within	   an	   allowance,	   because	   the	   number	   of	   cells	   gradually	  





In	  order	   to	  examine	   the	  effect	  of	  mixing	  solution	  on	   the	  handling	  and	  mechanical	  properties	  of	  
β-­‐TCP	  cement,	  we	  used	  six	  types	  of	  mixing	  solutions	  with	  and	  without	  polysaccharides	   for	  cement	  
fabrications.	   	   When	  mixing	   solutions	   containing	  additives	  were	  used,	   the	  handling	  property	  of	   all	  
the	   cement	   pastes	  was	   improved.	   	   Among	   the	   examined	   cement	   specimens,	   the	   cement	  with	   the	  
highest	  CS	  (17.4	  MPa)	  was	  obtained	  using	  Chito	  W10.	   	   The	  setting	  time	  of	  the	  cement	  pastes	  using	  
Chito	  W10	   was	   8	   min.	   	   Although	   the	   cell	   viability	   co-­‐cultured	   with	   the	   cement	   specimens	   using	  
additives	  was	  less	  than	  that	  of	  the	  control	  and	  water	  on	  the	  first	  day,	  the	  number	  of	  cells	  gradually	  
increased	  until	  the	  fifth	  day.	   	   In	  conclusion,	  the	  chelate-­‐setting	  β-­‐TCP	  cement	  fabricated	  with	  Chito	  
W10	  is	  promising	  for	  enhancement	  of	  mechanical	  properties	  and	  improvement	  of	  handling	  property	  
of	  the	  cement.	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A	   novel	   powder	   preparation	   process,	   described	   in	   section	   2.2,	   Chapter	   2,	   was	   applied	   to	   the	  
fabrication	  of	  chelate-­‐setting	  β-­‐tricalcium	  phosphate	  (IP6-­‐β-­‐TCP)	  cement	  to	  investigate	  the	  effect	  of	  
milling	  time	  and	  concentration	  of	   inositol	  phosphate	  (IP6)	  on	   the	  material	  properties	  the	  resulting	  
cement,	   in	   particular,	   anti-­‐washout	   property	   [5].	   	   Biodegradability	   and	   osteoconductivity	   of	   the	  
IP6-­‐β-­‐TCP	  cement	  were	  evaluated	  in	  vitro	  using	  osteoclasts	  and	  in	  vivo	  using	  a	  pig	  model.	  
	  
	  
3.2.1	  Materials	  and	  methods	  
	  
3.2.1.1	  Preparation	  and	  characterization	  of	  β-­‐TCP	  powders	  for	  cement	  fabrication	  
Inositol	  phosphate	  solutions	  with	  concentrations	  of	  0,	  1000,	  3000,	  5000,	  8000,	  and	  10000	  ppm	  
were	  prepared	  using	  50	  mass%	  phytic	  acid	  (Wako	  Pure	  Chemical	  Industries,	  Ltd.),	  and	  adjusting	  to	  
pH	  7.3	  with	  NaOH	  solution.	  
β-­‐tricalcium	  phosphate	  (β-­‐TCP)	  powders	  were	  prepared	  to	  investigate	  the	  effect	  of	  milling	  time	  
on	  the	  powders	  and	  the	  anti-­‐washout	  properties	  of	  the	  cement	  paste.	   	   Ten	  grams	  of	  commercially	  
available	  β-­‐TCP	  powder	  (β-­‐TCP-­‐100,	  Taihei	  Chemical	  Industrial	  Co.	  Ltd.,	  Japan)	  were	  simultaneously	  
ground	  and	  surface-­‐modified	  by	  ball-­‐milling	  with	  3000	  ppm	  IP6	  solution	  (40cm3)	  using	  a	  planetary	  
mill	  (Pulverisette	  6,	  Fritsch,	  Germany)	  for	  1,	  2,	  3,	  4,	  5,	  and	  6	  h	  at	  a	  rotation	  rate	  of	  300	  rpm	  in	  a	  ZrO2	  
pot	  with	  180	  g	  of	  2	  mm-­‐diameter	  ZrO2	  beads.	   	   After	  ball-­‐milling,	  the	  slurry	  mixture	  was	  filtered	  and	  
freeze-­‐dried	   for	   24	   h	   to	   obtain	   the	   IP6	   surface-­‐modified	   β-­‐TCP	   powders.	   	   An	   IP6	   solution	  with	   a	  
concentration	  of	  3000	  ppm	  was	  selected	  in	  the	  present	  study,	  because	  3000	  ppm	  IP6	  solution	  was	  
previously	   used	   for	   the	   surface-­‐modification	   of	   β-­‐TCP	   powders	   [2-­‐4].	   	   Hereafter,	   samples	   are	  
denoted	   according	   to	   the	   milling	   time	   and	   IP6	   concentration;	   for	   example,	   the	   β-­‐TCP	   powder	  
ball-­‐milled	  for	  3	  h	  in	  3000	  ppm	  IP6	  solution	  is	  denoted	  as	  β-­‐TCP-­‐3h(3000),	  and	  β-­‐TCP-­‐0h(0)	  denotes	  
as-­‐received	  β-­‐TCP-­‐100	  powder.	  
To	   examine	   the	   effect	   of	   IP6	   concentration	   on	   the	   properties	   of	   the	   β-­‐TCP	   powder	   and	   the	  
material	   properties	   of	   the	   resulting	   cement,	   β-­‐TCP	   powders	   were	   prepared	   by	   ball-­‐milling	   the	  
β-­‐TCP-­‐100	  powder	  at	  a	  constant	  period	  of	  3	  h	  with	  surface	  modification	  using	  0,	  1000,	  3000,	  5000,	  
8000,	  and	  10000	  ppm	  IP6	  solutions.	  
X-­‐ray	  diffraction	  (XRD;	  Ultima	  IV,	  Rigaku,	  Japan)	  analysis	  of	  the	  powders	  was	  conducted	  using	  a	  
CuKα	  radiation	  source.	   	   Data	  were	  collected	  in	  the	  range	  of	  2θ=10-­‐50°	  with	  a	  step	  size	  of	  0.02°	  and	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counting	  time	  of	  1.0	  s/step.	   	   The	  crystal	  phase	  was	   identified	  with	  respect	  to	  the	  JCPDS	  reference	  
patterns	   for	   β-­‐TCP	   (#09-­‐0169)	   and	   HAp	   (#09-­‐0432).	   The	   HAp	   content	   in	   the	   ball-­‐milled	   β-­‐TCP	  
powders	  was	  calculated	  using	   the	   typical	  peaks	  of	  β-­‐TCP	   (2θ=31.03°)	  and	  HAp	  (2θ=31.77°).	   	   The	  
relative	  crystallinity	  of	  the	  ball-­‐milled	  β-­‐TCP	  powders	  was	  calculated	  using	  Eq.	  (1).	  
	  
Relative	  crystallinity	  (%)	  =	  (Iβ-­‐TCP-­‐(th)([IP6]))/(Iβ-­‐TCP-­‐0h(0))	  ×	  100	   	   	   	   (1)	  
	  
where,	   Iβ-­‐TCP-­‐0h(0)	   is	   the	   XRD	   intensity	   of	   the	   peak	   for	   the	   β-­‐TCP-­‐0h(0)	   powder	   (2θ=31.03°)	   and	  
Iβ-­‐TCP-­‐(th)([IP6])	  is	  the	  XRD	  intensity	  of	  the	  peak	  (2θ=31.03°)	  for	  each	  ball-­‐milled	  β-­‐TCP	  powder.	  
The	   specific	   surface	   area	   (SSA)	   of	   the	   ball-­‐milled	   β-­‐TCP	   powders	   was	   determined	   by	   the	  
Brunauer-­‐Emmett-­‐Teller	  (BET)	  method	  using	  a	  BET	  surface	  area	  analyzer	  (Flowsorb	  III,	  Shimadzu,	  
Japan)	  and	  the	  median	  particle	  size	  was	  measured	  with	  a	  laser	  particle	  size	  analyzer	  (LA-­‐300,	  Horiba,	  
Japan).	  
The	   ball-­‐milled	   β-­‐TCP	   particles	   were	   observed	   by	   transmission	   electron	   microscopy	   (TEM;	  
JEM-­‐2100F,	  JEOL,	  Japan)	  at	  an	  accelerating	  voltage	  of	  200	  kV.	   	   Samples	  for	  TEM	  observation	  were	  
dispersed	  in	  ethanol	  and	  deposited	  them	  onto	  carbon-­‐coated	  copper	  grids	  (400	  mesh,	  JEOL,	  Japan).	  
Dissolution	   of	   Ca2+	   ions	   released	   from	   the	   ball-­‐milled	   β-­‐TCP	   powder	   was	   measured	   using	  
ion-­‐selective	  potentiometry.	   	   Twenty-­‐five	  milligrams	  of	  each	  β-­‐TCP	  powder	  was	  added	  to	  0.2	  dm3	  
of	  0.05	  mol·dm-­‐3	  of	  tris(hydroxymethyl)aminomethane-­‐hydrochloric	  acid	  (Tris-­‐HCl)	  buffer	  at	  pH7.3	  
and	   25±3°C	   with	   stirring	   at	   430	   rpm.	   	   The	   concentration	   of	   free	   Ca2+	   ions	   in	   the	   solution	   was	  
measured	  as	  a	  function	  of	  time	  for	  90	  min.	  
	  
3.2.1.2	  Fabrication	  and	  evaluation	  of	  β-­‐TCP	  cement	  pastes	  
The	  β-­‐TCP	  cement	  paste	  was	  prepared	  by	  mixing	  the	  β-­‐TCP	  powder	  and	  2.5	  mass%	  of	  Na2HPO4	  
solution	   at	   various	   powder/liquid	   (P/L)	   ratios	   (1/0.5-­‐1/1.1	   [g/cm3]).	   	   After	   preparation	   of	   the	  
cement	  pastes,	   the	  initial	  setting	  time	  (IST)	  of	  the	  cement	  paste	  packed	  in	  a	  plastic	  mold	  (8	  mm	  in	  
diameter,	   2	  mm	   in	   height)	  was	  measured	   according	   to	   ISO	  9917-­‐1:2007	   (Dentistry	   −Water-­‐based	  
cements−	  Part	  1:	  Powder/liquid	  acid-­‐base	  cements)	  using	  a	   light	  Gilmore	  needle	   (113.4	  g).	   	   Each	  
P/L	  ratio	  corresponding	  to	  the	  highest	  CS	  for	  the	  β-­‐TCP	  cement	  was	  selected.	  
The	  effect	  of	  ball-­‐milling	  time	  on	  the	  anti-­‐washout	  properties	  of	  the	  cement	  paste	  was	  examined	  
by	  mixing	  cement	  paste	  consisting	  of	  0.50	  g	  of	  the	  β-­‐TCP	  powder	  and	  2.5	  mass%	  Na2HPO4	  solution	  at	  
a	  P/L	  ratio	  of	  1/0.8	  [g/cm3].	   	   At	  5	  min	  after	  mixing	  the	  cement	  paste,	  0.5	  cm3	  of	  the	  cement	  paste	  
was	  pushed	  out	  by	  a	   syringe	   into	  pure	  water	   (30	   cm3).	   	   After	  24	  h	   immersion,	   the	   samples	  were	  
evaluated	  by	  naked-­‐eye	  observation;	  the	  test	  cement	  paste	  was	  deemed	  to	  pass	  if	  no	  disintegration	  
was	  evident.	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Compressive	   strength	   (CS)	   tests	  were	   conducted	   by	   packing	   the	   resulting	   cement	   paste	   into	   a	  
cylindrical	  Teflon®	  mold	  (6	  mm	  in	  diameter,	  12	  mm	  in	  height)	  and	  maintaining	  it	  at	  37°C	  at	  100%	  
humidity	  for	  24	  h.	   	   The	  CS	  of	  the	  cement	  specimen	  was	  measured	  using	  a	  universal	  testing	  machine	  
(Autograph	  AGS-­‐X,	  Shimadzu,	  Japan)	  with	  a	  5	  kN	  load	  cell	  at	  a	  crosshead	  speed	  of	  500	  μm·min-­‐1.	  
The	   microstructure	   of	   the	   fractured	   cement	   was	   observed	   by	   scanning	   electron	   microscopy	  
(SEM;	   JSM-­‐6390LA,	   JEOL,	   Japan)	   at	   an	   accelerating	   voltage	   of	   10	   kV.	   	   The	   samples	   were	  
sputter-­‐coated	  with	  Pt	  prior	  to	  SEM	  observation.	  
XRD	  patterns	   of	   the	   cement	   after	   the	  CS	   testing	  were	  measured	   to	  determine	   the	  HAp	   content	  
after	  setting	  for	  24	  h.	  
The	  relative	  densities	  (RDs)	  of	  the	  cement	  specimens	  were	  calculated	  from	  the	  measured	  density	  
of	  the	  cylindrical	  specimen	  divided	  by	  the	  theoretical	  density	  of	  the	  β-­‐TCP/HAp	  calculated	  using	  Eq.	  
(2).	  
	  
Theoretical	  density	  of	  the	  β-­‐TCP/HAp	  (g/cm3)	  =	  
3.07×(100-­‐HAp	  content	  (%))/100	  +	  3.16×(HAp	  content	  (%))/100	   	   	   (2)	  
	  
where,	  3.07	  and	  3.16	  (g/cm3)	  are	  the	  theoretical	  densities	  of	  pure	  β-­‐TCP	  and	  HAp,	  respectively.	  
Dissolution	   of	   Ca2+	   ions	   released	   from	   the	   β-­‐TCP-­‐3h(0)	   and	   β-­‐TCP-­‐3h(3000)	   cements	   was	  
measured	   using	   ion-­‐selective	   potentiometry.	   	   The	   cement	   specimens	   for	   in	   vitro	   dissolution	   test	  
were	  prepared	  by	  mixing	   the	  β-­‐TCP	  powder	  and	  2.5	  mass%	  of	  Na2HPO4	  solution	  at	  a	  P/L	   ratio	  of	  
1/0.7	  [g/cm3].	   	   The	  resulting	  cements	  were	  packed	  into	  a	  cylindrical	  stainless	  mold,	  and	  uniaxially	  
compressed	  at	  10	  MPa	  to	  obtain	  specimens	  that	  were	  10	  mm	  in	  diameter	  and	  1-­‐2	  mm	  in	  thickness.	   	  
The	  HAp	  cement	  specimen	  was	  also	  prepared	  by	  mixing	  the	  0-­‐IP6-­‐HAp	  powder	  (see,	  Section	  2.2	  in	  
Chapter	  2)	  and	  pure	  water	  at	   a	  P/L	   ratio	  of	  1/0.3	   [g/cm3],	   and	  molded	  as	  above-­‐mentioned	  same	  
method.	   	   The	  cement	  specimens	  were	  added	  to	  0.2	  dm3	  of	  0.08	  mol·dm-­‐3	  of	  acetate	  buffer	  at	  pH5.5	  
and	   25±3°C	   with	   stirring	   at	   430	   rpm.	   	   The	   concentration	   of	   free	   Ca2+	   ions	   in	   the	   solution	   was	  
measured	  as	  a	  function	  of	  time	  for	  180	  min.	   	   	  
	  
3.2.1.3	  In	  vitro	  evaluation	  of	  the	  β-­‐TCP	  cement	  
The	   cement	   specimens	   for	   in	   vitro	   evaluation	   were	   prepared	   by	   mixing	   the	   β-­‐TCP	   powder	  
(β-­‐TCP-­‐3h(0)	  and	  β-­‐TCP-­‐3h(3000)	  powders	  were	  selected)	  and	  2.5	  mass%	  of	  Na2HPO4	  solution	  at	  a	  
P/L	   ratio	   of	   1/0.2	   [g/cm3].	   	   The	   resulting	   cements	  were	  packed	   into	   a	   cylindrical	   stainless	  mold,	  
and	  uniaxially	  compressed	  at	  100	  MPa	  to	  obtain	  specimens	   that	  were	  22	  mm	  in	  diameter	  and	  1-­‐2	  
mm	   in	   thickness.	   	   The	  high	  P/L	   ratio	   (1/0.2)	  was	   selected	   to	   fabricate	   compressed	   cements	  with	  
same	  surface	   roughness,	  because	   the	  surface	   roughness	  of	   the	  cements	  affects	   the	  cell	   attachment	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and	  proliferation.	   	   The	  surface	  roughness	  of	  the	  cements	  was	  measured	  using	  a	  surface	  roughness	  
tester	   (SV3100,	   Mitutoyo,	   Japan).	   	   Ethylene	   oxide	   gas	   (EOG)	   was	   used	   to	   sterilize	   the	   cement	  
specimens.	  
Osteoblast-­‐like	  cells	   (MC3T3-­‐E1)	   [15]	  were	  cultured	  on	   the	  cement	  specimens	  and	  polystyrene	  
plate	   (control)	   in	   growth	   medium	   at	   37°C,	   5%	   CO2,	   and	   100%	   humidity.	   	   The	   number	   of	  
proliferated	  cells	  was	  counted	  after	  seeding	  for	  1,	  3,	  and	  5	  days.	   	   The	  osteoblast-­‐like	  cells	  cultured	  
on	  the	  cement	  specimens	  for	  1	  day	  were	  rinsed	  with	  phosphate	  buffered	  saline	  (PBS),	  fixed	  with	  4%	  
paraformaldehyde/PBS,	  and	  permeabilized	  with	  0.25%	  Triton	  X-­‐100/PBS	  (pH7.4)	  for	  15	  min.	   	   The	  
cells	  were	  washed	  with	  PBS	   and	   then	  double	   stained	  with	  Alexa	   Fluor®488-­‐labeled	  phalloidin	   for	  
F-­‐actin	  and	  4’,	  6-­‐diamidino-­‐2-­‐phenylindole	  (DAPI)	  for	  nuclei.	   	   After	  washing	  with	  PBS,	  the	  cement	  
specimens	  were	  examined	  using	  an	  epifluorescence	  microscope	  (IX71,	  Olympus,	  Japan).	  
	  
3.2.1.4	  In	  vivo	  evaluation	  of	  the	  β-­‐TCP	  cement	  
The	  osteoconductivity	  of	   the	  cement	  specimens	  was	  evaluated	  by	  an	   in	  vivo	  pilot	   study	  using	  a	  
female	   pig	   (110	   kg),	   according	   to	   the	   guidelines	   of	   the	   animal	   care	   and	   use	   committee	   at	   Meiji	  
University.	   	   The	   cement	   specimens	   for	   in	   vivo	   evaluation	   were	   prepared	   by	   mixing	   the	   β-­‐TCP	  
powder	   and	   2.5	  mass%	   of	   Na2HPO4	   solution	   at	   a	   P/L	   ratio	   of	   1/1.1	   [g/cm3]	   for	   β-­‐TCP-­‐3h(0)	   and	  
1/1.0	  for	  β-­‐TCP-­‐3h(3000).	   	   The	  resulting	  cement	  pastes	  were	  packed	  into	  a	  cylindrical	  acrylic	  mold	  
(4	  mm	  in	  diameter,	  6	  mm	  in	  height).	   	   EOG	  was	  used	  to	  sterilize	  the	  cement	  specimens.	  
The	  right	  tibia	  of	  the	  female	  pig	  was	  exposed	  and	  four	  cylindrical	  defects	  (4.3	  mm	  in	  diameter)	  
were	  drilled	  in	  the	  epiphysis	  of	  the	  tibia.	   	   Two	  cement	  specimens	  of	  each	  type	  were	  pushed	  into	  a	  
defect	  by	  hand.	   	   After	  implantation	  for	  4	  weeks,	  the	  pig	  was	  sacrificed	  and	  the	  tibia	  was	  removed.	   	  
The	  tibia	  was	  fixed	  with	  4%	  formalin	  solution	  for	  3	  days,	  and	  fat	  was	  removed	  in	  a	  1/1[v/v]	  solution	  
of	  chloroform	  and	  methanol	  for	  3	  days.	   	   Following	  these	  processes,	  the	  tibia	  was	  washed	  in	  99.5%	  
ethanol	   for	   1	   day	   and	   in	   pure	  water	   for	   1	   day,	   and	   then	   successively	   dehydrated	   in	   10%	   sucrose	  
solution	   for	   12	   h	   and	   15%	   sucrose	   solution	   for	   12	   h.	   	   The	   resulting	   tibia	  was	   embedded	   using	   a	  
super-­‐cryoembedding	  medium	  (Leica	  Microsystems,	  Japan),	  and	  the	  frozen	  blocks	  were	  sectioned	  at	  
16	   μm	  using	   a	   rotary	  microtome	   (CM3050S,	   Leica	  Microsystems,	   Japan).	   	   The	   thin	   sections	  were	  






3.2.2.1	  Effect	  of	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  properties	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  anti-­‐washout	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the	  cement	  paste	  
Figure	  3-­‐2-­‐1	   shows	  XRD	  patterns	  of	   the	  β-­‐TCP	  powders	  prepared	  by	   simultaneous	  ball-­‐milling	  
and	   surface-­‐modification.	   	   The	   XRD	   pattern	   of	   the	   β-­‐TCP-­‐0h(0)	   powder	   (as-­‐received	   β-­‐TCP-­‐100)	  
indicates	   the	   typical	  β-­‐TCP	  single	  phase	  with	  high	  crystallinity.	   	   The	  XRD	  patterns	  of	   the	  1	   to	  3	  h	  
ball-­‐milled	   β-­‐TCP	   powders,	   (β-­‐TCP-­‐1h(3000),	   β-­‐TCP-­‐2h(3000),	   and	   β-­‐TCP-­‐3h(3000))	   also	   show	  
typical	   β-­‐TCP	   single	   phase;	   however,	   the	   β-­‐TCP-­‐3h(3000)	   has	   a	   small	   amount	   of	   the	   HAp	   phase	  
(4.9±2.4%).	  
Table	   3-­‐2-­‐1	   gives	   the	   SSA,	   median	   particle	   size,	   relative	   crystallinity,	   and	   HAp	   content	   of	   the	  
resulting	   β-­‐TCP	   powders.	   	   The	   SSA	   of	   the	   ball-­‐milled	   β-­‐TCP	   powder	   increased	  with	  milling	   time.	   	  
The	   median	   particle	   size	   of	   the	   β-­‐TCP-­‐1h(3000)	   powder	   decreased	   compared	   to	   that	   of	   the	  
β-­‐TCP-­‐0h(0)	   powder.	   	   However,	   the	   median	   particle	   size	   of	   the	   ball-­‐milled	   β-­‐TCP	   powders	  
increased	   with	   an	   increase	   in	   the	   milling	   time,	   due	   to	   aggregation	   of	   the	   particles	   caused	   by	  
formation	  of	  the	  HAp.	   	   The	  relative	  crystallinity	  calculated	  using	  Eq.	  (1)	  decreased	  with	  an	  increase	  
in	   the	   ball-­‐milling	   time.	   	   The	   β-­‐TCP	   powders	   ball-­‐milled	   for	   4	   to	   6	   h	   (β-­‐TCP-­‐4h(3000),	  
β-­‐TCP-­‐5h(3000),	   and	  β-­‐TCP-­‐6h	   (3000))	  were	  consisted	  of	  both	  β-­‐TCP	  and	  HAp	  phases.	   	   The	  HAp	  
content	   in	   the	  ball-­‐milled	  β-­‐TCP	  powder	   increased	  approximately	   fivefold:	  4.9±2.4%	   for	  β-­‐TCP-­‐3h	  
(3000)	  to	  25.1±2.6%	  for	  β-­‐TCP-­‐4h(3000).	  
The	   particle	  morphology	   of	   the	   ball-­‐milled	   β-­‐TCP	   powder	  was	   observed	   using	   the	   TEM.	   	   The	  
β-­‐TCP-­‐0h(0)	  powder	  was	  sintered	  particles	  with	  necks	  composed	  of	  smooth-­‐surfaced	  particles	  (Figs.	  
3-­‐2-­‐2a	  and	  b).	   	   Figures	  3-­‐2-­‐2c,	  e,	  and	  g	  show	  that	  the	  amount	  of	  sintered	  particles	  decreased	  with	  
an	   increase	   in	   the	   milling	   time,	   while	   the	   nanosized	   particles	   increased.	   	   The	   surface	   of	   the	  
β-­‐TCP-­‐2h(3000)	  and	  β-­‐TCP-­‐3h(3000)	  particles	  was	  rougher	   than	   that	  of	   the	  β-­‐TCP-­‐0h(0)	  particles	  
(Figs.	   3-­‐2-­‐2d	   and	   f),	   and	   that	   of	   the	   β-­‐TCP-­‐4h(3000)	   particle	   was	   composed	   of	   agglomerated	  
needle-­‐shaped	  crystals	  (Fig.	  3-­‐2-­‐2h),	  which	  corresponds	  to	  the	  increase	  in	  HAp	  content	  and	  SSA	  of	  
β-­‐TCP-­‐4h(3000)	  powder	  (Table	  3-­‐2-­‐1).	  
The	   dissolution	   of	   Ca2+	   ions	   from	   the	   ball-­‐milled	   β-­‐TCP	   powders	   was	   examined	   by	   an	  
ion-­‐selective	   potentiometry	   (Fig.	   3-­‐2-­‐3).	   	   The	   β-­‐TCP-­‐0h(0)	   powder	   had	   the	   lowest	   amount	   of	  
released	   Ca2+	   ions	   among	   the	   examined	   samples.	   	   The	   amount	   of	   Ca2+	   ions	   released	   from	   the	  
β-­‐TCP-­‐1h(3000),	   β-­‐TCP-­‐2h(3000),	   and	   β-­‐TCP-­‐3h(3000)	   powders	   increased	   with	   the	   milling	   time.	   	  
In	   contrast,	   the	   amount	   of	   Ca2+	   ions	   released	   from	   the	   β-­‐TCP-­‐4h(3000),	   β-­‐TCP-­‐5h(3000)	   and	  
β-­‐TCP-­‐6h(3000)	  powders	  was	  less	  than	  that	  from	  the	  β-­‐TCP-­‐0h(0)	  powder.	  
An	  overview	  of	  anti-­‐washout	  properties	  of	  the	  β-­‐TCP	  cement	  pastes	  is	  shown	  in	  Fig.	  3-­‐2-­‐4.	   	   At	  5	  
min	   after	   cement	   preparation,	   only	   the	   cement	   paste	   prepared	   with	   the	   most	   soluble	  
β-­‐TCP-­‐3h(3000)	   was	   set	   within	   5	   min	   and	   exhibited	   anti-­‐washout	   characteristics,	   which	  
corresponds	  to	  the	  results	  for	  the	  dissolution	  of	  Ca2+	  ions	  from	  the	  β-­‐TCP	  powder.	   	  











Figure	  3-­‐2-­‐1	   	   XRD	  patterns	  of	  the	  β-­‐TCP	  powders	  ball-­‐milled	  in	  3000	  ppm	  IP6	  solution	  for	  various	  
periods.	   	   Black	  and	  white	  circles	  indicate	  typical	  β-­‐TCP	  and	  HAp	  peaks,	  respectively.	  
	  
	   	  








Table	   3-­‐2-­‐1	   	   Effect	   of	   milling	   time	   in	   3000	   ppm	   IP6	   solution	   on	   the	   SSA,	   median	   particle	   size,	  
relative	  crystallinity,	  and	  HAp	  content	  of	  β-­‐TCP	  powders.	  
	  
	  
a	  Relative	  crystallinity	  was	  calculated	  using	  Eq.	  (1).	  
Plus	  or	  minus	  (±)	  indicate	  standard	  deviation	  (n=3).	  
	  












β-­‐TCP-­‐0h(0)	   1.4±0.03	   5.4±0.2	   100	   0.2±0.1	  
β-­‐TCP-­‐1h(3000)	   7.8±0.2	   1.3±0.01	   48.1±4.8	   0.2±0.1	  
β-­‐TCP-­‐2h(3000)	   10.7±0.03	   1.2±0.04	   31.8±3.4	   1.0±0.6	  
β-­‐TCP-­‐3h(3000)	   18.6±1.1	   1.9±0.1	   27.0±1.6	   4.9±2.4	  
β-­‐TCP-­‐4h(3000)	   76.5±0.5	   3.1±0.2	   21.4±4.7	   25.1±2.6	  
β-­‐TCP-­‐5h(3000)	   83.6±1.0	   5.2±0.4	   20.2±3.6	   32.6±3.5	  
β-­‐TCP-­‐6h(3000)	   80.5±0.4	   10.9±0.2	   18.3±2.1	   39.8±0.6	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3.2.2.2	  Effect	  of	  IP6	  concentration	  on	  the	  β-­‐TCP	  powder	  properties	  and	  material	  properties	  of	  
the	  β-­‐TCP	  cement	  
The	   XRD	   patterns	   showed	   that	   all	   the	   surface-­‐modified	   β-­‐TCP	   powders	   using	   various	  
concentrations	  of	  IP6	  at	  a	  constant	  ball-­‐milling	  time	  of	  3	  h,	  except	  for	  the	  β-­‐TCP-­‐3h(0)	  powder,	  were	  
composed	  of	  β-­‐TCP	  single	  phase	  (Fig.3-­‐2-­‐5).	   	   However,	  β-­‐TCP-­‐3h(0)	  contained	  28.1%	  of	  HAp	  phase.	  
The	  SSA	  and	  median	  particle	  size	  of	  the	  surface-­‐modified	  β-­‐TCP	  powders	  are	  shown	  in	  Fig.	  3-­‐2-­‐6.	   	  
The	  SSAs	  of	  the	  β-­‐TCP	  powders	  were	  almost	  all	  the	  same,	  except	  for	  the	  β-­‐TCP-­‐3h(0)	  powder,	  which	  
had	  the	  highest	  SSA	  (46.8±0.5	  m2/g)	  among	  the	  examined	  β-­‐TCP-­‐3h	  powders.	   	   The	  median	  particle	  
sizes	  of	  all	  the	  β-­‐TCP	  powders	  increased	  with	  IP6	  concentration	  at	  more	  than	  5000	  ppm	  IP6.	  
Figure	  3-­‐2-­‐7	  shows	   that	  both	   the	   (A)	  CS	  and	  (B)	  RD	  of	   the	  β-­‐TCP	  cement	  specimens	  decreased	  
with	   reduction	   of	   the	   P/L	   ratio.	   	   The	   maximum	   CS	   obtained	   was	   13.4±0.8	   MPa	   for	   the	  
β-­‐TCP-­‐3h(3000)	   cement	   specimen	   (P/L=1/0.7	   [g/cm3]),	   which	   also	   had	   the	   maximum	   relative	  
density	  (53.4±2.6%).	  
Table	   3-­‐2-­‐2	   gives	   the	   IST	   with	   P/L	   ratio	   corresponding	   to	   the	   highest	   CS	   for	   each	   β-­‐TCP-­‐3h	  
cement	   and	  HAp	   content	   of	   the	   cement	   specimens.	   	   The	   shortest	   of	   IST	  was	   5.7±0.5	  min	   for	   the	  
β-­‐TCP-­‐3h(1000)	  cement	  specimen.	  
The	  XRD	  patterns	  and	  HAp	  content	  of	  the	  cement	  is	  shown	  in	  Fig.	  3-­‐2-­‐8.	   	   The	  HAp	  content	  after	  
setting	   for	   24	   h	   decreased	   with	   increase	   in	   the	   IP6	   concentration.	   	   The	   β-­‐TCP-­‐3h(0)	   cement	  
specimens	  fabricated	  from	  the	  non-­‐surface-­‐modified	  β-­‐TCP-­‐3h(0)	  powder	  were	  mostly	  composed	  of	  
the	   HAp	   phase	   (79.4%).	   	   In	   contrast,	   the	   β-­‐TCP-­‐3h(3000)	   cement	   specimens	   with	   maximum	   CS	  
contained	  24.9%	  of	  the	  HAp	  phase,	  which	  suggests	  that	  hydrolysis	  of	  the	  β-­‐TCP	  powders	  during	  the	  
setting	  reaction	  was	  inhibited	  with	  an	  increase	  in	  the	  IP6	  concentration.	  
The	  microstructures	  of	  the	  cement	  fracture	  surfaces	  were	  observed	  using	  the	  SEM.	   	   In	  the	  β-­‐TCP	  
cement	  specimens	  that	  contained	  the	  HAp	  phase	  (Figs.	  3-­‐2-­‐9a-­‐c),	  the	  cement	  particles	  were	  tightly	  
packed	  with	  each	  other.	   	   In	  contrast,	   the	  cement	  particles	   in	   the	  β-­‐TCP-­‐3h(10000)	  specimen	  (Fig.	  
3-­‐2-­‐9d),	  which	  did	  not	  contain	  the	  HAp	  phase,	  were	  slightly	  packed	  with	  each	  other,	  and	  many	  voids	  
were	  present	  among	   the	  cement	  particles.	   	   In	  addition,	  unreacted	  β-­‐TCP	  grains	  were	  observed	   in	  
the	   β-­‐TCP-­‐3h(3000)	   cement	   specimen,	   as	   indicated	   by	   the	   arrows	   in	   Fig.	   3-­‐2-­‐9b.	   	   A	   highly	  
magnified	  image	  revealed	  needle-­‐shaped	  HAp	  particles.	  
The	  dissolution	  of	  Ca2+	   ions	   from	   the	  β-­‐TCP-­‐3h(0)	  and	  β-­‐TCP-­‐3h(3000)	   cement	   specimens	  was	  
examined	  by	  an	  ion-­‐selective	  potentiometry	  (Fig.	  3-­‐2-­‐10).	   	   The	  amount	  of	  Ca2+	   ions	  released	  from	  
the	   β-­‐TCP-­‐3h(0)	   and	   β-­‐TCP-­‐3h(3000)	   cements	   was	   about	   three	   times	   higher	   than	   that	   from	   the	  
0-­‐IP6-­‐HAp	  cement.	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Figure	  3-­‐2-­‐3	   	   Amount	  of	  Ca2+	  ions	  released	  from	  ball-­‐milled	  β-­‐TCP	  powders	  in	  a	  Tris-­‐HCl	  solution.	  
	  
	  
	   	  














Figure	   3-­‐2-­‐4	   	   Photographs	   providing	   an	   overview	   of	   the	   anti-­‐washout	   properties	   of	   the	   β-­‐TCP	  
cement	   pastes.	   	   At	   5	   min	   after	   cement	   preparation,	   only	   the	   cement	   paste	   prepared	   with	   the	  
β-­‐TCP-­‐3h(3000)	  was	  set	  within	  5	  min	  and	  exhibited	  anti-­‐washout	  characteristics.	  
	  
	   	  










Figure	  3-­‐2-­‐5	   	   XRD	  patterns	  of	  the	  β-­‐TCP	  powders	  ball-­‐milled	  in	  various	  concentrations	  of	  IP6	  at	  a	  
constant	   ball-­‐milling	   time	   of	   3	   h.	   	   Black	   and	  white	   circles	   indicate	   typical	   β-­‐TCP	   and	  HAp	   peaks,	  
respectively.	  
	  
	   	  










Figure	   3-­‐2-­‐6	   	   SSA	   and	   median	   particle	   size	   for	   β-­‐TCP	   powders	   ball-­‐milled	   in	   various	  
concentrations	  of	  IP6.	  
	  
	   	  






Figure	  3-­‐2-­‐7	   	   Relationship	  between	  the	  P/L	  ratio	  and	  the	  (A)	  CS	  and	  (B)	  RD	  of	  the	  β-­‐TCP	  cement	  
specimens.	  
	  
	   	  










Table	  3-­‐2-­‐2	   	   Initial	  setting	  time	  with	  P/L	  ratio	  corresponding	  to	  the	  highest	  CS	  for	  each	  β-­‐TCP-­‐3h	  
cement	  and	  HAp	  content	  of	  the	  cement	  specimens	  after	  setting	  for	  24	  h.	  
	  
	  
a	  Plus	  or	  minus	  (±)	  indicates	  standard	  deviation	  (n=3).	  
	  
	   	  




β-­‐TCP-­‐3h(0)	   1/0.8	   6.3±0.8	  
β-­‐TCP-­‐3h(1000)	   1/0.8	   5.7±0.5	  
β-­‐TCP-­‐3h(3000)	   1/0.7	   6.5±0.5	  
β-­‐TCP-­‐3h(5000)	   1/0.6	   10.0±0.6	  
β-­‐TCP-­‐3h(10000)	   1/0.5	   20.3±2.0	  











Figure	  3-­‐2-­‐8	   	   XRD	  patterns	  and	  HAp	  content	  of	  the	  β-­‐TCP	  cement	  specimens	  after	  setting	  for	  24	  h.	   	  
Black	  and	  white	  circles	  indicate	  typical	  β-­‐TCP	  and	  HAp	  peaks,	  respectively.	  
	   	  










Figure	   3-­‐2-­‐9	   	   Microstructures	   of	   the	   β-­‐TCP	   cement	   specimens:	   (a)	   β-­‐TCP-­‐3h(0)	   (P/L=1/0.8	  
[g/cm3]),	   (b)	   β-­‐TCP-­‐3h(3000)	   (P/L=1/0.7),	   (c)	   β-­‐TCP-­‐3h(5000)	   (P/L=1/0.6),	   and	   (d)	  
β-­‐TCP-­‐3h(10000)	  (P/L=1/0.5).	   	   Arrows	  indicate	  unreacted	  β-­‐TCP	  grains.	  
	  
	   	  











Figure	  3-­‐2-­‐10	   	   Amount	  of	  Ca2+	  ions	  released	  from	  β-­‐TCP	  and	  HAp	  cement	  specimens	  in	  an	  acetate	  
buffer:	   (a)	   β-­‐TCP-­‐3h(0)	   (P/L=1/0.7	   [g/cm3]),	   (b)	   β-­‐TCP-­‐3h(3000)	   (P/L=1/0.7),	   and	   0-­‐IP6-­‐HAp	  
(P/L=1/0.3)	  cement	  specimens.	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3.2.2.3	  In	  vitro	  evaluation	  of	  the	  β-­‐TCP	  cement	  
Osteoblast-­‐like	   cells	   were	   cultured	   on	   the	   β-­‐TCP-­‐3h(0)	   and	   β-­‐TCP-­‐3h(3000)	   cement	   specimens.	   	  
The	  surface	  roughness	  of	  β-­‐TCP-­‐3h(0)	  and	  β-­‐TCP-­‐3h(3000)	  cement	  specimens	  was	  almost	  the	  same,	  
at	  0.27±0.10	  and	  0.25±0.05	  μm,	  respectively,	  whereas	   that	  of	   the	  control	  material	  was	  0.06±0.002	  
μm.	   	   Cell	   proliferation	   on	   the	   two	   types	   of	   β-­‐TCP	   cement	   specimens	   was	   less	   than	   that	   on	   the	  
control	  (polystyrene	  plate);	  the	  number	  of	  cells	  on	  the	  cement	  specimens	  was	  decreased	  by	  43	  and	  
50%,	  respectively,	  by	  the	  first	  day	  (Fig.	  3-­‐2-­‐11).	   	   However,	  the	  number	  of	  cells	  at	  the	  third	  day	  was	  
recovered	   up	   to	   the	   number	   of	   seeded	   cells.	   	   At	   the	   fifth	   day,	   the	   number	   of	   cells	   was	   slightly	  
increased	   compared	   to	   that	   at	   the	   third	  day.	   	   No	   significant	  difference	   in	   the	  number	  of	   cultured	  
cells	  was	  observed	  between	  the	  β-­‐TCP-­‐3h(0)	  and	  β-­‐TCP-­‐3h(3000)	  cement	  specimens.	  
The	  cell	  morphology	  of	  cultures	  on	  the	  β-­‐TCP-­‐3h(0)	  and	  β-­‐TCP-­‐3h(3000)	  cement	  specimens	  after	  
1	  day	  was	  observed	  using	  an	  epifluorescence	  microscope.	   	   The	  images	  in	  Fig.	  3-­‐2-­‐12	  show	  that	  cells	  
attached,	   spread	   and	   grew	   on	   both	   the	   β-­‐TCP-­‐3h(0)	   and	   β-­‐TCP-­‐3h(3000)	   cement	   specimens	  with	  
filopodia	   extending	   from	   the	   cell	   edges;	   therefore,	   no	   obvious	   difference	   in	   the	   cell	   morphology	  
between	  β-­‐TCP-­‐3h(0)	  and	  β-­‐TCP-­‐3h(3000)	  cement	  specimens	  was	  observed.	  
	  
3.2.2.4	  In	  vivo	  evaluation	  of	  the	  β-­‐TCP	  cement	  
The	   osteoconductivity	   of	   the	   β-­‐TCP(0)	   and	   β-­‐TCP(3000)	   cement	   specimens	  were	   evaluated	   by	  
implantation	   into	   the	   tibia	  of	  a	  pig.	   	   Histological	  observation	  of	   the	  β-­‐TCP	  cement	  specimens	  was	  
performed	  using	  toluidine	  blue	  staining.	   	   Low-­‐magnification	  images	  (Figs.	  3-­‐2-­‐13a	  and	  c)	  show	  the	  
entire	  cement	  specimen	  (denoted	  C),	  and	  both	  the	  cement	  specimens	  were	  directly	  in	  contact	  with	  
the	  host	  bones	  and	  newly	  formed	  bones	  without	  fibrous	  tissue	  layers.	   	   Figures	  3-­‐2-­‐13	  b	  and	  d	  show	  
high-­‐magnification	   images	   of	   the	   areas	   indicated	   by	   dotted	   line	   squares	   in	   Figs.	   3-­‐2-­‐13a	   and	   c,	  
respectively,	   where	   newly	   formed	   bones	   are	   evident	   by	   light	   purple	   staining,	   and	   concentric	  
haversian	   canals	   (red	   asterisk)	   were	   confirmed	   in	   the	   newly	   formed	   bones	   around	   the	  
β-­‐TCP-­‐3h(3000)	  cement	  specimen,	  as	  shown	  in	  Fig.	  3-­‐2-­‐13d.	   	   The	  newly	  formed	  osteoids	  indicated	  
by	   light	   blue	   areas	  between	  osteoblast-­‐like	   cells	   (black	   arrows)	   and	  mature	  bones	   (M),	  which	   are	  
represented	   by	  white	   dotted	   arrows,	   were	   formed	   by	   osteoblast-­‐like	   cells.	   	   In	   contrast,	   both	   the	  
cement	   specimens	   were	   resorbed	   by	   osteoclast-­‐like	   cells	   (white	   arrows)	   on	   the	   surface	   of	   the	  
cement	  specimen.	   	   The	  sectional	  areas	  of	  the	  cement	  specimens	  before	  and	  after	  implantation	  for	  4	  
weeks,	  which	  were	  calculated	  from	  Figs.	  3-­‐2-­‐13a	  and	  c,	  were	  decreased	  by	  13%	  for	  β-­‐TCP-­‐3h(0)	  and	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3.2.3	  Discussion	  
	  
The	  β-­‐TCP	  cement	  based	  on	  a	  chelate-­‐setting	  mechanism	  of	  IP6	  has	  been	  previously	  reported	  [2-­‐4].	   	  
In	  addition,	  we	  have	  recently	  established	  a	  novel	  powder	  preparation	  process	  for	  the	  development	  
of	  a	   chelate-­‐setting	  HAp	  cement	  with	  anti-­‐washout	  properties,	   in	  which	   the	  starting	  HAp	  powders	  
for	  the	  cement	  fabrication	  were	  prepared	  by	  simultaneous	  ball-­‐milling	  and	  surface-­‐modification	  in	  
IP6	   solution	   [16].	   	   In	   the	   present	   study,	   this	   process	   was	   applied	   to	   the	   chelate-­‐setting	   β-­‐TCP	  
cement.	  
The	   hydrolysis	   of	   the	   highly	   crystalline	   β-­‐TCP	   powder	   to	   calcium-­‐deficient	   HAp	   is	   slow	   [1];	  
therefore,	  mechanical	  milling	  of	  the	  β-­‐TCP	  powder	  has	  been	  previously	  reported	  [17-­‐20].	   	   Gbureck	  
et	  al.	  reported	  that	  dissolution	  of	  Ca2+	  ions	  released	  from	  β-­‐TCP	  powders	  ball-­‐milled	  for	  prolonged	  
periods	  was	  increased,	  due	  to	  transformation	  from	  the	  crystalline	  to	  the	  amorphous	  phases,	  which	  
led	  to	  an	  increase	  in	  the	  formation	  enthalpy	  of	  the	  compounds	  [17,18].	   	   However,	  no	  morphological	  
investigation	  of	  the	  ball-­‐milled	  β-­‐TCP	  particles	  was	  available.	  
In	  the	  present	  study,	  TEM	  observation	  revealed	  that	  ball-­‐milling	  of	  the	  β-­‐TCP	  powder	  up	  to	  3	  h	  in	  
IP6	   solution	   caused	   an	   increase	   in	   nanosized	   particles	   (Figs.	   3-­‐2-­‐2c-­‐f).	   	   Consequently,	   the	  
crystallinity	  of	  the	  β-­‐TCP	  powders	  decreased	  (Table	  3-­‐2-­‐1),	  and	  an	  amorphous	  phase	  was	  formed	  on	  
the	   surface	   of	   the	   β-­‐TCP	   particles.	   	   Therefore,	   the	   amount	   of	   Ca2+	   ions	   released	   from	   the	   β-­‐TCP	  
powder	   increased	   for	   ball-­‐milling	   up	   to	   3	   h	   (Fig.	   3-­‐2-­‐3),	   and	   only	   β-­‐TCP-­‐3h(3000)	   cement	   paste	  
exhibited	  anti-­‐washout	  characteristics	  (Fig.	  3-­‐2-­‐4).	   	   The	  needle-­‐shaped	  crystals	  in	  β-­‐TCP-­‐4h(3000)	  
(Fig.	  3-­‐2-­‐2h)	  and	  the	  increase	  in	  the	  SSA	  and	  HAp	  contents	  of	  β-­‐TCP-­‐4h(3000)	  compared	  to	  that	  of	  
β-­‐TCP-­‐3h(3000)	  (Table	  3-­‐2-­‐1)	  indicated	  the	  formation	  of	  a	  low	  crystalline	  HAp	  phase	  on	  the	  surface	  
of	   the	  β-­‐TCP	  powder	  after	  ball-­‐milling	  for	  4	  h,	  which	  caused	  a	  decrease	   in	  the	  amount	  of	  Ca2+	   ions	  
released	   from	   the	   β-­‐TCP	   powders	   (Fig.	   3-­‐2-­‐3).	   	   Furthermore,	   more	   needle-­‐shaped	   crystals	   were	  
presumed	  to	  be	   formed	  on	  the	  surfaces	  of	   the	  β-­‐TCP-­‐5h(3000)	  and	  β-­‐TCP-­‐6h(3000)	  powders	  than	  
that	   on	   the	   β-­‐TCP-­‐4h(3000)	   powder,	   because	   the	   HAp	   content	   in	   the	   β-­‐TCP-­‐5h(3000)	   and	  
β-­‐TCP-­‐6h(3000)	  powders	  increased.	  
The	   hydrolysis	   of	   β-­‐TCP	   powders	   ball-­‐milled	   in	   various	   concentrations	   of	   IP6	   solution	   was	  
inhibited	   (Fig.	   3-­‐2-­‐5).	   	   However,	   the	   β-­‐TCP-­‐3h(0)	   powder	   was	   hydrolyzed	   during	   ball-­‐milling	   in	  
pure	   water,	   which	   resulted	   in	   the	   formation	   of	   low	   crystalline	   HAp	   on	   the	   surface	   of	   the	   β-­‐TCP	  
particles	   and	   an	   increase	   in	   the	   SSA	   (Fig.	   3-­‐2-­‐6).	   	   We	   have	   previously	   reported	   that	   IP6	   is	  
dose-­‐dependently	   adsorbed	   on	   the	   surface	   of	   HAp	   particles	   [16].	   	   It	   was	   considered	   that	   IP6	  
adsorbed	  on	  the	  surface	  of	  the	  β-­‐TCP	  powder	  during	  ball-­‐milling	   inhibited	  the	  hydrolysis	  of	  β-­‐TCP	  
into	  the	  HAp	  phase.	   	   IP6	  can	  adsorb	  Ca2+	  ions,	  as	  previously	  reported	  [21,22];	  therefore,	  when	  IP6	  
is	  adsorbed	  on	  the	  surface	  of	  β-­‐TCP	  particles,	  the	  dissolution	  of	  Ca2+	  ions	  from	  the	  β-­‐TCP	  particles	  is	   	  












Figure	  3-­‐2-­‐11	   	   Comparison	  of	  cell	  proliferation	  on	  (a)	  a	  polystyrene	  plate	  control	  material,	  and	  on	  
(b)	  β-­‐TCP-­‐3h(0)	  (P/L=1/0.2	  [g/cm3])	  and	  (c)	  β-­‐TCP-­‐3h(3000)	  (P/L=1/0.2)	  cement	  specimens.	  
	  
	  
	   	  






Figure	   3-­‐2-­‐12	   	   Morphology	  of	   cells	   cultured	  on	  β-­‐TCP	  cement	   specimens	   for	  1	  day	   showing	   that	  
cells	  attached,	  spread	  and	  grew	  on	  both	  the	  cement	  specimens	  with	  filopodia	  extending	  from	  the	  cell	  
edges:	   (a)	   β-­‐TCP-­‐3h(0)	   (P/L=1/0.2	   [g/cm3])	   and	   (b)	   β-­‐TCP-­‐3h(3000)	   (P/L=1/0.2).	   	   Scale	   bars	  
represent	  100	  μm.	  
	  
	   	  








Figure	  3-­‐2-­‐13	   	   Histological	  observation	  of	  the	  β-­‐TCP	  cement	  specimens	  implanted	  into	  the	  tibia	  of	  
a	   pig:	   (a,	   b)	   β-­‐TCP-­‐3h(0)	   (P/L=1/1.1	   [g/cm3]),	   (c,	   d)	   β-­‐TCP-­‐3h(3000)	   (P/L=1/1.0).	   The	  
low-­‐magnification	   images	  (a	  and	  c)	  present	   the	  entire	  cement	  specimen	  (C),	  and	  (b)	  and	  (d)	  show	  
high	  magnification	   images	   of	   the	   dotted	   square	   areas	   shown	   in	   (a)	   and	   (c).	   	   The	   red	   asterisk	   (*)	  
indicates	   haversian	   canals.	   	   Black	   arrows	   indicate	   osteoblast-­‐like	   cells	   and	  white	   arrows	   indicate	  
osteoclast-­‐like	  cells.	   	   Light	  blue	  areas	  formed	  between	  osteoblasts	  and	  mature	  bones	  (M)	  represent	  
newly	  formed	  osteoids,	  indicated	  by	  white	  dotted	  arrows.	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decreased,	  so	  that	  the	  hydrolysis	  of	  β-­‐TCP	  into	  the	  HAp	  phase	  would	  be	  inhibited.	   	   Increase	  in	  the	  
median	  particle	  size	  at	  more	  than	  5000	  ppm	  IP6	  was	  presumably	  because	  the	  β-­‐TCP	  particles	  were	  
slightly	  decalcified	  during	  ball-­‐milling,	  which	  became	  unstable	  and	  were	  agglomerated.	  
Sodium	   hydrogen	   phosphate	   solution	   (2.5	   mass%)	   was	   used	   as	   a	   mixing	   solution	   for	   cement	  
fabrication	   in	   the	   present	   study.	   	   The	   phosphate	   compound	   has	   been	   reported	   to	   accelerate	   the	  
setting	   reaction	   for	   the	   TTCP-­‐dicalcium	   phosphate	   anhydrous	   (CaHPO4;	   DCPA),	   α-­‐TCP,	   or	  
α-­‐TCP-­‐DCPA	  cement	  systems	  [23,24].	   	   Hydrolysis	  of	  β-­‐TCP-­‐3h	  powders	   into	  the	  HAp	  phase	   in	  the	  
cement	   specimens	   (Fig.	   3-­‐2-­‐8)	   revealed	   that	   the	   Na2HPO4	   solution	   reacted	   with	   the	   β-­‐TCP-­‐3h	  
powders	   in	   the	   present	   cement	   system.	   	   Cement	   specimens	   fabricated	   with	   β-­‐TCP	   powders	   that	  
were	  surface-­‐modified	  using	  various	  concentrations	  of	  IP6	  had	  different	  HAp	  contents	  (Fig.	  3-­‐2-­‐8),	  
which	   were	   because	   the	   amount	   of	   IP6	   adsorbed	   on	   the	   β-­‐TCP	   powders	   increased	   with	   the	   IP6	  
concentration.	   	   The	   results	   suggest	   that	   β-­‐TCP	   powders	   prepared	   with	   control	   of	   the	   IP6	  
concentration	   for	  surface	  modification	  enabled	  control	  of	   the	  hydrolysis	  rate	   in	   the	  β-­‐TCP	  cement.	   	  
In	   contrast,	   unreacted	   β-­‐TCP	   grains	  were	   observed	   in	   the	   fracture	   surface	   of	   the	   β-­‐TCP-­‐3h(3000)	  
cement	  specimen,	  as	  indicated	  by	  the	  arrows	  in	  Fig.	  3-­‐2-­‐9b.	   	   This	  indicates	  that	  the	  amorphous	  (or	  
low	  crystalline)	  phase	  formed	  within	  the	  nanosized	  β-­‐TCP	  particles	  by	  ball-­‐milling	  is	  involved	  in	  the	  
setting	  reaction	  of	  the	  β-­‐TCP	  cement,	  and	  the	  microsized	  β-­‐TCP	  grains	  shown	  in	  Fig.	  3-­‐2-­‐9b	  do	  not	  
react.	   	   This	   phenomenon	   is	   consistent	   with	   previously	   reported	   results,	   where	   most	   of	   the	  
amorphous	   phase	   within	   the	   β-­‐TCP	   powder	   reacted	   during	   setting,	   while	   the	   crystalline	   fraction	  
(β-­‐TCP	  grains)	  remained	  unreacted	  [17,20].	  
The	  dissolution	  of	   the	  β-­‐TCP-­‐3h(0)	  and	  β-­‐TCP-­‐3h(3000)	  cements	  was	  about	   three	   times	  higher	  
than	  that	  of	  the	  0-­‐IP6-­‐HAp	  cement,	  and	  that	  of	  the	  β-­‐TCP-­‐3h(3000)	  cement	  was	  slightly	  higher	  than	  
that	   of	   β-­‐TCP-­‐3h(0)	   cement	   (Fig.	   3-­‐2-­‐10).	   	   The	   β-­‐TCP-­‐3h(0)	   and	   β-­‐TCP-­‐3h(3000)	   cements	   after	  
setting	  for	  24	  h	  were	  composed	  of	  20.6%	  and	  75.1%	  of	  β-­‐TCP	  phase,	  respectively	  (Fig.	  3-­‐2-­‐8),	  and	  
thus,	  the	  β-­‐TCP-­‐3h(3000)	  cement	  was	  more	  soluble	  than	  the	  β-­‐TCP-­‐3h(0)	  cement.	  
The	  CS	  had	  a	  generally	  strong	  correlation	  with	  RD	  and	  the	  P/L	  ratio;	  reduction	  of	  the	  P/L	  ratio	  
led	   to	   a	   decrease	   in	   the	  RD	   of	   the	   cement	   specimen,	   and	   consequently	   to	   a	   low	  CS,	   as	   previously	  
reported	  [25,26].	   	   The	  CS	  and	  RD	  of	  the	  cement	  specimens	  tended	  to	  decrease	  with	  reduction	  of	  the	  
P/L	  ratio	  (Fig.	  3-­‐2-­‐7).	   	   In	  contrast,	  a	  linear	  relationship	  between	  the	  CS	  and	  HAp	  contents,	  as	  shown	  
by	  Gbureck	  et	  al.	  [17],	  was	  not	  obtained	  in	  the	  present	  study.	   	   Hydrolysis	  of	  the	  β-­‐TCP	  powder	  into	  
HAp	   is	  not	  only	  dependent	  on	  the	  amount	  of	   IP6	  adsorbed	  on	  the	  powder	  surface,	  but	  also	  on	  the	  
P/L	  ratio	  of	  the	  cement	  specimen.	   	   The	  effect	  of	  the	  P/L	  ratio	  on	  the	  CS	  and	  HAp	  contents	  is	  evident;	  
however,	  different	  P/L	  ratios	  were	  selected	  for	  comparison	  of	  the	  CS	  and	  HAp	  contents	  among	  the	  
β-­‐TCP	   cements	   fabricated	   with	   β-­‐TCP	   powders	   that	   were	   surface-­‐modified	   with	   different	  
concentrations	  of	  IP6.	   	   Therefore,	  a	  linear	  relationship	  between	  the	  CS	  and	  HAp	  contents	  could	  not	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be	  obtained.	  
The	   IST	   of	   the	   β-­‐TCP-­‐3h	   cements,	   except	   for	   the	   β-­‐TCP-­‐3h(0)	   cement,	   was	   extended	   with	  
increasing	   IP6	   concentration,	   and	   that	   of	   the	   β-­‐TCP-­‐3h(1000)	   cement	   was	   the	   fastest	   among	   the	  
examined	  cement	  specimens.	   	   This	  is	  due	  to	  inhibition	  of	  hydrolysis	  of	  the	  β-­‐TCP	  powder,	  because	  
the	  HAp	  content	  in	  these	  cements	  was	  decreased	  with	  increasing	  IP6	  concentration,	  as	  given	  in	  Fig.	  
3-­‐2-­‐8.	   	   The	   setting	   reaction,	   by	   hydrolysis	   of	   the	   β-­‐TCP	   powders,	   was	   faster	   than	   that	   by	   the	  
chelating	   reaction	   of	   the	   surface-­‐modified	   β-­‐TCP	   powders.	   	   Thus,	   the	   IST	   of	   the	   β-­‐TCP-­‐3h(1000)	  
cement	  was	  the	   fastest.	   	   In	  contrast,	   the	  β-­‐TCP-­‐3h(0)	  powder,	  which	  contained	  a	  small	  amount	  of	  
the	  HAp	  phase,	  and	  its	  surface	  was	  presumed	  to	  be	  partly	  composed	  of	  needle-­‐shaped	  HAp	  crystals,	  
had	   a	   higher	   SSA	   than	   the	   other	   β-­‐TCP-­‐3h	   powders	   (Fig.	   3-­‐2-­‐6).	   	   Therefore,	   the	   surface	   of	   the	  
β-­‐TCP-­‐3h(0)	  powder	  was	  less	  reactive	  than	  that	  of	  the	  β-­‐TCP-­‐3h(1000)	  powder,	  which	  resulted	  in	  a	  
slower	   IST	   for	   the	   β-­‐TCP-­‐3h(0)	   cement	   than	   that	   for	   the	   β-­‐TCP-­‐3h(1000)	   cement.	   	   However,	   the	  
HAp	  content	  for	  the	  β-­‐TCP-­‐3h(0)	  cement	  after	  setting	  for	  24	  h	  (79.4%)	  was	  the	  highest	  among	  the	  
examined	  cement	  specimens.	  
Osteoblast-­‐like	   cells	   attached	  and	  grew	   faster	   on	   the	   control	  material	   than	  on	   the	  β-­‐TCP-­‐3h(0)	  
and	  β-­‐TCP-­‐3h(3000)	  cement	  specimens;	  however,	   there	  was	  no	  significant	  difference	  between	   the	  
number	  of	   cells	   cultured	  on	   the	  β-­‐TCP-­‐3h(0)	  and	  β-­‐TCP-­‐3h(3000)	  cement	  specimens	   (Figs.	  3-­‐2-­‐11	  
and	   3-­‐2-­‐12).	   	   These	   results	   suggest	   that	   the	   in	   vitro	   biocompatibility	   of	   the	   two	   β-­‐TCP	   cement	  
specimens	  is	  less	  than	  that	  of	  the	  control	  material.	  
As	  for	  these	  results,	  a	  main	  reason	  is	  considered	  to	  be	  dissolution	  of	  calcium	  phosphate.	   	   Suzuki	  
et	   al.	   reported	   that	   the	   high	   solubility	   of	   β-­‐TCP-­‐HAp	   ceramics	   caused	   an	   initial	   decrease	   in	   the	  
attachment	  of	   fibroblastic	   L929	   cells	   [27].	   	   Moreover,	   they	   reported	   that	   cell	   proliferation	  on	   the	  
β-­‐TCP-­‐HAp	  ceramics	  treated	  with	  10%	  fetal	  bovine	  serum/minimum	  essential	  medium	  for	  various	  
pre-­‐incubation	   periods	  was	   increased	  with	   the	   pre-­‐incubation	   period	   [27].	   	   Their	   results	   suggest	  
that	   the	   dissolution	   of	   calcium	   phosphate	   is	   one	   of	   dominant	   factors	   in	   cell	   proliferation.	   	   In	  
addition,	  surface	  roughness	  of	  the	  cement	  specimens	  also	  affected	  the	  cell	  proliferation.	   	   Deligianni	  
et	  al.	  reported	  that	  cell	  attachment	  is	  dependent	  on	  the	  surface	  roughness	  of	  the	  substrate	  material	  
[28].	   	   The	   surface	   roughness	   of	   β-­‐TCP-­‐3h(0)	   and	   β-­‐TCP-­‐3h(3000)	   cement	   specimens	  was	   almost	  
the	  same,	  whereas	  that	  of	  the	  control	  material	  was	  smoother	  than	  that	  of	  both	  the	  cement	  specimens.	   	  
Therefore,	   the	   difference	   in	   surface	   roughness	   between	   the	   control	   material	   and	   the	   cement	  
specimens	   affected	   the	   initial	   cell	   attachment	   and	   the	   cell	   proliferation,	   although	   no	   significant	  
difference	  in	  the	  number	  of	  cells	  cultured	  on	  these	  cement	  specimens	  was	  evident.	  
The	  in	  vivo	  study	  showed,	  for	  the	  first	  time,	  the	  hydrolyzed	  β-­‐TCP/HAp	  biphasic	  cement	  in	  direct	  
contact	  with	  host	  and	  newly	  formed	  bones	  without	  fibrous	  tissue	  layers	  (Fig.	  3-­‐2-­‐13).	   	   Furthermore,	  
both	  the	  β-­‐TCP-­‐3h(0)	  and	  β-­‐TCP-­‐3h(3000)	  cement	  specimens	  were	  resorbed	  by	  osteoclast-­‐like	  cells	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on	  the	  surface	  of	  the	  cement	  specimen.	  
Some	   reports	   indicate	   that	   β-­‐TCP	   ceramics	   are	   resorbed	  when	   implanted	   in	   the	   body	   [29-­‐31];	  
however,	   other	   reports	   indicate	   that	   β-­‐TCP	   ceramics	   are	   incorporated	   and	   in	   direct	   contact	   with	  
newly	  formed	  bones,	  and	  are	  stable	  [32-­‐34].	   	   The	  biodegradability	  of	  β-­‐TCP	  materials	  is	  considered	  
to	   be	   dependent	   on	   the	   chemical	   composition,	   structure,	   and	   implant	   site.	   	   In	   general,	   β-­‐TCP	   is	  
chemically	  dissolved	  or	   resorbed	  by	  osteoclasts	  or	  macrophages	   in	   the	  host	  body.	   	   In	   addition,	   it	  
has	   been	   reported	   that	   β-­‐TCP	   is	  more	   soluble	   than	   the	   low	   crystalline	  HAp	   in	   vitro	   [35],	  which	   is	  
formed	  by	  hydrolysis	  of	  β-­‐TCP.	   	   Therefore,	  the	  β-­‐TCP-­‐3h(0)	  cement	  specimen,	  which	  is	  composed	  
of	  mostly	  HAp	  phase,	  would	   be	   resorbed	  by	   osteoclast-­‐like	   cells,	   and	   the	   β-­‐TCP-­‐3h(3000)	   cement	  
specimen,	  which	  is	  composed	  of	  mainly	  β-­‐TCP	  phase,	  would	  also	  be	  resorbed	  by	  osteoclast-­‐like	  cells,	  
and	   furthermore,	   has	   the	   potential	   to	   be	   chemically	   dissolved	   after	   prolonged	   implantation.	   	  
However,	  the	  sectional	  area	  of	  the	  β-­‐TCP-­‐3h(0)	  cement	  specimen	  after	  implantation	  for	  4	  weeks	  was	  
slightly	  smaller	  than	  that	  of	  the	  β-­‐TCP-­‐3h(3000)	  cement	  specimen.	   	   Therefore,	  reproducible	  in	  vivo	  






A	   novel	   powder	   preparation	   process	   was	   applied	   to	   the	   fabrication	   of	   chelate-­‐setting	   β-­‐TCP	  
cement	  to	  investigate	  the	  effect	  of	  milling	  time	  and	  IP6	  concentration	  on	  the	  material	  properties	  the	  
resulting	  cement,	  in	  particular,	  anti-­‐washout	  property.	   	   β-­‐TCP	  powders	  for	  cement	  fabrication	  were	  
prepared	   by	   ball-­‐milling	   for	   0	   to	   6	   h	   with	   simultaneous	   surface-­‐modification	   in	   3000	   ppm	   IP6	  
solution.	   	   The	  dissolution	  of	  Ca2+	  ions	  released	  from	  β-­‐TCP	  powder	  ball-­‐milled	  up	  to	  3	  h	  increased,	  
and	  only	  the	  β-­‐TCP-­‐3h(3000)	  cement	  immersed	  in	  water	  exhibited	  anti-­‐washout	  property.	   	   The	  IP6	  
concentration	   used	   for	   surface-­‐modification	   is	   considered	   to	   affect	   the	   susceptibility	   of	   the	   β-­‐TCP	  
powders	   to	   hydrolysis.	   	   The	   β-­‐TCP	   cement	   specimens	   prepared	   from	   β-­‐TCP	   powders	   that	   were	  
surface-­‐modified	   with	   various	   IP6	   concentrations	   had	   different	   HAp	   contents,	   due	   to	   different	  
amounts	  of	  IP6	  adsorbed	  on	  the	  β-­‐TCP	  powders	  during	  ball-­‐milling.	   	   Nanosized	  amorphous	  β-­‐TCP	  
particles	   formed	  on	  the	  surface	  of	  β-­‐TCP	  particles	  by	  ball-­‐milling	  were	  hydrolyzed	   in	   the	  Na2HPO4	  
mixing	  solution;	  however,	   the	  microsized	  β-­‐TCP	  grains	  did	  not	   react.	   	   A	  maximum	  CS	  of	  13.4±0.8	  
MPa	  was	  obtained	  for	  the	  β-­‐TCP-­‐3h(3000)	  cement	  specimen,	  and	  the	  IST	  of	  the	  cement	  was	  6.5±0.5	  
min.	   	   The	  β-­‐TCP-­‐3h(3000)	  cement	  was	  more	  soluble	  than	  the	  β-­‐TCP-­‐3h(0)	  cement	  in	  acetate	  buffer.	   	  
Cell	  proliferation	  on	  the	  β-­‐TCP-­‐3h(0)	  and	  β-­‐TCP-­‐3h(3000)	  cement	  specimens	  was	  less	  than	  that	  on	  
the	  control	  material,	  due	  to	  dissolution	  of	  the	  β-­‐TCP	  cement	  and	  difference	  in	  initial	  cell	  attachment	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caused	  by	  surface	  roughness;	  however,	  the	  number	  of	  cells	  at	  the	  third	  day	  was	  recovered	  up	  to	  the	  
number	   of	   seeded	   cells.	   	   An	   in	   vivo	   study	   revealed	   that	   the	   β-­‐TCP-­‐3h(0)	   and	   β-­‐TCP-­‐3h(3000)	  
cements	   were	   in	   direct	   contact	   with	   host	   and	   newly	   formed	   bones	   without	   fibrous	   tissue	   layers.	   	  
Furthermore,	   both	   cement	   specimens	  were	   resorbed	   by	   osteoclast-­‐like	   cells	   on	   the	   surface	   of	   the	  
cement	   specimen.	   	   The	   novel	   powder	   preparation	   process	   is	   promising	   for	   fabrication	   of	  
anti-­‐washout	  type	  chelate-­‐setting	  β-­‐TCP	  cement	  with	  both	  biodegradability	  and	  osteoconductivity.	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Chapter	  4.	   Fabrication	   of	   prototype	   chelate-­‐setting	   α-­‐tricalcium	  
phosphate	  cements	  with	  biodegradability	  and	  their	  evaluation	  
	  
	  
More	   soluble	   and	   reactive	  α-­‐tricalcium	  phosphate	   (α-­‐TCP)	   than	  β-­‐TCP	   is	   used	  mainly	   as	   a	   fine	  
powder	  in	  hydraulic	  calcium-­‐phosphate	  cement	  (CPC)	  [1-­‐10];	  thereby,	  there	  is	  difficulty	  to	  create	  a	  
biodegradable	  CPC	  composed	  of	  single-­‐phase	  α-­‐TCP	  without	  hydration	  reaction	  of	  it.	   	   Takahashi	  et	  
al.	  [11]	  have	  previously	  developed	  a	  prototype	  of	  chelate-­‐setting	  β-­‐TCP	  cement	  (IP6-­‐β-­‐TCP)	  using	  a	  
chelating	   mechanism	   of	   inositol	   phosphate	   (IP6),	   and	   Nishiyama	   et	   al.	   [12]	   have	   reported	   the	  
biocompatibility	  and	  osteoconductivity	  of	   the	   IP6-­‐β-­‐TCP	  cement.	   	   Therefore,	  author	  expected	  that	  
novel	  biodegradable	   cement	  based	  on	   chelate-­‐setting	  mechanism	  of	   IP6	   could	  be	  developed	  using	  
more	  soluble	  α-­‐TCP	  powder	  compared	  with	  β-­‐TCP	  powder.	  
In	  Chapter	  4,	  the	  α-­‐TCP	  cement	  based	  on	  chelate-­‐setting	  mechanism	  of	  IP6	  was	  fabricated	  [13].	   	  
The	   α-­‐TCP	   powders	   for	   cement	   fabrication	   were	   prepared	   by	   grinding	   and	   then	   modifying	   their	  
surfaces	  with	  IP6,	  and	  mechanical	  property	  of	  the	  α-­‐TCP	  cement	  was	  investigated	  in	  order	  to	  obtain	  
the	   basic	   findings	   for	   development	   of	   injectable	   CPC.	   	   Additionally,	   biocompatibility	   of	   the	  α-­‐TCP	  
cement	  was	  examined	  in	  vitro	  using	  osteoblasts	  and	  in	  vivo	  using	  rabbit	  models.	  
	  
	  
4.1	  Materials	  and	  methods	  
	  
4.1.1	  Preparation	  of	  the	  ball-­‐milled	  α-­‐TCP	  powders	  and	  their	  surface-­‐modification	  with	  IP6	  
The	   IP6	   (50	   mass%	   phytic	   acid,	   Wako	   Pure	   Chemical	   Industries,	   Ltd.,	   Japan)	   solution	   was	  
prepared	  with	   a	   concentration	   of	   1000	  ppm	  and	   adjusted	   to	   pH	  7.3	   using	   an	   aqueous	   solution	   of	  
NaOH	   (0.1	   mol·dm-­‐3).	   	   10	   grams	   of	   commercially	   available	   α-­‐TCP	   powder	   (α-­‐TCP-­‐A,	   Taihei	  
Chemical	   Industrial	   Co.,	   Ltd.,	   Japan)	   were	   ground	   using	   a	   planetary	   mill	   (Pulverisette	   6,	   Fritsch,	  
Germany)	  for	  30,	  60,	  90,	  120,	  180,	  240	  and	  270	  min	  at	  a	  rotation	  rate	  of	  300	  rpm	  in	  a	  ZrO2	  pot	  with	  
fifty	  10	  mm	  diameter	  ZrO2	  beads	  under	  wet	  conditions	  (40	  cm3	  of	  pure	  water).	   	   After	  ball-­‐milling,	  
the	   slurry	  mixtures	  were	   filtrated,	   and	   freeze-­‐dried	   for	  24	  h	   to	  prepare	  ball-­‐milled	  α-­‐TCP	  powder	  
without	   surface-­‐modification	   with	   IP6.	   	   To	   prepare	   the	   IP6	   surface-­‐modified	   α-­‐TCP	   powder,	   the	  
filter	  cake	  obtained	  was	  added	  into	  the	  IP6	  solution	  (400	  cm3),	  stirred	  at	  400	  rpm	  for	  24	  h,	  filtrated,	  
and	  freeze-­‐dried	  for	  24	  h.	  
Hereafter,	   samples	   are	   denoted	   according	   to	   the	  milling	   time;	   for	   example,	   the	   α-­‐TCP	   powder	  
ball-­‐milled	  for	  120	  min	  is	  denoted	  as	  “α-­‐TCP120”,	  and	  the	  α-­‐TCP120	  powder	  surface-­‐modified	  with	  
IP6	  is	  denoted	  as	  “IP6-­‐α-­‐TCP120”.	   	   As-­‐received	  α-­‐TCP-­‐A	  powder	  is	  denoted	  as	  “α-­‐TCP0”.	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4.1.2	  Characterization	  of	  the	  prepared	  α-­‐TCP	  powders	  
X-­‐ray	  diffraction	  (XRD;	  Ultima	  IV,	  Rigaku,	  Japan)	  analysis	  of	  the	  powders	  was	  conducted	  using	  a	  
CuKα	  radiation	  source.	   	   Data	  were	  collected	  in	  the	  range	  of	  2θ=25-­‐40°	  with	  a	  step	  size	  of	  0.02°	  and	  
counting	  time	  of	  1.2	  s/step.	   	   The	  crystal	  phase	  was	   identified	  with	  respect	  to	  the	  JCPDS	  reference	  
patterns	   for	  α-­‐TCP	  (#09-­‐0348)	  and	  HAp	  (#09-­‐0432).	  The	  HAp	  content	   in	   the	  α-­‐TCP	  powders	  with	  
and	  without	   IP6	  surface	  modification	  was	  calculated	  using	   the	   typical	  peaks	  of	  α-­‐TCP	  (2θ=30.75°)	  
and	  HAp	  (2θ=31.77°)	  by	  Eq.	  (1).	  
	  
HAp	  content	  (%)	  =	  (IHAp(t))/(Iα-­‐TCP(t)	  +	  IHAp(t))	  ×	  100	   	   	   	   	   (1)	  
	  
where,	   Iα-­‐TCP(t)	  and	   IHAp(t)	  are	   the	  XRD	   intensities	  of	   the	  α-­‐TCP	  (2θ=30.75°)	  and	  HAp	  (2θ=31.77°)	   in	  
the	   ball-­‐milled	   powder	   for	   t	   min	   (t=0-­‐270),	   respectively.	   	   The	   crystallite	   size	   of	   the	   ball-­‐milled	  
α-­‐TCP	  powders	  was	  calculated	  using	  Scherrer’s	  equation:	  
	  
Crystallite	  size	  (nm)	  =	  Kλ/βcosθ	  	   	   	   	   	   	   (2)	  
	  
where	  K	  is	  the	  shape	  coefficient	  (K=0.9),	  λ	  is	  the	  wavelength	  (λ=0.15405	  nm),	  and	  β	  is	  the	  half	  width	  
at	  2θ=30.75°.	  
The	   specific	   surface	   area	   and	   median	   particle	   size	   of	   the	   ball-­‐milled	   α-­‐TCP	   powders	   were	  
measured	   with	   a	   surface	   area	   analyzer	   (Flowsorb	   III,	   Shimadzu,	   Japan)	   and	   a	   laser	   particle	   size	  
analyzer	   (LA-­‐300,	  Horiba,	   Japan),	   respectively.	   	   The	  particle	  morphology	  of	   the	  ball-­‐milled	  α-­‐TCP	  
sputter-­‐coated	  with	  Au	  was	  observed	  with	  a	  scanning	  electron	  microscope	  (SEM;	  VE-­‐9800,	  Keyence,	  
Japan)	  at	  an	  accelerating	  voltage	  of	  10	  kV.	  
Dissolution	   of	   Ca2+	   ions	   released	   from	   the	   ball-­‐milled	   α-­‐TCP	   powder	   with	   and	   without	   IP6	  
surface-­‐modification	   was	   measured	   using	   ion-­‐selective	   potentiometry	   (F-­‐73,	   Horiba,	   Japan).	   	  
Twenty-­‐five	   milligrams	   of	   each	   α-­‐TCP	   powder	   were	   added	   to	   0.2	   dm3	   of	   0.05	   mol·dm-­‐3	  
tris(hydroxymethyl)aminomethane	   hydrochloric	   acid	   (Tris-­‐HCl)	   buffer	   at	   pH7.3	   and	   25±3°C	   with	  
stirring	  at	  430	  rpm.	   	   The	  concentration	  of	  free	  Ca2+	  ions	  in	  the	  solution	  was	  measured	  as	  a	  function	  
of	  time	  up	  to	  180	  min.	  
	  
4.1.3	  Fabrication	  of	  the	  α-­‐TCP	  cement	  specimens	  and	  their	  material	  properties	  
Cement	  specimens	  were	  fabricated	  by	  mixing	  0.25	  g	  of	  prepared	  α-­‐TCP	  powder	  with	  and	  without	  
surface	  modification	  with	   IP6	  and	  pure	  water	  at	  powder/liquid	  (P/L)	  ratio	  of	  1/0.40	   [g/cm3],	  and	  
packing	  into	  a	  5	  mm	  diameter	  cylindrical	  stainless	  mold.	   	   The	  resulting	  cement	  specimens	  (5	  mm	  in	  
diameter,	  7	  mm	  in	  height)	  were	  kept	  at	  room	  temperature	  for	  24	  h.	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The	   compressive	   strength	   of	   the	   cement	   specimens	   was	   measured	   using	   a	   universal	   testing	  
machine	   (Autograph	   AGS-­‐X,	   Shimadzu,	   Japan)	   with	   a	   5	   kN	   load	   cell	   at	   a	   crosshead	   speed	   of	   500	  
μm·min-­‐1.	   	   XRD	   patterns	   of	   the	   cement	   after	   the	   compressive	   strength	   testing	  were	  measured	   to	  
determine	  the	  HAp	  content	  after	  setting	  for	  24	  h,	  and	  the	  HAp	  content	  in	  the	  cement	  specimen	  was	  
also	  calculated	  by	  Eq.	  (1).	   	   The	  microstructure	  of	  the	  fracture	  cement	  sputter-­‐coated	  with	  Au	  was	  
observed	  with	  SEM	  at	  an	  accelerating	  voltage	  of	  10	  kV.	   	   The	  bulk	  density	  of	  the	  cylindrical	  cement	  
specimens	   was	   calculated	   by	   measuring	   the	   diameter,	   height,	   and	   weight	   of	   the	   cement.	   	   The	  
relative	   density	   of	   the	   cement	   specimen	   was	   calculated	   from	   the	   bulk	   density	   divided	   by	   the	  
theoretical	  density	  of	  α-­‐TCP/HAp,	  which	  was	  calculated	  by	  Eq.	  (3).	  
	  
Theoretical	  density	  of	  α-­‐TCP/HAp	  (g/cm3)	  =	  
2.86×(100-­‐HAp	  content	  (%))/100	  +	  3.16×(HAp	  content	  (%))/100	   	   	   (3)	  
	  
where,	  2.86	  and	  3.16	  [g/cm3]	  are	  theoretical	  density	  of	  the	  α-­‐TCP	  and	  HAp,	  respectively.	  
	  
4.1.4	  In	  vitro	  evaluation	  of	  the	  α-­‐TCP	  cement	  specimens	  
In	   order	   to	   evaluate	   the	   biocompatibility	   of	   the	   cement	   specimens,	   we	   have	   compared	   cell	  
proliferation	   between	   polystyrene	   plate	   (control)	   and	   cement	   specimens	   (both	   α-­‐TCP120	   and	  
IP6-­‐α-­‐TCP120).	   	   The	  IP6-­‐α-­‐TCP120	  cement	  with	  the	  highest	  compressive	  strength	  and	  lowest	  HAp	  
contents	  were	  selected,	  which	  would	  be	  expected	  as	  the	  most	  biodegradable	  material.	  
The	   cement	   specimens	   for	   in	   vitro	   evaluation	  were	  prepared	  by	  mixing	   the	  α-­‐TCP	  powder	   and	  
pure	   water	   at	   P/L	   ratio	   of	   1/0.4	   [g/cm3],	   and	   packing	   into	   a	   cylindrical	   stainless	   mold.	   	   The	  
resulting	   cement	   specimens	   (5	  mm	   in	   diameter,	   7	  mm	   in	   height)	  were	   kept	   at	   room	   temperature	  
under	  atmospheric	  conditions	  for	  24	  h,	  and	  sterilized	  with	  ethylene	  oxide	  gas	  (EOG).	  
Osteoblast-­‐like	   cells	   (MC3T3-­‐E1)	  were	   seeded	   into	  12	  well	   tissue	   culture	  plates	   at	   a	  density	  of	  
6×104	  cells/well	  and	  precultured	  for	  1	  day.	   	   The	  cement	  specimens	  were	  then	  set	  on	  a	  membrane	  
of	  Transwell®	  kit	  (Corning,	  USA)	  to	  culture	  the	  cells	  in	  a	  humidified	  5%	  CO2	  balanced-­‐air	  incubator	  
at	  37°C.	   	   The	  number	  of	  proliferated	  cells	  was	  counted	  after	  culturing	  for	  1,	  2	  and	  4	  days.	  
	  
4.1.5	  In	  vivo	  evaluation	  of	  the	  α-­‐TCP	  cement	  specimens	  
Based	   on	   in	   vitro	   cell	   proliferation	   assay,	   biodegradability	   and	   biocompatibility	   of	   the	  
IP6-­‐α-­‐TCP120	  cement	  specimens	  in	  vivo	  were	  evaluated.	  
In	  vivo	  studies	  of	  the	  IP6-­‐α-­‐TCP120	  cement	  specimens	  were	  performed	  using	  16	  weeks	  old	  male	  
rabbits	   (average	  weight;	  3	  kg)	   according	   to	   the	  guidelines	  of	   the	   laboratory	  animal	   center	   at	  Keio	  
University.	   	   The	   cement	   specimens	   for	   in	   vivo	   evaluation	  were	   prepared	   in	   the	   same	  manner	   as	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described	   in	   section	   4.1.4.	   	   The	   dimensions	   of	   the	   resulting	   cement	   specimens	   were	   4	   mm	   in	  
diameter	  and	  7	  mm	  in	  height.	   	   The	  cement	  specimens	  were	  sterilized	  with	  EOG.	  
A	   cylindrical	   defect	   (4.4	   mm	   diameter)	   was	   drilled	   in	   the	   epiphysis	   of	   a	   rabbit’s	   tibia.	   	   The	  
cement	  specimen	  was	  implanted	  into	  the	  defect	  for	  4,	  8	  and	  24	  weeks.	   	   At	  appropriate	  period,	  the	  
rabbit	   was	   sacrificed	   using	   sodium	   pentobarbital	   and	   the	   tibia	   was	   removed.	   	   Decalcified	   and	  
undecalcified	   sections	   were	   then	   prepared	   for	   histological	   evaluation.	   	   The	   decalcified	   sections	  
were	   stained	  with	   tartrate-­‐resistant	  acid	  phosphatase	   (TRAP)	  and	   the	  undecalcified	   sections	  were	  
stained	  with	  hematoxylin	  and	  eosin	  (HE).	   	   The	  histological	  sections	  were	  observed	  with	  an	  upright	  





4.2.1	  Characterization	  of	  the	  prepared	  α-­‐TCP	  powders	  
Typical	   XRD	   patterns,	   crystallite	   size	   and	   HAp	   content	   of	   the	   prepared	   α-­‐TCP	   powders	   were	  
shown	   in	  Figs.	  4-­‐1	  and	  4-­‐2,	   respectively.	  The	  XRD	  patterns	  of	  as-­‐received	  α-­‐TCP	  powder	  (α-­‐TCP0)	  
and	  the	  IP6	  surface-­‐modified	  powder	  (IP6-­‐α-­‐TCP0)	  showed	  that	  α-­‐TCP	  had	  a	  single	  phase	  with	  high	  
crystallinity.	   The	   XRD	   patterns	   of	   the	   α-­‐TCP	   powders	   ball-­‐milled	   up	   to	   120	   min	   and	   their	  
surface-­‐modified	  powders	  showed	  mostly	  α-­‐TCP	  phase.	  
In	   Fig.	   4-­‐2,	   the	   crystallite	   size	   of	   the	   prepared	   α-­‐TCP	   powders	   with	   and	   without	   IP6	   surface	  
modification	   decreased	   with	   milling	   time,	   and	   the	   prepared	   α-­‐TCP	   powders	   were	   composed	   of	  
nano-­‐sized	   α-­‐TCP	   crystals	   less	   than	   50	   nm.	   	   Although	   the	   α-­‐TCP180	   and	   IP6-­‐α-­‐TCP180	   powders	  
were	  mostly	  composed	  of	  α-­‐TCP	  phase,	  small	  amount	  of	  HAp	  phase	  was	  contained:	  9.9±0.6%	  for	  the	  
α-­‐TCP180	   and	   12.2±1.1%	   for	   the	   IP6-­‐α-­‐TCP180.	   The	   HAp	   contents	   in	   the	   IP6	   surface-­‐modified	  
α-­‐TCP	  powders	  over	  90	  min	  of	  ball-­‐milling	  were	  more	  than	  those	  of	  the	  α-­‐TCP	  powders	  without	  IP6	  
surface	   modification,	   which	   suggested	   that	   the	   α-­‐TCP	   powders	   without	   IP6	   surface	   modification	  
were	  hydrolyzed	  during	  IP6	  surface	  modification.	  
Specific	  surface	  area	  and	  median	  particle	  size	  of	  the	  prepared	  α-­‐TCP	  powders	  were	  shown	  in	  Fig.	  
4-­‐3.	   	   Specific	  surface	  area	  of	  the	  α-­‐TCP	  powders	  up	  to	  120	  min	  of	  ball-­‐milling	  did	  not	  change	  before	  
and	  after	   IP6	  surface	  modification;	  however,	   that	  of	   the	   IP6	  surface-­‐modified	  α-­‐TCP	  powders	  over	  
180	  min	  of	  milling	  was	  higher	  than	  that	  of	  the	  α-­‐TCP	  powders	  before	  IP6	  surface	  modification.	   	   The	  
results	  corresponded	  to	  the	  increase	  in	  HAp	  contents	  of	   IP6	  surface-­‐modified	  α-­‐TCP	  powders	  over	  
180	  min	  of	  milling	  in	  Fig.	  4-­‐2.	   	   Median	  particle	  size	  of	  the	  prepared	  α-­‐TCP	  powders	  decreased	  with	  
increasing	   milling	   time,	   and	   that	   of	   the	   prepared	   α-­‐TCP	   powders	   with	   and	   without	   IP6	   surface	  
modification	  did	  not	  change.	   	   Although	  the	  median	  particle	  size	  of	  IP6-­‐α-­‐TCP0	  powder	  was	  about	   	  








Fig.	  4-­‐1	   	   XRD	  patterns	  of	  the	  prepared	  α-­‐TCP	  powders	  with	  and	  without	  IP6	  surface	  modification.	   	  
Closed	   circles	   indicate	   typical	   α-­‐TCP	  peaks,	   and	   closed	   triangles	   indicate	   typical	  HAp	  peaks.	   	   The	  
single	  phase	  α-­‐TCP	  was	  maintained	  up	  to	  120	  min	  of	  milling,	  and	  the	  α-­‐TCP	  powders	  over	  120	  min	  
of	  milling	  were	  composed	  of	  the	  both	  α-­‐TCP	  and	  HAp	  phases.	  
	   	  









Fig.	   4-­‐2	   	   Crystallite	   size	   and	  HAp	   content	   of	   the	   prepared	   α-­‐TCP	   powders	  with	   and	  without	   IP6	  
surface	  modification	  as	  a	  function	  of	  milling	  time.	   	   Error	  bars	  indicate	  standard	  error	  of	  the	  mean	  
(n=3).	   	   The	   crystallite	   size	   of	   the	   prepared	   α-­‐TCP	   powders	   with	   and	   without	   IP6	   surface	  
modification	  decreased	  with	  milling	   time,	   and	  HAp	   contents	   of	   the	  prepared	  α-­‐TCP	  powders	  with	  
and	  without	  IP6	  surface	  modification	  increased	  with	  milling	  time.	  
	   	  









Fig.	   4-­‐3	   	   Specific	   surface	  area	  and	  median	  particle	   size	  of	   the	  prepared	  α-­‐TCP	  powders	  with	  and	  
without	   surface-­‐modification	   as	   a	   function	   of	  milling	   time.	   	   Error	   bars	   indicate	   standard	   error	   of	  
the	  mean	  (n=3).	   	   The	  specific	  surface	  area	  of	  the	  α-­‐TCP	  powders	  up	  to	  120	  min	  of	  ball-­‐milling	  did	  
not	   change	   before	   and	   after	   IP6	   surface	   modification;	   however,	   that	   of	   the	   IP6	   surface-­‐modified	  
α-­‐TCP	   powders	   over	   180	   min	   of	   milling	   was	   higher	   than	   that	   of	   the	   α-­‐TCP	   powders	   before	   IP6	  
surface	   modification.	   	   Median	   particle	   size	   of	   the	   prepared	   α-­‐TCP	   powders	   decreased	   with	  
increasing	  milling	  time.	  
	   	  




Fig.	   4-­‐4	   	   Particle	   morphology	   of	   the	   prepared	   α-­‐TCP	   powders:	   (a)	   α-­‐TCP0,	   (b)	   IP6-­‐α-­‐TCP0,	   (c)	  
α-­‐TCP60,	   (d)	   IP6-­‐α-­‐TCP60,	   (e)	   α-­‐TCP120,	   (f)	   IP6-­‐α-­‐TCP120,	   (g)	   α-­‐TCP180,	   and	   (h)	   IP6-­‐α-­‐TCP180.	   	  
Arrows	  indicate	  agglomerates.	   	   In	  Figs.	  4-­‐4(a)	  and	  (b),	   the	  α-­‐TCP0	  and	  IP6-­‐α-­‐TCP0	  powders	  were	  
tens	  of	  microns	  of	  grains;	  however,	  the	  particle	  size	  of	  the	  α-­‐TCP	  powders	  decreased	  with	  increasing	  
milling	   time	  (Figs.	  4-­‐4(c)-­‐(h)).	  The	  α-­‐TCP180	  and	   IP6-­‐α-­‐TCP180	  powders	  were	  composed	  of	  small	  
particles	  and	  aggregates	  as	  indicated	  by	  arrows	  (Figs.	  4-­‐4(g)	  and	  (h)).	  	   	  









Fig.	  4-­‐5	   	   Dissolution	  of	  Ca2+	   ions	  from	  the	  prepared	  α-­‐TCP	  powders	  with	  and	  without	  IP6	  surface	  
modification.	   	   Dissolution	  of	  the	  IP6-­‐α-­‐TCP	  powders	  was	  lower	  than	  that	  of	  α-­‐TCP	  powders	  without	  
IP6	  surface	  modification.	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9.2±0.2	   μm,	   that	   of	   IP6-­‐α-­‐TCP120	   powder	   composed	   of	   a	   single	   phase	   α-­‐TCP	   decreased	   to	  
approximately	  3.1±0.04	  μm.	  
Figure	  4-­‐4	  showed	  particle	  morphology	  of	  the	  prepared	  α-­‐TCP	  powders.	   	   In	  Figs.	  4-­‐4a	  and	  b,	  the	  
α-­‐TCP0	  and	   IP6-­‐α-­‐TCP0	  powders	  were	   tens	  of	  microns	  of	  grains;	  however,	   the	  particle	   size	  of	   the	  
α-­‐TCP	  powders	  decreased	  with	  increasing	  milling	  time	  (Figs.	  4-­‐4c-­‐h).	   	   The	  results	  were	  consistent	  
with	  the	  decrease	  in	  median	  particle	  size	  and	  crystallite	  size	  of	  the	  prepared	  α-­‐TCP	  powders.	   	   The	  
α-­‐TCP180	  and	  IP6-­‐α-­‐TCP180	  powders	  were	  composed	  of	  small	  particles	  and	  aggregates	  as	  indicated	  
by	  arrows	  (Figs.	  4-­‐4g	  and	  h),	  and	  in	  highly-­‐magnification	  images	  these	  aggregates	  were	  composed	  of	  
needle-­‐shaped	   crystals	   (data	   not	   shown).	   	   In	   addition,	   no	   obvious	   difference	   in	   the	   particle	  
morphology	  with	  and	  without	  IP6	  surface	  modification	  was	  observed.	  
The	  dissolution	  of	  Ca2+	  ions	  from	  the	  prepared	  α-­‐TCP	  powders	  was	  shown	  as	  a	  function	  of	  time	  
up	   to	   180	   min	   (Fig.	   4-­‐5).	   	   Dissolution	   of	   the	   IP6-­‐α-­‐TCP	   powders	   was	   lower	   than	   that	   of	   α-­‐TCP	  
powders	   without	   IP6	   surface	   modification,	   whereas	   dissolution	   of	   the	   α-­‐TCP	   powders	   with	   and	  
without	  IP6	  surface	  modification	  increased	  with	  milling	  time.	  
	  
4.2.2	  Evaluation	  of	  the	  α-­‐TCP	  cement	  specimens	  
XRD	  patterns	  of	  the	  cement	  specimens	  after	  setting	  for	  24	  h	  fabricated	  from	  the	  α-­‐TCP	  powders	  
with	   and	   without	   IP6	   surface	   modification	   at	   the	   P/L=1/0.40	   [g/cm3]	   were	   measured,	   and	   HAp	  
content	   of	   those	   cement	   specimens	  was	   calculated	   using	   Eq.	   (1)	   (Fig.	  4-­‐6).	   	   The	   XRD	   patterns	   of	  
α-­‐TCP0,	   α-­‐TCP60,	   and	   α-­‐TCP120	   cement	   specimens	   with	   and	   without	   IP6	   surface	   modification	  
showed	  mostly	  α-­‐TCP	  phase,	  whereas	  HAp	   contents	   in	   those	   cement	   specimens	   slightly	   increased	  
with	  milling	  time	  and	  were	  more	  than	  those	  in	  the	  starting	  cement	  powders.	   	   The	  HAp	  contents	  in	  
the	   α-­‐TCP180	   and	   IP6-­‐α-­‐TCP180	   cement	   specimens	   were	   two	   times	   more	   than	   those	   in	   other	  
cement	   specimens.	   	   The	  HAp	  contents	   in	   the	   IP6-­‐α-­‐TCP120	  and	   IP6-­‐α-­‐TCP180	  cement	   specimens	  
were	  significantly	  more	  than	  those	  in	  the	  α-­‐TCP120	  and	  α-­‐TCP180	  cement	  specimens,	  respectively	  
(P<0.05).	  
The	   compressive	   strength	   and	   relative	   density	   of	   the	   cement	   specimens	   fabricated	   from	   the	  
α-­‐TCP	  powders	  with	  and	  without	  IP6	  surface	  modification	  were	  shown	  in	  Fig.	  4-­‐7.	   	   The	  maximum	  
compressive	   strength	   of	   the	   IP6-­‐α-­‐TCP	   cement	   specimens	   mostly	   composed	   of	   α-­‐TCP	   phase	   was	  
8.5±1.1	  MPa	  for	  the	  IP6-­‐α-­‐TCP120	  cement	  specimen.	   	   In	  contrast,	  the	  compressive	  strength	  of	  the	  
α-­‐TCP180	   cement	   specimens	   composed	   of	   α-­‐TCP/HAp	   biphase	  was	   significantly	   higher	   (19.0±2.7	  
MPa)	   than	   that	   of	   IP6-­‐α-­‐TCP180	   cement	   specimens	   (P<0.05).	   	   No	   significant	   difference	   in	   the	  
relative	  density	  between	  the	  α-­‐TCP	  and	  IP6-­‐α-­‐TCP	  cement	  specimens	  was	  confirmed.	  
Figure	  4-­‐8a	  and	  e	  showing	  the	  microstructure	  of	  fracture	  cement	  provided	  many	  voids	  among	  the	  
grains	  in	  the	  fracture	  surface.	   	   In	  Figs.	  4-­‐8b-­‐d	  and	  f-­‐h,	  small	  particles	  packed	  among	  the	  grains	  were	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observed,	   and	   small	   particles	   increased	   with	   milling	   time.	   	   No	   obvious	   difference	   in	   the	  
microstructure	  of	  fracture	  cement	  between	  α-­‐TCP	  and	  IP6-­‐α-­‐TCP	  cement	  specimens	  was	  observed.	  
Next,	  in	  order	  to	  evaluate	  the	  biocompatibility	  of	  the	  cement	  specimens,	  we	  have	  compared	  cell	  
proliferation	  between	  polystyrene	  plate	  and	  cement	  specimens	  (α-­‐TCP120	  and	  IP6-­‐α-­‐TCP120).	   	   We	  
have	   selected	   the	   IP6-­‐α-­‐TCP120	   cement	   with	   the	   highest	   compressive	   strength	   and	   lowest	   HAp	  
contents	  among	  the	  single	  phase	  α-­‐TCP	  cements	  was	  selected,	  because	  that	  would	  be	  expected	  as	  the	  
most	  biodegradable	  material.	  
	  
4.2.3	  In	  vitro	  evaluation	  of	  the	  α-­‐TCP	  cement	  specimens	  
Figure	  4-­‐9	   showed	   cell	   proliferation	   co-­‐cultured	  with	   the	  α-­‐TCP120	   and	   IP6-­‐α-­‐TCP120	   cement	  
specimens	   using	   Transwell®	   kit.	   	   In	   comparison	   with	   cell	   proliferation	   of	   control	   (polystyrene	  
plate)	  and	  α-­‐TCP120	  cement,	  no	  significant	  differences	  between	  control	  and	  α-­‐TCP120	  cement	  was	  
observed.	   	   The	   results	   suggested	   that	   any	   component	   from	   the	  α-­‐TCP120	   cement,	  which	   affected	  
the	  cell	  proliferation,	  did	  not	  release	  into	  a	  medium.	  
Next,	  in	  order	  to	  evaluate	  whether	  IP6	  surface	  modification	  affected	  cell	  proliferation	  or	  not,	   cell	  
proliferation	  assay	  using	  IP6-­‐α-­‐TCP120	  cement	  was	  performed.	   	   The	  cell	  proliferation	  co-­‐cultured	  
with	   IP6-­‐α-­‐TCP120	  cement	  was	   comparable	  with	   that	  of	  α-­‐TCP120	  cement,	   and	  no	   significance	   in	  
the	  cell	  proliferation	  between	  α-­‐TCP120	  and	  IP6-­‐α-­‐TCP120	  cements	  was	  confirmed.	   	   This	  indicated	  
that	   IP6	  surface	  modification	  did	  not	  have	  effects	  on	   the	  cell	  proliferation,	  and	  both	   the	  α-­‐TCP120	  
and	  IP6-­‐α-­‐TCP120	  cements	  were	  biocompatible	  materials.	  
	  
4.2.4	  In	  vivo	  evaluation	  of	  the	  α-­‐TCP	  cement	  specimens	  
As	  a	   result	   of	   in	   vitro	   evaluation,	  no	  obvious	   changes	   in	   cell	   proliferation	   co-­‐cultured	  with	   and	  
without	  cement	  specimens	  were	  seen	  for	  each	  time	  point	  (Fig.	  4-­‐9).	   	   Following	  the	  in	  vitro	  study,	  in	  
vivo	   biodegradability	   and	   biocompatibility	   of	   the	   IP6-­‐α-­‐TCP120	   cement	   specimen	  were	   evaluated	  
due	  to	  their	  excellent	  cell	  proliferation	  in	  vitro.	  
Histological	   observation	   of	   the	   IP6-­‐α-­‐TCP120	   cement	   specimens	   after	   4,	   8	   and	   24	   weeks	   of	  
implantation	   was	   performed	   using	   HE	   (Figs.	   4-­‐10a-­‐f)	   and	   TRAP	   (Figs.	   4-­‐10g-­‐i)	   stainings.	   	  
Low-­‐magnification	   images	   (Figs.	   4-­‐10a-­‐c)	   showing	   the	   entire	   cement	   specimens	   (C)	   were	   not	  
directly	   in	   contact	   with	   newly-­‐formed	   bones	   (N).	   	   Figures	   4-­‐10d-­‐f	   showed	   high-­‐magnification	  
images	   of	   the	   areas	   indicated	   by	   dotted	   line	   squares	   in	   Fig.	   10(a)-­‐(c),	   respectively,	   where	   the	  
newly-­‐formed	  bones	  were	  evident	  by	  light	  pink	  staining	  and	  those	  increased	  with	  milling	  time	  at	  a	  
slight	   distance	   from	   the	   cement	   specimens	   and	   grew	   mature	   at	   24	   weeks.	   	   In	   the	   areas	   of	   the	  
newly-­‐formed	   bones,	   aligning	   osteoblast-­‐like	   cells	   (arrows)	   forming	   the	   newly-­‐formed	   osteoids	  
were	  confirmed	  in	  all	  the	  implant	  periods	  (Figs.	  4-­‐10d-­‐f).	   	   Meanwhile,	  TRAP	  positive	  osteoclast-­‐like	  	   	  







Fig.	   4-­‐6	   	   HAp	   content	   of	   the	   cement	   specimens	   after	   setting	   for	   24	   h,	   fabricated	   from	   the	   α-­‐TCP	  
powders	   (a)	   with	   and	   (b)	   without	   IP6	   surface	   modification	   at	   P/L=1/0.40	   [g/cm3].	   	   Error	   bars	  
indicate	  standard	  error	  of	  the	  mean	  (n=3).  The	  asterisks	  (*)	  show	  P<0.05	  by	  t	  test.	   	   HAp	  contents	  
in	  α-­‐TCP0,	  α-­‐TCP60,	  α-­‐TCP120	  cement	  specimens	  with	  and	  without	  IP6	  surface	  modification	  slightly	  
increased	  with	  milling	   time	  and	  were	  more	   than	   those	   in	   the	  starting	  cement	  powders.	   	   The	  HAp	  
contents	  in	  the	  α-­‐TCP180	  and	  IP6-­‐α-­‐TCP180	  cement	  specimens	  were	  two	  times	  more	  than	  those	  in	  
other	  cement	  specimens.	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Fig.	   4-­‐7	   	   Compressive	  strength	  (A)	  and	  relative	  density	  (B)	  of	   the	  cement	  specimens	  after	  setting	  
for	  24	  h,	   fabricated	   from	   the	  α-­‐TCP	  powders	   (a)	  with	  and	   (b)	  without	   IP6	   surface	  modification	  at	  
P/L=1/0.40	   [g/cm3].	   	   Error	   bars	   indicate	   standard	   error	   of	   the	   mean	   (n=3).	   	   The	   asterisk	   (*)	  
shows	  P<0.05	  by	   t	   test.	   	   The	  maximum	  compressive	  strength	  of	   the	   IP6-­‐α-­‐TCP	  cement	  specimens	  
mostly	  composed	  of	  α-­‐TCP	  phase	  was	  8.5±1.1	  MPa	  for	  the	  IP6-­‐α-­‐TCP120	  cement	  specimen,	  whereas	  
the	  compressive	  strength	  of	  the	  α-­‐TCP180	  cement	  specimens	  composed	  of	  α-­‐TCP/HAp	  biphase	  was	  
the	  highest	  (19.0±2.7	  MPa).	   	  
	   134	  
	   	  




















































































































































































































































































Fig.	   4-­‐9	   	   Cell	   proliferation	   co-­‐cultured	   with	   the	   α-­‐TCP120	   and	   IP6-­‐α-­‐TCP120	   cement	   specimens	  
using	  Transwell®	  kit:	   (a)	  Control	   (Polystyrene	  plate),	   (b)	  α-­‐TCP120	   (P/L=1/0.40	   [g/cm3]),	   and	   (c)	  
IP6-­‐α-­‐TCP120	   (P/L=1/0.40).	   	   The	   cement	   specimens	   were	   set	   on	   the	   membrane	   of	   Transwell®	  
after	  the	  cells	  were	  cultured	  for	  24	  h.	   	   Error	  bars	  indicate	  standard	  error	  of	  the	  mean	  (n=3).	   	   The	  
cell	   proliferation	   co-­‐cultured	   with	   α-­‐TCP120	   and	   IP6-­‐α-­‐TCP120	   cement	   specimens	   was	   the	   same	  
levels	  compared	  with	  that	  of	  control,	  and	  no	  significant	  difference	  among	  them	  was	  observed.	  
	  
	   	  





Fig.	   4-­‐10	   	   Histological	   sections	   showing	   IP6-­‐α-­‐TCP120	   (P/L=1/0.40	   [g/cm3])	   cement	   specimens	  
implanted	  into	  the	  rabbit	  tibia.	   	   (a)-­‐(f):	  undecalcified	  sections	  stained	  with	  HE,	   	   (g)-­‐(i):	  decalcified	  
sections	   stained	   with	   TRAP.	   	   (a),	   (d),	   and	   (g):	   4	   weeks	   implantation,	   (b),	   (e),	   and	   (h):	   8	   weeks	  
implantation,	  (c),	  (f),	  and	  (i):	  24	  weeks	  implantation.	   	   The	  low-­‐magnification	  images	  (a-­‐c)	  show	  the	  
entire	   cement	   specimen	   (C),	   and	   (d)-­‐(f)	   present	   high-­‐magnification	   images	   of	   the	   dotted	   square	  
areas	   shown	   in	   (a)-­‐(c),	   respectively.	   	   The	   arrows	   in	   (d)-­‐(f)	   indicate	   aligning	   osteoblast-­‐like	   cells	  
forming	   the	   newly	   formed	   bones	   (N).	   	   The	   asterisks	   (*)	   in	   (g)-­‐(i)	   represent	   TRAP	   positive	  
osteoclast-­‐like	  cells	  resorbing	  the	  cement.	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cells	   (asterisk)	   on	   the	   surface	   of	   the	   cement	   specimen	   resorbing	   the	   cement	   specimens	   were	  
observed	   throughout	   all	   the	   implant	   periods	   (Figs.	   4-­‐10g-­‐i).	   	   Rate	   of	   resorption,	   which	   was	  
calculated	  from	  the	  sectional	  areas	  of	  the	  cement	  specimens	  before	  and	  after	  implantation	  for	  4,	  8,	  





It	  is	  well	  known	  that	  α-­‐TCP	  could	  be	  hydrolyzed,	  resulting	  in	  forming	  a	  CDHA	  as	  indicated	  by	  Eq.	  
(4)	  [5,14,15].	  
	  
3Ca3(PO4)2	  +	  H2O	  →	  Ca9(PO4)5(HPO4)OH	   	   	   	   	   	   (4)	  
	  
The	  α-­‐TCP	  was	  used	  as	  a	  solid	  component	  of	  the	  CPC	  because	  of	  its	  high	  reactivity,	  and	  final	  product	  
of	  the	  CPC	  was	  CDHA	  [1,5,7].	   	   In	  order	  to	  adjust	  the	  particle	  size	  of	  α-­‐TCP	  as	  a	  solid	  component	  of	  
the	  CPC,	   the	  α-­‐TCP	  was	  mechanically	  ball-­‐milled	   for	   appropriate	  periods	   [5-­‐9].	   	   Moreover,	   it	  was	  
reported	  that	   the	  mechanically	  ball-­‐milled	  α-­‐TCP	  caused	  decrease	   in	  XRD	  intensities	  of	  α-­‐TCP,	  and	  
led	   to	   transformation	   from	  crystalline	   to	  amorphous	  state	   [5-­‐9].	   	   The	  decrease	   in	  XRD	   intensities	  
and	  crystallite	  size	  of	  the	  α-­‐TCP	  powders	  was	  confirmed	  with	  increasing	  of	  milling	  time	  (Fig.	  4-­‐1	  and	  
4-­‐2),	  implying	  that	  the	  ball-­‐milled	  α-­‐TCP	  powders	  contained	  the	  amorphous	  phase	  in	  part.	  
Most	  of	  α-­‐TCP	  phase	  was	  maintained	  up	  to	  120	  min	  of	  milling,	  and	  the	  α-­‐TCP	  powders	  over	  120	  
min	   of	   milling	   were	   composed	   of	   the	   both	   α-­‐TCP	   and	   HAp	   phases	   (Fig.	   4-­‐1).	   	   The	   phase	  
transformation	  of	  α-­‐TCP	  to	  HAp	  in	  milling	  duration	  of	  120	  min	  and	  longer	  was	  due	  to	  hydrolysis	  of	  
the	  α-­‐TCP	  during	  ball-­‐milling,	  which	  was	  evident	  by	  the	  increase	  in	  HAp	  content	  and	  specific	  surface	  
area.	   	   In	  the	  previous	  report	  by	  Gbureck	  et	  al.	  [5],	  they	  showed	  that	  prolonged	  ball-­‐milling	  of	  α-­‐TCP	  
did	  not	  lead	  to	  α-­‐TCP	  and	  HAp	  biphase	  but	  amorphous	  α-­‐TCP	  in	  XRD	  pattern.	   	   They	  used	  a	  99.9%	  of	  
ethanol	  as	  a	  milling	  solvent;	  however,	  we	  used	  pure	  water	  as	  a	  milling	  solvent	  in	  the	  present	  study.	   	  
Consequently,	  the	  α-­‐TCP	  was	  hydrolyzed	  in	  pure	  water	  over	  120	  min	  of	  milling.	  
The	  particle	  size	  of	  the	  prepared	  IP6-­‐α-­‐TCP	  powders	  decreased	  with	  increasing	  milling	  time.	   	   As	  
a	  consequence,	  the	  dissolution	  of	  the	  α-­‐TCP	  powders	  with	  and	  without	  IP6	  surface	  modification	  also	  
increased.	   	   The	  results	  suggested	  that	  the	  decrease	  in	  particle	  size	  was	  dominant	  for	  dissolution	  of	  
the	  α-­‐TCP	  powders.	   	   In	  addition,	  IP6	  can	  chelate	  with	  Ca2+	  ions,	  as	  previously	  reported	  [16,17];	  thus,	  
the	  adsorption	  of	   IP6	  on	   the	  surface	  of	  α-­‐TCP	  powders	  may	   inhibit	   the	  dissolution	  of	  α-­‐TCP	   itself.	   	  
As	  a	  result,	  the	  dissolution	  of	  the	  IP6-­‐α-­‐TCP	  powders	  was	  lower	  than	  that	  of	  α-­‐TCP	  powders	  without	  
IP6	  surface	  modification,	  as	  shown	  in	  Fig.	  4-­‐5.	   	   However,	  no	  direct	  evidence	  could	  be	  obtained	  that	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the	   IP6	  was	   surface-­‐modified	   successfully.	   	   Because	  of	   low	   IP6	   concentration	  used	   in	   the	  present	  
study	   (1000	   ppm),	   it	   was	   not	   detected	   by	   Fourier	   transform	   infrared	   spectroscopic	   analysis.	   	  
Therefore,	  further	  analysis	  will	  be	  necessary	  for	  detection	  of	  IP6	  on	  the	  surface	  of	  α-­‐TCP.	  
The	  α-­‐TCP	  cement	  based	  on	  chelating	  mechanism	  of	  IP6	  was	  developed	  for	  the	  first	  time	  in	  the	  
present	   study.	   	   The	   compressive	   strength	   of	   the	   α-­‐TCP	   cement	   specimens	   with	   and	   without	   IP6	  
surface	   modification	   increased	   with	   milling	   time;	   however,	   the	   relative	   density	   of	   these	   cement	  
specimens	  did	  not	   change	   and	  HAp	   contents	   of	   these	   cement	   specimens,	   excluding	  α-­‐TCP180	  and	  
IP6-­‐α-­‐TCP180,	   also	   did	   not	   change	   compared	   to	   those	   of	   the	   cement	   powders.	   	   Increase	   in	  
compressive	  strength	  of	  the	  α-­‐TCP	  cement	  specimens	  was	  due	  to	  decrease	  in	  particle	  size	  of	  α-­‐TCP	  
powders,	   which	   was	   evident	   by	   increase	   in	   packing	   degree	   of	   the	   α-­‐TCP	   powders	   in	   Fig.	   4-­‐8.	   	  
However,	  difference	   in	   the	   relative	  density	  of	   the	   cement	   specimens	  was	  not	  observed	  because	  of	  
small	   change	   in	   the	   compressive	   strength.	   	   Furthermore,	   the	   cement	   specimens	   were	   fabricated	  
with	  high	  P/L	  ratio	  (1/0.40	  [g/cm3])	  and	  the	  α-­‐TCP	  powders	  were	  barely	  hydrolyzed	  during	  setting	  
of	   the	   cements;	   therefore,	   no	   change	   in	   HAp	   contents	   of	   α-­‐TCP	   cement	   specimens,	   except	   for	  
α-­‐TCP180	  and	  IP6-­‐α-­‐TCP180,	  was	  observed.	   	   Significances	  in	  the	  HAp	  contents	  between	  α-­‐TCP120	  
and	  IP6-­‐α-­‐TCP120,	  and	  α-­‐TCP180	  and	  IP6-­‐α-­‐TCP180	  were	  because	  of	  the	  higher	  HAp	  contents	  in	  the	  
IP6-­‐α-­‐TCP120	  and	   IP6-­‐α-­‐TCP180	  powders	   than	   those	  of	   the	  α-­‐TCP120	  and	  α-­‐TCP180	  powders	   as	  
shown	  in	  Fig.	  4-­‐2.	   	   The	  HAp	  contents	  in	  α-­‐TCP180	  and	  IP6-­‐α-­‐TCP180	  cement	  specimens	  were	  more	  
than	   those	   of	   other	   cement	   specimens,	   and	   the	   compressive	   strength	   of	   the	   α-­‐TCP180	   cement	  
specimen	  was	   significantly	  more	   than	   that	   of	   α-­‐TCP180	   cement	   specimen.	   	   The	   results	   indicated	  
that	   the	   α-­‐TCP180	   and	   IP6-­‐α-­‐TCP180	   powders	   were	   slightly	   hydrolyzed	   during	   setting	   of	   the	  
cements.	   	   As	  a	  consequence,	  enhancement	  in	  compressive	  strength	  of	  these	  two	  cement	  specimens	  
was	  not	  presumably	  caused	  by	  only	  increase	  in	  HAp	  contents	  but	  also	  entanglement	  of	  each	  particle	  
and	  chelate-­‐bonding	  of	   IP6.	   	   However,	  obvious	  needle-­‐shaped	  or	  plate-­‐shaped	  crystals	   formed	  by	  
hydrolysis	  of	   the	  α-­‐TCP	  as	   reported	  by	  TenHuisen	  and	  Brown	   [2]	   and	  Ginebra	  et	   al.	   [1],	  were	  not	  
observed	  in	  the	  microstructures	  (Fig.	  4-­‐8).	  
Regarding	   in	   vitro	   evaluation	   of	   HAp	   cements,	   we	   have	   previously	   elucidated	   that	   IP6	   surface	  
modification	   of	   the	   HAp	   particles	   with	   1000	   ppm	   IP6	   did	   not	   affect	   the	   biocompatibility	   of	   the	  
cement	   specimen	   in	   vitro	   [18,19].	   	   The	   present	   cell-­‐culture	   test	   using	   Transwell®	   kit	   (Fig.	   4-­‐9)	  
indicated	   that	   there	   was	   no	   significance	   in	   cell	   proliferation	   between	   α-­‐TCP	   cements	   with	   and	  
without	  IP6	  surface	  modification,	  and	  both	  α-­‐TCP	  cements	  did	  not	  affect	  the	  biocompatibility.	  
In	   vivo	   studies	   indicated	   that	   the	   newly-­‐formed	   bones	   increased	   with	   milling	   time	   at	   a	   slight	  
distance	  from	  the	  cement	  specimens	  and	  grew	  mature	  at	  24	  weeks	  (Figs.	  4-­‐10d-­‐f).	   	   The	  surface	  of	  
the	   IP6-­‐α-­‐TCP120	   cement	   specimens	   was	   resorbed	   by	   TRAP	   positive	   osteoclast-­‐like	   cells	   (Figs.	  
4-­‐10g-­‐i)	  throughout	  all	  the	  implant	  periods.	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The	  biological	  behavior	  of	  α-­‐TCP	  has	  previously	  been	  studied	  in	  several	   in	  vivo	  studies	  [20-­‐25];	  
however,	   no	   report	   existed	   about	   α-­‐TCP	   based	   cement	   composed	   of	   α-­‐TCP	   phase,	   because	   α-­‐TCP	  
was	   used	   as	   the	   solid	   component	   of	   hydraulic	   CPC.	   	   Kihara	   et	   al.	   [33]	   reported	   that	   in	   the	  
implantation	   of	   α-­‐TCP	   particles	   (~300	   µm	   diameter)	   into	   cranial	   bone	   defects	   in	   rabbits,	   a	  
“reticulate	  structure”	  was	  developed	  among	  the	  α-­‐TCP	  particles	  after	  1	  week	  as	  a	  consequence	  of	  the	  
degradation	   of	   α-­‐TCP,	   and	   newly-­‐formed	   bone	   was	   observed	   after	   8	   weeks.	   	   Yamada	   et	   al.	   [24]	  
conducted	   a	   histological	   and	   histomorphometrical	   study	   of	   porous	   α-­‐TCP	   blocks	   as	   bone	   graft	  
material	  for	  augmenting	  alveolar	  ridges.	   	   The	  α-­‐TCP	  block	  notably	  started	  degrading	  after	  4	  weeks,	  
and	  was	  severely	  degraded	  after	  8	  weeks.	   	   Residual	  α-­‐TCP	  particles	  surrounded	  by	  newly-­‐formed	  
bone	  decreased	  over	  time,	  and	  both	  particles	  and	  newly-­‐formed	  bone	  were	  simultaneously	  resorbed	  
by	   osteoclast-­‐like	   cells.	   	   Both	   the	   reports	   suggested	   that	   the	   α-­‐TCP	   ceramics	   were	   potential	  
biodegradable	   material.	   	   In	   the	   present	   study,	   the	   resorption	   of	   the	   cement	   specimens	   by	  
osteoclast-­‐like	  cells	  was	  observed	  throughout	  all	  the	  implant	  periods;	  however,	  most	  of	  the	  cements	  
(83.8%)	  remained	  even	  after	  24	  weeks	  of	  implantation.	   	   Oonishi	  et	  al.	  reported	  that	  α-­‐TCP	  granules	  
with	  300	  μm	  in	  diameter	  were	  mostly	  resorbed	  after	  12	  weeks	  of	  implantation	  in	  the	  rabbit	  model	  
[21].	   	   The	   present	   IP6-­‐α-­‐TCP120	   cements	   were	   relatively	   dense	   (56.8±0.9%	   of	   relative	   density)	  
with	  no	  interconnected	  pores	  in	  the	  cement,	  and	  could	  be	  resorbed	  chemically	  and	  biologically	  only	  
from	   the	   surface	   of	   the	   cement.	   	   Thus,	   the	   resorption	   rate	   of	   the	   IP6-­‐α-­‐TCP	   cement	   was	   slow.	   	  
Furthermore,	   less	   dissolution	   of	   the	   IP6-­‐α-­‐TCP120	   powder	   than	   that	   of	   the	   α-­‐TCP120	   powder	   as	  
shown	  in	  Fig.	  4-­‐5	  suggested	  that	  the	  IP6-­‐α-­‐TCP120	  cement	  was	  less	  soluble	  than	  α-­‐TCP120	  cement.	   	  




The	  single	  phase	  α-­‐TCP	  powder	  for	  fabrication	  of	  IP6-­‐α-­‐TCP	  cement	  was	  obtained	  by	  ball-­‐milling	  
of	  α-­‐TCP	  for	  120	  min.	   	   The	  resulting	  cement,	  which	  was	  fabricated	  by	  mixing	  the	  IP6-­‐α-­‐TCP120	  and	  
pure	  water,	  was	  mostly	  composed	  of	  α-­‐TCP	  phase,	  and	  the	  compressive	  strength	  of	  the	  cement	  was	  
8.5±1.1	  MPa,	   which	   suggested	   that	   the	   cements	   set	  with	   keeping	   the	   crystallite	   phase	   of	   starting	  
cement	  powder.	   	   The	  enhancement	  in	  the	  compressive	  strength	  with	  milling	  time	  was	  achieved	  by	  
a	   decrease	   in	   particle	   size	   of	   the	   cement	   powders.	   	   In	   vitro	   cell-­‐culture	   test	   indicated	  
biocompatibility	   of	   the	   cement.	   	   In	   vivo	   studies	   showed	   that	   the	   newly-­‐formed	   bones	   increased	  
with	  milling	  time	  at	  a	  slight	  distance	  from	  the	  cement	  specimens	  and	  grew	  mature	  at	  24	  weeks,	  and	  
the	   surface	   of	   the	   cement	  was	   resorbed	   by	   TRAP	  positive	   osteoclast-­‐like	   cells	   up	   till	   24	  weeks	   of	  
implantation.	   	   The	   present	   IP6-­‐α-­‐TCP	   cement	   with	   biodegradability	   and	   biocompatibility	   is	   a	  
promising	  candidate	  for	  application	  as	  a	  novel	  paste-­‐like	  artificial	  bone.	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Chapter	  5.	   Comparative	   study	   on	   biodegradability	   of	   chelate-­‐	  
setting	  cements	  fabricated	  with	  various	  calcium	  phosphates	  
	  
	  
In	   Chapter	   2,	   3,	   4,	   hydroxyapatite	   (HAp),	   β-­‐tricalcium	   phosphate	   (β-­‐TCP),	   and	   α-­‐	   tricalcium	  
phosphate	   (α-­‐TCP)	   cements	  based	  on	   chelate-­‐setting	  mechanism	  of	   inositol	   phosphate	   (IP6)	  were	  
developed,	   respectively.	   	   These	   cements	   (IP6-­‐HAp,	   IP6-­‐β-­‐TCP	   and	   IP6-­‐α-­‐TCP	   cements)	   were	  
expected	  to	  have	  different	  biodegradability	  due	  to	  their	  different	  chemical	  compositions	  of	  starting	  
materials,	  which	  will	  enable	  “tailor-­‐made	  treatment”	  as	  novel	  paste-­‐like	  artificial	  bones,	  according	  to	  
bone	  metabolism	  of	  patients.	  
In	   Chapter	   5,	   biocompatibility	   and	   biodegradability	   of	   the	   chelate-­‐setting	   cements	   and	  
commercially-­‐available	   cement	   (Biopex®-­‐R)	   were	   histologically	   evaluated	   in	   vivo	   using	   rabbit	  
models	  for	  4,	  8,	  and	  24	  weeks,	  in	  addition	  to	  their	  dissolution	  in	  vitro	  [1].	   	   For	  evaluation,	  prototype	  
three	  types	  of	  cements	  were	  selected:	  IP6-­‐HAp	  [2,3],	  IP6-­‐β-­‐TCP	  [4],	  and	  IP6-­‐α-­‐TCP	  [5]	  cements.	  
	  
	  
5.1	  Materials	  and	  methods	  
	  
5.1.1	  Preparation	  of	  cement	  powders	  
Inositol	   phosphate	   (IP6)	   solutions	  with	   concentrations	   of	   1000	   and	   3000	   ppm	  were	   prepared	  
using	   50	  mass%	   phytic	   acid	   (Wako	   Pure	   Chemical	   Industries,	   Ltd.),	   and	   adjusting	   to	   pH	   7.3	  with	  
NaOH	  solution	  (0.1	  mol·dm-­‐3).	   	   To	  prepare	  the	  HAp	  powders	  surface-­‐modified	  with	  IP6	  (IP6-­‐HAp),	  
HAp	  (HAp-­‐100,	  Taihei	  Chemical,	  Japan)	  powders	  were	  added	  into	  the	  200	  cm3	  of	  IP6	  solution	  (1000	  
ppm),	   and	   then	   stirred	   at	   400	   rpm	   for	   5	   h.	   	   After	   that,	   the	   slurry	   mixtures	   were	   filtrated	   and	  
freeze-­‐dried	   for	   24	   h.	   	   β-­‐tricalcium	   phosphate	   (β-­‐TCP-­‐100,	   Taihei	   Chemical,	   Japan)	   and	   α-­‐TCP	  
(α-­‐TCP-­‐A,	  Taihei	  Chemical,	  Japan)	  powders	  were	  ball-­‐milled	  in	  40	  cm3	  of	  pure	  water	  for	  4	  and	  2	  h,	  
respectively,	  using	  ZrO2	  pod	  and	  beads	  with	  10	  mm	  in	  diameter.	   	   To	  prepare	  the	  β-­‐TCP	  and	  α-­‐TCP	  
powders	   surface-­‐modified	   with	   IP6	   (IP6-­‐β-­‐TCP	   and	   IP6-­‐α-­‐TCP),	   the	   ball-­‐milled	   β-­‐TCP	   and	   α-­‐TCP	  
particles	  were	   added	   into	   3000	   and	  1000	  ppm	   IP6	   solution,	   respectively,	   and	   then	   stirred	   at	   400	  
rpm	  for	  24	  h.	   	   After	  that,	  the	  slurry	  mixtures	  were	  filtrated	  and	  freeze-­‐dried	  for	  24	  h.	   	   The	  changes	  
in	   the	   crystallite	   phase	   before	   and	   after	   surface-­‐modification	   were	   determined	   using	   X-­‐ray	  
diffractometer	  (XRD;	  MiniFlex,	  Rigaku,	  Japan).	   	   Data	  were	  collected	  in	  the	  range	  of	  2θ=10-­‐50°	  with	  
a	  step	  size	  of	  0.04°	  and	  counting	  time	  of	  4	  s/step.	   	   The	  crystal	  phase	  was	  identified	  by	  means	  of	  the	  
JCPDS	  reference	  patterns	  for	  HAp	  (#09-­‐0432),	  β-­‐TCP	  (#09-­‐0169)	  and	  α-­‐TCP	  (#09-­‐0348).	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5.1.2	  Fabrication	  of	  chelate-­‐setting	  cements	  
To	   fabricate	   the	   chelate-­‐setting	   cement	   for	   in	   vitro	   and	   in	   vivo	   study,	   three	   types	   of	   cement	  
powders,	   IP6-­‐HAp,	   IP6-­‐β-­‐TCP	   and	   IP6-­‐α-­‐TCP	   powders,	   were	   mixed	   with	   the	   pure	   water	   at	  
powder/liquid	  ratio	  of	  1/0.3,	  1/0.2,	  and	  1/0.4	   [g/cm3],	   respectively.	   	   The	  resulting	  cements	  were	  
packed	  in	  the	  cylindrical	  stainless	  mold	  and	  kept	  under	  room	  temperature	  for	  24	  h.	   	   The	  resulting	  
cement	   specimens	   were	   with	   size	   of	   4.2	   mm	   in	   diameter	   and	   7	   mm	   in	   height.	   	  
Commercially-­‐available	  cement	  (Biopex®-­‐R)	  with	  size	  of	  4.2	  mm	  in	  diameter	  and	  7	  mm	  in	  height	  was	  
also	  prepared	  according	  to	  the	  protocol	  instructed	  by	  manufacturer.	   	   The	  cement	  specimens	  were	  
sterilized	   using	   an	   ethylene	   oxide	   gas.	   	   The	   XRD	   pattern	   of	   the	   cements	  was	  measured	   as	   above	  
mentioned.	  
	  
5.1.3	  In	  vitro	  evaluation	  of	  chelate-­‐setting	  cements	  
Dissolution	   of	   Ca2+	   ions	   from	   the	   various	   chelate-­‐setting	   cements	   was	   measured	   using	  
ion-­‐selective	  potentiometer.	   	   The	  IP6-­‐HAp,	  IP6-­‐β-­‐TCP	  and	  IP6-­‐α-­‐TCP	  cements	  were	  immersed	  into	  
20	  cm3	  of	  physiological	  saline	  (0.9	  mass%	  NaCl),	  and	  shaken	  at	  37°C	  for	  appropriate	  periods.	  
	  
5.1.4	  In	  vivo	  evaluation	  of	  chelate-­‐setting	  cements	  
The	   above-­‐mentioned	   three	   types	  of	   cement	   specimens	  were	   implanted	   into	   tibiae	  of	   Japanese	  
rabbits	  (average	  weight,	  3	  kg)	  for	  4,	  8	  and	  24	  weeks,	  together	  with	  Biopex®-­‐R	  specimens	  as	  a	  control.	   	  
After	  the	  implantation,	  the	  rabbits	  were	  sacrificed	  to	  remove	  the	  tibiae	  including	  cement	  specimens,	  
and	   then	   undecalcified	   and	   decalcified	   sections	   were	   prepared	   for	   histological	   evaluation.	   	   The	  
undecalcified	  sections	  were	  stained	  with	  toluidine	  blue	  (TB),	  and	  decalcified	  sections	  were	  stained	  
with	   tartrate-­‐resistant	   acid	   phosphatase	   (TRAP).	   	   The	   stained	   sections	   were	   observed	   with	   an	  
epifluorescence	  microscope	  (BX51,	  Olympus,	   Japan).	   	   Resorption	  rate	   for	  the	  IP6-­‐HAp,	  Biopex®-­‐R,	  
IP6-­‐β-­‐TCP,	   and	   IP6-­‐α-­‐TCP	   cements	   were	   calculated	   by	   Eq.	   (1)	   using	   image	   analysis	   software	  
(WinRoof,	  Mitani	  corporation,	  Japan).	  
	  




5.2.1	  Characterization	  of	  cement	  powders	  and	  chelate-­‐setting	  cements	  
Figure	   5-­‐1	   shows	   the	   XRD	   pattern	   of	   the	   cement	   powders	   before	   and	   after	   IP6	   surface	  
modification.	   	   The	  change	  in	  crystalline	  phase	  of	  the	  cement	  powders	  before	  and	  after	  IP6	  surface	  
modification	  could	  not	  be	  detected.	   	   Although	  the	  β-­‐TCP	  and	  α-­‐TCP	  powders	  before	  ball-­‐milling	  and	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surface-­‐modifying	   showed	  high	   crystallinity,	   that	   of	   IP6-­‐β-­‐TCP	  and	   IP6-­‐α-­‐TCP	  powders	  decreased.	   	  
However	   both	   the	   powders	   showed	   β-­‐TCP	   and	   α-­‐TCP	   single	   phase,	   respectively.	   	   These	   results	  
indicate	  that	  IP6	  surface	  modification	  of	  the	  powders	  did	  not	  affect	  the	  crystallite	  phase.	  
The	  three	  types	  of	  cements	  and	  Biopex®-­‐R	  were	  fabricated	  from	  the	  above-­‐mentioned	  powders	  
and	  commercial	  Biopex®-­‐R	  cement	  kit.	   	   Figure	  5-­‐2	  shows	  XRD	  patterns	  of	   three	   types	  of	  cements	  
and	  Biopex®-­‐R	  before	  implantation.	   	   In	  the	  three	  types	  of	  cement	  specimens,	  change	  in	  crystalline	  
phase	  of	   the	   cements	   could	  not	  be	   confirmed.	   	   The	   results	   reveal	   that	   the	   cements	  were	   set	  with	  
maintenance	   of	   the	   crystalline	   phase	   of	   their	   starting	   powders.	   	   In	   contrast,	   the	   Biopex®-­‐R	   was	  
composed	  of	  mainly	  α-­‐TCP	  phase	  containing	  slight	  amount	  of	  HAp	  phase	  (25%).	  
	  
5.2.2	  In	  vitro	  evaluation	  of	  chelate-­‐setting	  cements	  
Release	  profiles	  of	  Ca2+	  ions	  from	  three	  types	  of	  cements	  (IP6-­‐HAp,	  IP6-­‐β-­‐TCP	  and	  IP6-­‐α-­‐TCP)	  are	  
shown	   in	   Fig.	   5-­‐3.	   	   The	   release	   of	   Ca2+	   ions	   from	   the	   cements	   increased	   with	   shaking	   time,	   and	  
increased	  in	  the	  order	  of	  IP6-­‐HAp,	  IP6-­‐β-­‐TCP	  and	  IP6-­‐α-­‐TCP	  cements.	  
	  
5.2.3	  In	  vivo	  evaluation	  of	  chelate-­‐setting	  cements	  
The	  three	  kinds	  of	  cements	  (IP6-­‐HAp,	  IP6-­‐β-­‐TCP	  and	  IP6-­‐α-­‐TCP)	  and	  Biopex®-­‐R	  were	  implanted	  
into	  tibiae	  of	  Japanese	  rabbits	  for	  4,	  8	  and	  24	  weeks.	   	   Figure	  5-­‐4	  shows	  histological	  sections	  of	  the	  
Biopex®-­‐R	  and	  IP6-­‐HAp	  cements.	   	   The	  newly-­‐formed	  bones	  (N)	  were	  directly	  in	  contact	  with	  both	  
the	   IP6-­‐HAp	   and	   Biopex®-­‐R	   cement	   specimens	   (I)	   throughout	   24	   weeks,	   without	   formation	   of	  
fibrous	  tissue	  layers.	   	   In	  both	  the	  cements,	  the	  newly-­‐formed	  bones	  (N)	  as	  shown	  in	  dark	  purple	  at	  
4	  weeks	  gradually	  changed	   to	  mature	  bones	  as	  shown	   in	   light	  purple	  at	  24	  weeks.	   	   These	  results	  
indicate	   that	   the	   newly-­‐formed	   bones	   grew	   mature	   at	   24	   weeks.	   	   No	   inflammation	   reaction	   to	  
surrounding	  tissues	  around	  the	  cement	  specimens	  could	  be	  observed.	  
Figure	  5-­‐5	  shows	  histological	  sections	  of	  the	  IP6-­‐β-­‐TCP	  (A)	  and	  IP6-­‐α-­‐TCP	  (B)	  cements	  stained	  with	  
TB	  and	  TRAP.	   	   In	  the	  TB	  stained	  sections,	  the	  newly-­‐formed	  bones	  were	  not	  directly	  in	  contact	  with	  
both	   IP6-­‐β-­‐TCP	  and	   IP6-­‐α-­‐TCP	  cements;	  however,	   those	   increased	   time-­‐dependently	  slightly	  apart	  
from	   the	   cement	   specimens	   and	   grew	   mature	   at	   24	   weeks.	   	   No	   inflammation	   reaction	   to	  
surrounding	   tissues	   around	   the	   cement	   specimen	   also	   could	   be	   observed.	   	   In	   contrast,	   the	   TRAP	  
stained	  sections	  indicated	  that	  TRAP	  positive	  osteoclasts	  were	  present	  around	  the	  cement	  specimen,	  
and	  the	  cement	  remained	  to	  be	  resorbed	  throughout	  all	  the	  implant	  periods.	  
Resorption	  rate	  for	  the	  Biopex®-­‐R,	  IP6-­‐HAp	  IP6-­‐β-­‐TCP,	  and	  IP6-­‐α-­‐TCP	  cements	  was	  calculated	  by	  
Eq.	  (1)	  (Fig.	  5-­‐6).	   	   At	  24	  weeks	  implantation,	  the	  resorption	  rate	  of	  Biopex®-­‐R,	  IP6-­‐HAp	  IP6-­‐β-­‐TCP,	  
and	   IP6-­‐α-­‐TCP	   cements	  was	  7.2,	   5.0,	   13.7,	   and	  16.2%,	   respectively.	   	   The	  order	  of	   resorption	   rate	  
was	  the	  same	  order	  in	  Ca2+	  release	  in	  vitro.	   	   The	  IP6-­‐β-­‐TCP	  and	  IP6-­‐α-­‐TCP	  cements	  were	  resorbed-­‐	   	  









Fig.	   5-­‐1	   XRD	   pattern	   of	   the	   cement	   powders.	   	   Black	   circles,	   black	   squares,	   and	   black	   triangles	  
indicate	  typical	  HAp,	  β-­‐TCP,	  and	  α-­‐TCP	  peaks,	  respectively.	  
	   	  









Fig.	   5-­‐2	   XRD	   pattern	   of	   the	   cements.	   	   Black	   circles,	   black	   squares,	   and	   black	   triangles	   indicate	  
typical	  HAp,	  β-­‐TCP,	  and	  α-­‐TCP	  peaks,	  respectively.	  
	   	  









Fig.	  5-­‐3	   	   Release	  of	  Ca2+	  ions	  from	  three	  types	  of	  cements	  in	  physiological	  saline	  (n=3).	  
	   	  









Fig.	   5-­‐4	   	   Histological	   observation	   of	   the	   Biopex®-­‐R	   and	   IP6-­‐HAp	   cement	   stained	   with	   TB.	   	  
Newly-­‐formed	   bones	   (N)	   were	   directly	   in	   contact	   with	   both	   the	   cement	   specimens	   (I).	   	   The	  
newly-­‐formed	  bones	  (N)	  shown	  in	  dark	  purple	  at	  4	  weeks	  gradually	  grew	  into	  mature	  bones	  shown	  
in	  light	  purple	  at	  24	  weeks.	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Fig.	   5-­‐5	   	   Histological	   observation	   of	   the	   IP6-­‐β-­‐TCP	   and	   IP6-­‐α-­‐TCP	   cements	   stained	  with	   TB	   and	  
TRAP:	  (A)	  IP6-­‐β-­‐TCP	  and	  (B)	  IP6-­‐α-­‐TCP	  cements.	   	   Upper	  and	  lower	  sections	  indicate	  TB	  and	  TRAP	  
stains,	   respectively.	   	   Newly-­‐formed	   bones	   (N)	   were	   present	   at	   point	   distant	   from	   the	   cement	  
specimens,	   and	  were	   not	   directly	   in	   contact	  with	   both	   the	   cement	   specimens	   (I).	   	   TRAP-­‐positive	  
osteoclasts	  (*)	  were	  present	  around	  the	  cement	  specimen.	  
	   	  
(B) 









Fig.	  5-­‐6	   	   Resorption	  rates	  of	  various	  CPCs.	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more	   than	  Biopex®-­‐R	   and	   IP6-­‐HAp	   cements;	   however,	  most	   of	   IP6-­‐β-­‐TCP	   and	   IP6-­‐α-­‐TCP	   cements	  





No	  change	  in	  crystallite	  phase	  of	  IP6	  surface-­‐modified	  powders	  and	  their	  cements	  was	  confirmed.	   	  
In	   contrast,	   the	  Biopex®-­‐R	  was	  composed	  of	  mainly	  α-­‐TCP	  phase	  containing	   slight	  amount	  of	  HAp	  
phase	   (25%).	   	   The	   Biopex®-­‐R	   cement	   is	   generally	   set	   by	   hydrolysis	   of	   α-­‐TCP;	   however,	   that	  was	  
barely	   hydrolyzed	   before	   implantation.	   	   It	   is	   considered	   that	   Biopex®-­‐R	   is	   gradually	   hydrolyzed	  
after	  implantation.	  
The	  release	  of	  Ca2+	  ions	  from	  the	  cements	  was	  in	  the	  order	  of	  IP6-­‐HAp,	  IP6-­‐β-­‐TCP	  and	  IP6-­‐α-­‐TCP	  
cements.	   	   Ducheyne	   et	   al.	   reported	   that	   dissolution	   of	   calcium-­‐	   phosphate	   powders	   in	   Tris-­‐HCl	  
buffer	   increased	   in	   the	   order	   of	   stoichiometric	   HAp,	   β-­‐TCP	   and	   α-­‐TCP	   [6],	   which	   are	   in	   good	  
consistent	   with	   our	   present	   results.	   	   Additionally,	   it	   was	   found	   that	   IP6	   surface	   modification	   of	  
calcium	  phosphates	  did	  not	  affect	  the	  order	  of	  their	  dissolution.	  
Histological	  studies	  of	  the	  Biopex®-­‐R	  and	  IP6-­‐HAp	  cements	  showed	  that	  the	  newly-­‐formed	  bones	  
(N)	  were	  directly	  in	  contact	  with	  both	  the	  IP6-­‐HAp	  and	  Biopex®-­‐R	  cement	  specimens	  (I)	  throughout	  
24	  weeks,	  without	  formation	  of	  fibrous	  tissue	  layers.	  
It	  is	  known	  that	  HAp	  bioceramics	  are	  osteoconductive,	  and	  are	  in	  direct	  contact	  with	  host	  bones	  
and	   newly-­‐formed	   bones	   [7].	   	   The	   present	   histological	   studies	   of	   the	   IP6-­‐HAp	   cements	   revealed	  
that	   the	   IP6-­‐HAp	   cement	   is	   also	   osteoconductive	   material	   and	   osteoconductivity	   of	   the	   IP6-­‐HAp	  
cement	  is	  comparable	  to	  that	  of	  Biopex®-­‐R.	  
Regarding	   the	   IP6-­‐β-­‐TCP	   and	   IP6-­‐α-­‐TCP	   cements,	   the	   newly-­‐formed	   bones	   increased	  
time-­‐dependently	   slightly	   apart	   from	   the	   cement	   specimens	   and	   grew	  mature	   at	   24	  weeks.	   	   The	  
TRAP	  positive	  osteoclasts	  were	  present	  around	  the	  cement	  specimens,	  and	  the	  cements	  remained	  to	  
be	  resorbed	  throughout	  all	   the	   implant	  periods.	   	   Both	  the	  TCP	  cements	  chemically	  resorbed	   from	  
the	  surface	  of	  cement	  specimen,	  and	  that	  was	  faster	  than	  formation	  of	  new	  bones.	   	   Therefore,	  the	  
newly-­‐formed	  bones	  were	  not	  directly	  in	  contact	  with	  both	  the	  cement.	  
The	  order	  of	   resorption	   rate	  of	   the	   cement	   in	   vivo	  was	   the	   same	  order	   in	  Ca2+	   release	   in	   vitro:	  
IP6-­‐α-­‐TCP	  >	  IP6-­‐β-­‐TCP	  >	  The	  IP6-­‐β-­‐TCP	  >	  Biopex®-­‐R	  >	  IP6-­‐HAp	  cements	  (Fig.	  5-­‐6).	   	   Yamada	  et	  al.	  
[8]	   conducted	   a	  histological	   and	  histomorphometrical	   study	  of	  porous	  β-­‐TCP	  and	  α-­‐TCP	  blocks	   as	  
bone	   graft	  materials	   for	   augmenting	   alveolar	   ridges.	   	   The	   α-­‐TCP	   block	   notably	   started	   degrading	  
after	   4	   weeks,	   whereas	   degradation	   of	   β-­‐TCP	   blocks	   had	   just	   begun	   at	   that	   time	   and	   scarcely	  
progressed	   after	   8	   weeks.	   	   These	   results	   suggest	   that	   resorption	   of	   α-­‐TCP	   is	   faster	   than	   that	   of	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β-­‐TCP,	  which	  is	  consistent	  with	  the	  present	  results	  (Fig.	  5-­‐6).	  
However,	  most	  of	  IP6-­‐β-­‐TCP	  and	  IP6-­‐α-­‐TCP	  cements	  remained	  even	  after	  24	  weeks	  implantation.	   	  
Oonishi	   et	   al.	   reported	   that	   β-­‐TCP	   and	   α-­‐TCP	   granules	   with	   300	   μm	   in	   diameter	   were	   mostly	  
resorbed	  after	  12	  weeks	   implantation	  [9].	   	   The	  IP6-­‐β-­‐TCP	  and	  IP6-­‐α-­‐TCP	  cements	  were	  relatively	  
dense	   (about	   60%	   of	   relative	   density)	   and	   no	   interconnected	   pores.	   	   Consequently,	   both	   the	  
cements	  could	  be	  resorbed	  chemically	  and	  biologically	  only	  from	  the	  surface	  of	  the	  cement.	   	   Thus,	  





Biocompatibility	   and	   biodegradability	   of	   the	   chelate-­‐setting	   CPCs	   and	   Biopex®-­‐R	   were	  
histologically	   evaluated	   in	   vivo	   using	   rabbit	   model	   for	   4,	   8,	   and	   24	   weeks,	   in	   addition	   to	   their	  
dissolution	   in	  vitro.	   	   The	  newly-­‐formed	  bones	  were	  directly	   in	  contact	  with	  both	  the	  IP6-­‐HAp	  and	  
Biopex®-­‐R	  cements.	   	   As	   for	  the	  IP6-­‐β-­‐TCP	  and	  IP6-­‐α-­‐TCP	  cements,	  newly-­‐formed	  bones	   increased	  
time-­‐dependently	   slightly	   apart	   from	   the	   cement	   specimens.	   	   The	   resorption	   rate	   for	   Biopex®-­‐R,	  
IP6-­‐HAp,	  IP6-­‐β-­‐TCP,	  and	  IP6-­‐α-­‐TCP	  cements	  after	  24	  weeks	  implantation	  were	  of	  7.2,	  5.0,	  13.7,	  and	  
16.2%,	  respectively,	  compared	  to	  original	  cements,	  which	  were	  of	  same	  order	  in	  dissolution	  in	  vitro.	   	  
The	  present	  chelate-­‐setting	  cements	  with	  different	  biodegradability	  are	  promising	  candidates	  for	  a	  
tailor-­‐made	  treatment	  as	  the	  novel	  CPCs.	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The	   improvement	   in	   the	   quality	   of	   life	   (QOL)	   and	   consequent	   increase	   of	   life	   expectancy	   are	  
accompanied	  by	  the	  expanding	  demand	  for	  the	  repair	  of	  damaged	  organs	  and	  tissues.	   	   Bone	  tissue	  
regeneration	  remains	  an	  important	  challenge	  in	  the	  field	  of	  orthopedic,	  maxillofacial,	  dental	  surgery.	   	  
For	   most	   of	   these	   surgeries,	   there	   is	   a	   great	   need	   for	   grafting	   materials.	   	   In	   general,	   grafting	  
materials	   can	   be	   divided	   into	   the	   categories	   of	   natural	   bone	   grafts	   (autograft,	   allograft,	   and	  
xenograft)	  and	  synthetic	  bone	  grafts	  (metals,	  ceramics,	  polymers,	  and	  composites).	   	   Because	  of	  the	  
disadvantages	  of	  natural	  bone	  grafts	  such	  as	  additional	  invasive	  surgical	  procedure	  which	  may	  lead	  
to	  post-­‐operative	  pain,	  and	  infection,	  there	  is	  a	  great	  need	  for	  further	  development	  of	  synthetic	  bone	  
grafts	  that	  are	  widely	  available	  and	  can	  easily	  be	  tailored	  depending	  on	  the	  intended	  application.	  
Synthetic	   hydroxyapatite	   (HAp),	   β-­‐tricalcium	   phosphate	   (β-­‐TCP),	   and	   α-­‐tricalcium	   phosphate	  
(α-­‐TCP)	   are	   key	  materials	   due	   to	   their	   potential	   biocompatibility	   and	   osteoconductivity.	   	   Among	  
synthetic	  calcium-­‐phosphate	  biomaterials,	  calcium-­‐	  phosphate	  cement	  (CPC)	  has	  largely	  advantages,	  
which	  can	  be	  easily	  shaped	  during	  operation	  or	  injected	  into	  cavities	  using	  a	  syringe	  with	  minimal	  
invasiveness.	  
In	   contrast,	   the	   order	   in	   relative	   dissolution	   of	   these	  materials	   is	   α-­‐TCP	   >	   β-­‐TCP	   >	  HAp.	   	   It	   is	  
hypothesized	   that	   CPCs	   with	   different	   biodegradability	   are	   promising	   candidates	   for	   tailor-­‐made	  
treatment	  according	  to	  bone	  metabolism	  of	  patients.	  
Therefore,	  the	  present	  study	  aimed	  to	  fabricate	  novel	  CPCs	  with	  different	  biodegradability	  using	  
various	   calcium-­‐phosphate	   phases	   (HAp,	   β-­‐TCP	   and	   α-­‐TCP)	   and	   chelate-­‐setting	   mechanism	   of	  
inositol	   phosphate	   (IP6).	   	   Moreover,	   dissolution	   of	   resulting	   cements	   in	   vitro	   using	   Ca2+	  
ion-­‐selective	   potentiometry	   and	   biodegradability	   of	   resulting	   cements	   in	   vivo	   using	   rabbit	  models	  
were	  also	  examined.	  
	  
In	  Chapter	  1,	  general	  information	  of	  calcium	  phosphates,	  inositol	  phosphate,	  calcium-­‐	  phosphate	  
cements,	  aim	  of	  the	  present	  study	  were	  described	  to	  gain	  better	  understandings	  of	  this	  thesis.	  
	  
In	  Chapter	  2,	   it	  was	  described	  to	  investigate	  various	  types	  of	  powder	  preparation	  processes	  for	  
cement	  fabrication	  to	  improve	  mechanical	  strength,	  and	  handling	  and	  anti-­‐washout	  properties	  of	  the	  
chelate-­‐setting	  HAp	  (IP6-­‐HAp)	  cement.	  
In	  section	  2.1,	  using	  wet	  chemical	  synthesized	  HAp,	  the	  effect	  of	  powder	  preparation	  process	  for	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cement	  fabrication	  on	  the	  morphology,	  crystallinity,	  median	  particle	  size,	  and	  specific	  surface	  area	  of	  
the	   cement	   powders	   was	   examined	   to	   fabricate	   the	   IP6-­‐HAp	   cement	   with	   enhanced	   mechanical	  
properties.	   	   The	  smallest	  crystallite	  and	  median	  particle	  sizes,	  and	  the	  highest	  specific	  surface	  area	  
were	   obtained	   from	   ball-­‐milling	   of	   as-­‐synthesized	   HAp	   powder	   under	   wet	   conditions	   and	   then	  
freeze-­‐drying.	   	   The	  IP6-­‐HAp	  cement	  fabricated	  with	  this	  powder	  led	  to	  the	  better	  compaction	  of	  the	  
cement	   particles;	   consequently,	   had	   a	  maximum	   compressive	   strength	   of	   23.1±2.1	  MPa.	   	   In	   vitro	  
cell-­‐culture	   test	   on	   the	   cement	   showed	   excellent	   cell	   proliferation.	   	   In	   vivo	   histological	   studies	  
revealed	   that	   the	   IP6-­‐HAp	   cements	   were	   directly	   in	   contact	   with	   newly	   formed	   and	   host	   bones.	   	  
Thus,	   the	  starting	  cement	  powder	  obtained	  from	  ball-­‐milling	  of	  as-­‐synthesized	  HAp	  powder	  under	  
wet	  conditions	  and	  then	   freeze-­‐drying	   is	  effective	   for	   fabrication	  of	   IP6-­‐HAp	  cement	  with	  enhance	  
material	  properties.	  
In	  section	  2.2,	  a	  novel	  powder	  preparation	  process	  (hereafter,	  modified	  process)	  for	  the	  cement	  
fabrication	   was	   established,	   whereas,	   previous	   report	   demonstrated	   preparation	   of	   the	   starting	  
cement	   powder	   for	   the	   cement	   fabrication	   by	   IP6	   surface	  modification	   after	   ball-­‐milling	   the	   HAp	  
powder	   (hereafter,	   conventional	   process).	   	   In	   the	   novel	   developed	  modified	   process,	   the	   starting	  
HAp	   powders	   were	   prepared	   by	   ball-­‐milling	   and	   simultaneously	   surface-­‐modifying	   the	  
commercially-­‐available	   HAp	   powders	   in	   the	   IP6	   solution.	   	   Afterward,	   the	   effect	   of	   the	   IP6	  
concentration	   on	   the	   material	   properties,	   such	   as	   compressive	   strength,	   setting	   time,	   handling	  
property	   (consistency),	   and	   anti-­‐washout	   property,	   of	   the	   IP6-­‐HAp	   cement	  was	   investigated,	  with	  
the	  aim	  to	  develop	  a	  paste-­‐like	  artificial	  bone	  with	  anti-­‐washout	  property.	   	   The	  adsorbed	  amount	  of	  
IP6	   on	   the	   surface	   of	   the	   HAp	   powders	   increased	   with	   the	   IP6	   concentration	   and	   resulted	   in	   a	  
negative	   charge	   on	   the	   powder	   surface.	   	   A	   workable	   cement	   paste	   was	   prepared	   from	   the	  
negatively	  charged	  IP6-­‐HAp	  powder	  (<	  −20	  mV)	  at	  a	  higher	  powder/liquid	  ratio,	  regardless	  of	   the	  
low	  water	   content.	   	   The	   compressive	   strength	   of	   the	   resulting	   cement	   specimens	   increased	   from	  
1.4	  MPa	  to	  8.3	  MPa	  with	  the	  relative	  density.	   	   Therefore,	   the	  HAp	  powders	  surface-­‐modified	  with	  
5000	   to	   10000	   ppm	   IP6	   at	   the	  modified	   process	   are	   effective	   for	   fabrication	   of	   IP6-­‐HAp	   cements	  
with	  enhanced	  mechanical,	  handling,	  anti-­‐washout	  properties.	  
Section	  2.3	  describes	  comparison	  of	  powder	  preparation	  process	  between	  the	  conventional	  and	  
modified	   processes	   using	   commercially-­‐available	   HAp	   powder,	   in	   addition	   to	   investigation	   on	  
adsorption	  behavior	  of	   IP6	  on	   the	   surface	  of	  HAp	   to	   clarify	   the	   chelating	  mechanism	  of	   IP6.	   	   The	  
adsorption	  efficiency	  of	  IP6	  at	  the	  modified	  process	  was	  lower	  than	  that	  at	  the	  conventional	  process;	  
however,	  the	  degree	  in	  dispersion	  of	  the	  HAp	  particles	  at	  the	  modified	  process	  was	  higher	  than	  that	  
at	   conventional	   process.	   	   The	   X-­‐ray	   photoelectron	   spectroscopic	   study	   revealed	   that	   the	   IP6	  
adsorbed	   on	   the	   surface	   of	   HAp	   powders.	   	   The	   modified	   process	   is	   effective	   for	   preparation	   of	  
highly-­‐dispersed	  HAp	  powders.	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The	   main	   conclusion	   from	   the	   studies	   described	   in	   Chapter	   2	   was	   that	   highly-­‐dispersed	   HAp	  
powders	   can	   prepare	   by	   the	   modified	   process,	   which	   enable	   better	   compaction	   of	   the	   cement;	  
consequently,	  could	  fabricate	  the	  paste-­‐like	  IP6-­‐HAp	  cement	  with	  anti-­‐washout	  property.	  
	  
Chapter	   3	   showed	   that	   improvements	   in	  mechanical,	   handling,	   anti-­‐washout	   properties	   of	   the	  
chelate-­‐setting	  β-­‐TCP	  (IP6-­‐β-­‐TCP)	  cements	  for	  clinical	  use.	  
Section	   3.1	   investigated	   effect	   of	   addition	   of	   various	   polysaccharides	   such	   as	   sodium	   alginate,	  
sodium	   dextran	   sulfate,	   sodium	   chondroitin	   sulfate,	   and	   chitosan	   into	   mixing	   solution	   on	   the	  
mechanical	  and	  handling	  properties	  of	  IP6-­‐β-­‐TCP	  cements.	   	   When	  mixing	  solutions	  containing	  the	  
above	  additives	  were	  used,	  the	  handling	  property	  of	  all	  the	  cement	  pastes	  was	  improved	  compared	  
with	   the	   case	   of	   pure	   water	   without	   polysaccharide.	   	   In	   particular,	   the	   cement	   with	   the	   highest	  
compressive	  strength	  (17.4	  MPa)	  was	  obtained	  using	  chitosan,	  which	  suggests	   that	   the	  addition	  of	  
chitosan	   into	   the	   mixing	   solution	   is	   promising	   for	   the	   fabrication	   of	   IP6-­‐β-­‐TCP	   cement	   with	  
enhanced	  handling	  and	  mechanical	  properties.	  
In	   section	   3.2,	   the	   novel	   powder	   preparation	   process,	   described	   in	   Chapter	   2,	   was	   applied	   to	  
fabrication	  of	  the	  IP6-­‐β-­‐TCP	  cement	  to	  investigate	  the	  effect	  of	  milling	  time	  and	  IP6	  concentration	  on	  
the	   material	   properties,	   in	   particular,	   anti-­‐washout	   property	   of	   the	   resulting	   cement.	   	   The	  
IP6-­‐β-­‐TCP	   cement	   with	   anti-­‐washout	   property	   was	   successfully	   fabricated	   by	   mixing	   the	   β-­‐TCP	  
powder	   ball-­‐milled	   in	   3000	   ppm	   IP6	   solution	   for	   3	   h	   and	   2.5	   mass%	   Na2HPO4	   solution,	   and	  
compressive	   strength	  of	   the	   cement	  was	  13.4±0.8	  MPa.	   	   An	   in	   vivo	   study	   revealed	   that	   the	  above	  
cement	  was	  directly	  in	  contact	  with	  host	  and	  newly	  formed	  bones	  without	  fibrous	  tissue	  layers,	  and	  
was	  resorbed	  by	  osteoclast-­‐like	  cells	  on	  the	  surface	  of	  the	  cement.	  
In	  conclusion	  from	  the	  studies	  described	  in	  Chapter	  3,	  the	  β-­‐TCP	  powder	  prepared	  by	  modified	  
process	   is	   effective	   for	   fabrication	   of	   anti-­‐washout	   type	   IP6-­‐β-­‐TCP	   cement	   with	   both	  
biodegradability	  and	  osteoconductivity.	   	   Furthermore,	  this	  IP6-­‐β-­‐TCP	  powder	  in	  combination	  with	  
various	  polysaccharides	  would	  create	  cements	  with	  much	  better	  material	  properties	   than	   those	   in	  
section	  3.2.	  
	  
In	  Chapter	  4,	  the	  chelate-­‐setting	  α-­‐TCP	  (IP6-­‐α-­‐TCP)	  cement	  based	  on	  chelate-­‐setting	  mechanism	  
of	   IP6	   was	   fabricated	   using	   more	   soluble	   α-­‐TCP	   powder	   compared	   with	   β-­‐TCP	   powder.	   	   The	  
single-­‐phase	  α-­‐TCP	  powder	  for	  cement	  fabrication	  was	  obtained	  by	  ball-­‐milling	  α-­‐TCP	  in	  water	  for	  
120	  min.	   	   The	  resulting	  cement	  was	  composed	  of	  mainly	  single-­‐phase	  α-­‐TCP,	  and	  the	  compressive	  
strength	   of	   the	   cement	   was	   8.5±1.1	   MPa.	   	   In	   vivo	   studies	   clarified	   that	   the	   newly-­‐formed	   bones	  
increased	  time-­‐dependently	  slightly	  apart	  from	  the	  cement	  specimens	  and	  grew	  mature	  at	  24	  weeks,	  
and	  the	  surface	  of	  the	  cement	  was	  resorbed	  by	  tartrate-­‐resistant	  acid	  phosphatase	  (TRAP)	  positive	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osteoclast-­‐like	   cells	   throughout	   24	   weeks.	   	   The	   biodegradable	   and	   osteoconductive	   IP6-­‐α-­‐TCP	  
cement	   is	   expected	   to	   apply	   as	   a	   novel	   paste-­‐like	   artificial	   bone	   by	   improvement	   of	   material	  
properties.	  
	  
In	   Chapter	   5,	   biocompatibility	   and	   biodegradability	   of	   the	   various	   chelate-­‐setting	   cements	  
(IP6-­‐HAp,	   IP6-­‐β-­‐TCP	   and	   IP6-­‐α-­‐TCP)	   and	   commercially-­‐available	   cement	   (Biopex®-­‐R)	   were	  
histologically	   evaluated	   in	   vivo	   using	   rabbit	   models	   for	   4,	   8,	   and	   24	   weeks,	   in	   addition	   to	   their	  
dissolution	  of	   these	   cements	   in	   vitro.	   	   The	  dissolution	  of	   these	   cements	   increased	   in	   the	  order	  of	  
IP6-­‐HAp,	   IP6-­‐β-­‐TCP	   and	   IP6-­‐α-­‐TCP	   cements.	   	   Histological	   studies	   clarified	   that	   the	   newly-­‐formed	  
bones	  were	  directly	  in	  contact	  with	  both	  the	  IP6-­‐HAp	  and	  Biopex®-­‐R	  cement	  specimens.	   	   As	  for	  the	  
IP6-­‐β-­‐TCP	   and	   IP6-­‐α-­‐TCP	   cements,	   newly-­‐formed	   bones	   were	   formed	   time-­‐dependently	   slightly	  
apart	   from	   the	   cement	   specimens.	   	   Resorption	   rate	   for	   Biopex®-­‐R,	   IP6-­‐HAp,	   IP6-­‐β-­‐TCP,	   and	  
IP6-­‐α-­‐TCP	   cements	   after	   24	   weeks	   implantation	   were	   of	   7.2,	   5.0,	   13.7,	   and	   16.2%,	   respectively,	  
compared	   to	   original	   cements.	   	   Three	   types	   of	   chelate-­‐setting	   cements	   with	   different	  
biodegradability	  are	  promising	  candidates	  for	  a	  “tailor-­‐made	  treatment”	  as	  the	  novel	  CPCs.	  
	  
In	   conclusion	   described	   in	   the	   present	   thesis,	   three	   types	   of	   novel	   chelate-­‐setting	   cements	  
(IP6-­‐HAp,	   IP6-­‐β-­‐TCP	   and	   IP6-­‐α-­‐TCP)	   with	   different	   biodegradability	   could	   fabricate	   using	  
chelate-­‐setting	   mechanism	   of	   IP6.	   	   These	   cements	   have	   the	   potency	   of	   application	   for	   a	  




6.2	  Future	  developments	  
	  
Based	  on	   the	   research	   conducted	  and	   the	   results	   of	   this	   study,	   several	   aspects	  of	   future	  work	  are	  
recommended	  as	  follows:	  
	  
(1) Investigation	  on	  non-­‐fragmentation	  of	  the	  cement	  
	  
The	   CPC	   is	   less	   resistant	   to	   washout	   by	   blood	   during	   setting	   than	   polymethyl-­‐	   methacrylate	  
(PMMA)	  cement.	   	   Furthermore,	   “fragmentation”	  which	  means	   that	  because	  of	  brittleness	  of	  CPCs,	  
they	  fragment	  in	  the	  body	  by	  successive	  loads	  after	  setting	  of	  the	  CPCs,	  is	  seen	  as	  a	  problem.	   	   Some	  
research	  on	  the	  fragmentation	  after	  kyphoplasty	  and	  vertebroplasty	  has	  been	  previously	  reported;	  
however,	  a	  proper	  evaluation	  method	  to	  assess	  the	  fragmentation	  of	  CPCs	  is	  not	  established.	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Thus,	  it	  is	  urgent	  to	  establish	  an	  evaluation	  method	  on	  the	  fragmentation	  in	  CPCs	  and	  investigate	  
whether	  the	  fragmentation	  occur	  in	  present	  chelate-­‐setting	  CPCs	  or	  not.	  
	  
(2) Addition	  of	  antibacterial	  property	  to	  the	  cement	  
	  
Synthetic	  calcium-­‐phosphate	  bone	  grafts	  are	  known	  to	  be	  vulnerable	  to	  bacterial	  infection;	  thus,	  
calcium	  phosphate	  bioceramics	  containing	  antibacterial	  metal,	   such	  as	  silver,	  zinc,	  or	  cupper,	  have	  
been	   investigated.	   	   In	  particular,	  silver	  exhibits	  a	  broad	  spectrum	  of	  antibacterial	  activity	  and	  has	  
therefore	   received	   much	   attention.	   	   Addition	   of	   antibacterial	   property	   to	   the	   present	  
chelate-­‐setting	  CPCs	  is	  one	  of	  the	  next	  strategies.	  
	  
(3) Improvement	  of	  biological	  performance	  
	  
Future	  research	  also	  should	  focus	  on	  improving	  biological	  performance	  of	  synthetic	  bone	  grafts	  
including	   chelate-­‐setting	   cement,	  which	   is	   still	   inferior	   to	   that	   of	   autograftsat	   the	  moment.	   	   Fully	  
synthetic	   “intelligent”	  biomaterials	   should	  be	   able	   to	  perform	  at	   least	   as	   good	  as	   autologous	  bone	  
graft.	   	   A	   group	   of	   potentially	   “intelligent”	   biomaterials	   is	   osteoinductive	   biomaterials.	   	  
Osteoinductivity	  can	  be	  defined	  as	   the	   induction	  of	  bone	   formation	  at	  ectopic	  sites	  such	  as	  muscle	  
and	  subcutaneous	  tissues.	   	   It	  has	  been	  known	  for	  a	   long	  time	  that	  certain	  growth	   factors,	  such	  as	  
bone	  morphogenetic	  proteins	  (BMP)	  is	  able	  to	  induce	  ectopic	  bone	  formation.	   	   Recent	  research	  has	  
shown	  that	  some	  synthetic	  biomaterials,	  which	  initially	  do	  not	  contain	  BMP,	  also	  possess	  the	  ability	  
to	   induce	   ectopic	   bone	   growth.	   	   Osteoinductive	   biomaterials	   are	   better	   for	   bone	   grafts	   than	   the	  
non-­‐osteoinductive	  biomaterials.	  
Biological	  apatite	  presented	  in	  bone	  and	  teeth	  of	  mammals	  contains	  trace	  element	  such	  as	  Na+,	  K+,	  
Mg2+,	  F-­‐,	  and	  CO32-­‐.	   	   In	  contrast,	  trace	  ions	  substituted	  in	  apatite,	  such	  as	  Zn2+,	  Sr2+,	  Cu2+	  and	  SiO44-­‐	  
also	   improve	   biological	   performance	   of	   synthetic	   bone	   grafts.	   	   Fabrication	   of	   the	   chelate-­‐setting	  
CPCs	   from	   calcium-­‐phosphate	   powders	   containing	   trace	   element(s)	   may	   be	   effective	   to	   improve	  
biological	  performance	  of	  the	  CPCs.	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